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ABSTRACT 
This dissertation focuses on the method development of C-H functionalization using photo-
redox catalysis and the synthesis of new thioglycoside donors towards O-glycosylation. Chapter 1 
describes the remote Csp3-H functionalization using photo-redox catalysis. The site-selective and 
high-yielding conversion of unreactive aliphatic C-H bonds has been a challenge for organic 
chemists for many years. In this work, inert C-H bonds were successfully converted to more useful 
C-C, C-N, and C-O bonds via hydrogen atom transfer (HAT), radical translocation and polar 
crossover. This mechanistic manifold was enacted by visible-light irradiation of o-diazoniaphenyl 
alkyl sulfones in the presence of Ru(bpy)3Cl2. Remote hydroxylation, etherification, amidation, 
and C-C bond formation were all successfully achieved via this transformation.  
Chapter 2 provides an overview of sugar chemistry and a mild, acid-catalyzed O-
glycosylation method with thioglycoside has been developed. Chemical synthesis of 
oligosaccharide has become a vital alternative way to acquire adequate quantity of pure product to 
study the function because of the microheterogeneity. Therefore, new glycosyl donors and 
glycosylation methods have been developed throughout these years. Herein, a newly-developed 4-
(4-methoxyphenyl)-3-butenyl thioglycoside (MBTG) has been used to achieve O-glycosylation 
using mild, acid-catalyzed conditions. A number of conditions have been applied to demonstrate 
the compatibility of the MBTG thioglycoside side chain. Most importantly, a latent-active strategy 
for multistep synthesis of oligosaccharides has been developed.  
Chapter 3 details a new class of thioglycoside development towards O-glycosylation. 
Thioglycosides are often used in oligosaccharide synthesis. Harsh reaction conditions would be 
applied to activate common thioglycosides due to their high stability. The development of a stable 
and easily-activated thioglycoside has become an urgent mission for chemists to prosper the 
carbohydrate community. In this research, I developed a new class of thioglycosides called 4-(4- 
 xiv 
methoxyphenyl)-4-pentenyl thioglycoside (MPTG), which has been proven much more effective 
than MBTGs with respect to yield and reaction with acceptors that are sterically and electronically 
deactivated. 
Chapter 4 centers upon the method development involving synthesis of a core 
pentasaccharide from an Acinetobacter baumannii lipooligosaccharide. Acinetobacter baumannii, 
which is a gram-negative coccobacillus, is a pathogenic bacterium to people with poor immune 
system. The pentasaccharide synthesized here is widely conserved in Acinetobacter baumannii 
and is a potential vaccine target. Total synthetic efforts are underway in the lab. 
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CHAPTER 1: VISIBLE-LIGHT-PROMOTED REMOTE C-H FUNCTIONALIZATION 
OF O-DIAZONIAPHENYL ALKYL SULFONES 
1.1       Introduction 
C-H bonds are the most abundant bonds in nature. Due to the high bond dissociation energy, 
sp3 hybridized C-H bonds are hard to break and functionalize. Therefore, seeking more efficient 
ways to convert C-H bonds to more useful C-C, C-N, and C-O bonds is of great importance. As 
such, direct C-H functionalization has become one of the most straightforward and valuable 
methods for the synthesis of value-added compounds, which is also the requirement of sustainable 
and economic chemistry.1 
The research on functionalization of C-H bonds has been the subject of great interest during 
the past two decades.2-6 The strategies often fall into two categories: directed and non-directed.7, 8 
Non-directed C-H functionalization depends on the innate reactivity of the C-H bonds. Directed 
C-H functionalization often needs the assistance of metals resulting in the formation of active 
organometallics. This strategy doesn’t require the prior activation of C-H bonds. Another approach 
to directed C-H functionalization is to produce a radical upon thermal, chemical, or photochemical 
activation. This radical can further abstract hydrogen from a remote C-H position in the same 
molecule (often referred as a radical translocation event).9  
Despite the recent advances in remote C-H functionalization,10 seeking milder conditions 
still remains a goal for synthetic chemists. Instead of using high-energy, unsafe ultraviolet light or 
large amounts of corrosive reagents, visible-light photo-redox catalysis provides an alternate route 
to solve those problems. In the past few decades, visible-light photo-redox catalysis has become 
more prosperous due to the mild conditions used for substrate activation.11 Direct C-H bond 
*This chapter was previously published as Shaofu Du, Elizabeth Ann Kimball, Justin R. 
Ragains, “Visible-Light-Promoted Remote C-H Functionalization of o-Diazoniaphenyl Alkyl 
Sulfones,” Org. Lett. 19 (2017): 5553-5556. Reprinted by permission of American Chemical 
Society.  
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replacements with alkyl,12 vinyl,13 CF3,14 and aryl groups15 have been achieved by using visible-
light irradiation in the presence of photocatalysts (Figure 1).  
The single-electron transfer (SET) processes that excited state photocatalysts undergo with 
organic molecules gives facile access to radical and radical ionic intermediates. Also, the electronic 
tunability of ligands coordinated to metal centers means that some photocatalysts can act as both 
oxidants and reductants depending on the nature of the quenching species that are present. For 
example, the commonly used photocatalyst fac-Ir(ppy)3 was excited from ground singlet state to 
excited triplet state via blue LED irradiation (λmax = 455 nm). After excitation, the photocatalyst 
fac-Ir(ppy)3* can either reduce an electron acceptor to generate [fac-Ir(ppy)3]+ (E1/2(Ir+/Ir*) = -
1.73 V vs saturated calomel electrode (SCE)), which then oxidizes the electron donor to close the 
fac-Ir(ppy)3                   Ir(dtbbpy)(ppy)2PF6                 Ru(bpy)3Cl2                        Eosin Y 
Figure 1.1 Commonly-used Photo-redox Catalysts 
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oxidative quenching cycle (E1/2(Ir+/Ir) = +0.77 V vs SCE), or oxidize the electron donor forming 
[fac-Ir(ppy)3]- (E1/2(Ir*/Ir-) = +0.31 V vs SCE), followed by oxidation to close the reductive 
quenching cycle (E1/2(Ir/Ir-) = -2.19 V vs SCE), (Figure 1.2). This dual photo-redox catalysis 
capability provides new mechanistic pathways for reaction design.16       
1.2     Representative Examples of Radical Translocation 
          The first known radical translocation was discovered in the late 1800s by Hofmann, Lӧffler, 
and Freytag, and further explored in the early 1900s. However, the mechanism was not 
understood.17 In 1950, Wawzonek and Thelen proposed the mechanism (Figure 1.3), which was 
finally confirmed by the work of Corey and Hertler in the 1960s.18 For example, one reaction 
began with N-chloro-N-methylcyclooctylamine 1a, which was protonated by sulfuric acid, 
followed by ultraviolet irradiation in the presence of chlorine. The resulting secondary nitrogen 
centered radical cation 1c abstracted a hydrogen from a carbon 5 (Figure 1.3) and generated a 
secondary carbon-centered radical intermediate 1d, which started a chain reaction to form the 
amine salt 1e, followed by the deprotonation with base to obtain the free amine 1f, which 
underwent an intramolecular SN2 attack, followed by deprotonation, to acquire the final product 
N-methylgranatanine 1h.  
N
Cl
1). H2SO4, hυ, Cl2                       
2). NaOH solution N
H
N
Cl H
uv irridiation
Cl
N H
H
1,6-hydrogen 
translocation
N H
H
NH
Cl
N H
H
Cl
OH
N H
Cl
Intramolecular
SN2 attack N
H
OH
1a 1h
1g1f1e1d1c1b
1
5
Figure 1.3 Predicted Mechanism for Hoffmann-Lӧffler-Freytag Reaction 
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In the 1970s, Breslow and co-workers employed a guided radical translocation reaction 
which they referred to as remote oxidation.19 Under irradiation with ultraviolet light, the 
benzophenone was excited and the carbonyl oxygen of the excited benzophenone abstracted the 
axial hydrogen on carbon 14 to generate the diradical intermediate, which further transferred the 
hydrogen on carbon 15 to the benzhydryl radical to complete the process (Figure 1.4). This ground-
breaking efficient oxidation of inactivated alkanes has led to more interest in remote 
functionalization reactions. 
More recently, a guided remote desaturation of aliphatic carbon chains was developed by 
Baran and co-workers.20 A special ‘portable desaturase’, TzoCl (Scheme 1.1), was used in this 
transformation (Figure 1.5). Ortho to sulfonyl is a N, N-diethyl triazene 1n, which was treated with 
O
H
C14
O
O
hυ, PhH (0.001 M)
55% OH
O
OO
O
O
H
H
1m1k1j
OH
NH2
TzoCl, DMAP, DCM X
S
O O
N
N
Et2N
Tzo groupX = O, NH
Scheme 1.1 Installation of Tzo Functionality 
Figure 1.5 Proposed Mechanism for the Desaturation Reaction 
Figure 1.4 Breslow’s Photochemical Transfer Hydroenation 
SO2
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acid to produce an aryl diazonium salt 1o, followed by reduction with 2,2,6,6-tetramethyl-1-
piperidinyloxy radical (TEMPO) to generate the aryl radical 1p with the loss of N2 and 
concomitant oxidation to TEMPO+. Once generated, the aryl radical underwent an unusual 1,7-
hydrogen-atom translocation (HAT) to generate a more stable tertiary radical intermediate 1q, 
which is oxidized by TEMPO+ to generate the corresponding carbocation intermediate 1r. This 
process also regenerated TEMPO. At the same time, the elimination led to the alkene product 1s. 
Though low yields were obtained, this transformation provides an alternative pathway to explore 
remote C-H functionalization.  
 Recently, the Ragains group has developed a remote hydroxylation method proceeding via 
radical translocation and polar crossover.21 This remote hydroxylation used the photo-redox 
catalyst fac-Ir(ppy)3 to achieve a single-electron transfer (SET) process (Figure 1.6). This reaction 
involved radical translocation, oxidation to carbocation, and nucleophilic trapping to provide 
various functional groups at the unreactive C-H position. However, when sulfonate ester was 
applied to standard conditions without photocatalyst, substantial amounts of alcohol and 
diazonium salt were generated, which suggested the potential decomposition risk of this substrate 
under acidic conditions. 
Figure 1.6 Hypothesis for Remote Hydroxylation 
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1.3       Results and Discussion 
Inspired by our original work with sulfonate esters and sulfonamides, we wondered if 
triazene-containing sulfones would give us similar results. In this way, we could eliminate the 
potential hydrolysis problem of the sulfonate ester/sulfonamide intermediates, increase product 
yield, and enable further manipulation of the sulfone. En route to our goal of mild conditions, 
remote C-H functionalization reactions were performed under visible-light irradiation. To begin 
with, we selected 3-phenyl-1-propanol as our model substrate. In order to synthesize the sulfonyl 
triazene compound 1.1a”, the hydroxy group in 3-phenylpropanol was replaced by iodine using 
triphenylphosphine and iodine with imidazole in dichloromethane. Once the iodide compound was 
obtained, displacement with 2-aminobenzenethiol generated 2-((3-phenylpropyl)thio)aniline 1.1a, 
which further reacted with HNO2 to generate the diazonium salt followed by nucleophilic trapping 
with diethylamine to give (E)-3,3-diethyl-1-(2-((3-phenylpropyl)thiophenyl)triaz-1-ene 1.1a’. 
Then 1.1a’ was oxidized with Oxone to give the final sulfonyltriazene compound (E)-3,3-diethyl-
1-(2-((3-phenylpropyl)sulfonyl)phenyl)triaz-1-ene 1.1a” (Scheme 1.2).  
With the sulfonyltriazene 1.1a” in hand, reaction conditions were screened.  To begin from 
our previous work, conditions were screened. We began our investigation using 1.1a” as a model 
substrate together with 10 mol% fac-Ir(ppy)3 and 48% tetrafluoroboric acid. We obtained 30% 
hydroxylation product. Later on, I screened additional reaction conditions which are summarized 
in Table 1.1. The yield increased with larger quantities of acid (entry 2). When triflic acid was 
OH 1). PPh3, I2, imidazole, DCM S Ph
NH22). DBU, DCM, 2-aminobenzenethiol   70%
1.1a
1). NaNO2, conc. HCl
2). Et2NH, KOH (1M)
68%
Oxone (4 equiv.)
MeOH, H2O
76%
S Ph
N
1.1a”
N
NEt2
O O
S Ph
N
1.1a’
N
NEt2
Scheme 1.2 Synthetic Route to Sulfonyltriazene 1.1c 
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used, the yield increased (entry 3). The temperature dependency of the same reaction conditions 
as entry 3 were studied (entries 4,5), and we found that the reaction proceeded best at room 
temperature. When we turned off the light, the reaction could still occur resulting in 17% yield 
(entry 6). Lowering the amount of catalyst (entry 7) or changing to the more weakly-reducing 
Table 1.1 Attempted Optimization of the Reaction Conditions 
 
entry                           catalyst/ mol%                             acid/ equiv.                            Yield (%)d 
1                               fac-Ir(ppy)3/ 10                           48% HBF4/ 2 30 
2                              fac-Ir(ppy)3/ 10                            48% HBF4/ 10 45                                      
3                               fac-Ir(ppy)3/ 10                            triflic acid/ 2 47 
4a                             fac-Ir(ppy)3/ 10                             triflic acid/ 2  31 
5b                             fac-Ir(ppy)3/ 10                             triflic acid/ 2  25 
6c                             fac-Ir(ppy)3/ 10                             triflic acid/ 2  17 
7                              fac-Ir(ppy)3/ 1                             triflic acid/ 2  23 
8                       Ir(dtbbpy)(ppy)2 PF6/ 5                 triflic acid/ 2   13 
aReaction performed at 50 oC for 69 hours. bReaction performed at 0 oC for 36 hours. cReaction 
performed without light. dIsolated yields.            
 
catalyst Ir(dtbbpy)(ppy)2PF6 (entry 8) decreased the yield. Based on the screening, we chose entry 
2 as our standard reaction conditions. When these conditions were applied to (E)-3,3-diethyl-1-(2-
(isopentylsulfonyl)phenyl)triaz-1-ene 1.2a”, the undesired diazene compound 1.2’, which resulted 
from the attack of the generated tertiary radical on diazonium ion, was isolated. After 21 hours of 
S Ph
N
N N
O O
Catalyst (mol%), Acid 
CH3NO2 : H2O = 10ml : 2ml
Blue LEDs, 21h
S Ph
O O
OH
1.1a” 1.1
 8 
irradiation, the starting 1.2a” was not fully consumed. Further reactions proved sluggish and low-
yielding compared with sulfonate esters or sulfonamides (Scheme 1.3). 
Based on our previously proposed mechanism, we wondered if the direct use of diazonium 
salts would be more beneficial. Though the diazonium salt is somewhat unstable at room 
temperature, it has certain merits. For example, acid can be omitted from this transformation, and 
problems with sluggish conversion of triazene would be avoided. Most importantly, the 
arenediazonium tetrafluoroborates are not explosive. To acquire the diazonium salt, starting with 
1.1a, oxidation with Oxone in a water and methanol mixture afforded 2-((3-
phenylpropyl)sulfonyl)aniline 1.1b (Scheme 1.4). The reaction was complete in less than 5 
minutes. 1.1b was then converted to the corresponding 2-((3-
phenylpropyl)sulfonyl)benzenediazonium tetrafluoroborate 1.1c using a previously published 
procedure (Scheme 1.4).  
With the diazonium salt 1.1c in hand, remote hydroxylation conditions were explored. The 
initial experiment was performed with 10 mol% fac-Ir(ppy)3. Only 31% of hydroxylation product 
1.1 was obtained (Table 1.2). Further optimization found that decreasing catalyst loading could 
slightly increase the yield (entry 2). Screening the effect of various catalysts showed us that 
S Ph
NH2
1.1a
Oxone (4 equiv.)
MeOH, H2O
92%
S Ph
N
O O
S Ph
NH2
O O
48% HBF4
NaNO2, H2O
61% N
BF4
1.1b 1.1c
S
N
N N
O O fac-Ir(ppy)3 (10 mol%)
CH3NO2 : H2O = 5:1
HOTf (2 equiv), 
Blue LEDs, 21h
S
O O
OH S
O
O
+
10%
1.2’
30%
1.21.2a”
SNN
O
O
Scheme 1.3 Remote Hydroxylation of 1.2a” 
 
 
Scheme 1.4 Synthesis of 1.1c 
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Ru(bpy)3Cl2·6H2O was the best for this transformation (entries 3-7), giving us the highest yield 
observed (entry 8). A series of controls established that light, photocatalyst, and exclusion of 
oxygen are all essential to this transformation (entries 9-11).22 
Table 1.2 Optimization of Remote Hydroxylationa 
                                
 
 
 
aReaction conditions: sulfonyl diazonium salt (1.1c, 0.2 mmol), Ru(bpy)3Cl2·6H2O (0.5 mol%, 
0.001 mmol), CH3NO2 (10 mL), H2O (2 mL). bIsolated yield. cReaction was irradiated with green 
LEDs. dReaction performed without freeze-pump-thaw. eReaction performed without irradiation.  
 
 
 
 
entry catalyst/ mol% Yield (%)b 
1 fac-Ir(ppy)3/ 10 31 
2 fac-Ir(ppy)3/ 1 37 
3 Ru(bpy)3Cl2·6H2O/ 1 58 
4 Cu(dap)2Cl/ 1 31 
5 Ru(phen)3(Barf)2/ 1 60 
6 Ir[dF(CF3)ppy]2(dtbbpy)PF6/ 1 52 
7c Eosin Y/ 1 24 
8 Ru(bpy)3Cl2·6H2O/ 0.5 79 
9d Ru(bpy)3Cl2·6H2O/ 1 33 
10 Ru(bpy)3Cl2·6H2O/ 0 0 
11e Ru(bpy)3Cl2·6H2O/ 1 0 
Catalyst (mol%)
CH3NO2 : H2O = 10ml : 2ml
freeze-pump-thaw
Blue LEDs, 24h
S Ph
O O
OH
1.1
S Ph
N
O O
N
BF4
1.1c
 10 
Encouraged by these results, we next evaluated the substrate scope that could be employed 
in this remote hydroxylation reaction (Table 1.3). An isoamyl alcohol derivative produced tertiary 
alcohol 1.2 in 52% yield (entry 1). Cyclohexylethanol derivative 1.3c gave a relatively low-
yielding conversion in 28% yield (entry 2) because of competing elimination. Considering 
electronic effects, we used p-Cl and p-OMe phenyl derivatives 1.4c and 1.5c, which gave moderate 
yields (entries 3&4). All the examples above involved 1,6-HAT. We also designed substrates to 
undergo 1,7- and 1,5-HAT. Aliphatic substrate 1.6c gave a poor (16%) yield (entry 5) while the 
corresponding benzylic substrate gave only trace alcohol product as evidenced by crude 1H NMR 
(entry 6). All of these results suggested that 1,7-HAT was less favorable than 1,6-HAT for this 
transformation. Also, substrate 1.8c was expected to undergo 1,5-HAT. Surprisingly, a mixture of 
alcohol and intramolecular cyclization product was obtained (entry 7). The aliphatic substrate 1.9c 
did not undergo hydroxylation, further demonstrating that 1,5-HAT is not favorable under these 
conditions. Further studies on aliphatic sulfone substrates 1.10c and 1.11c resulted in complex 
mixtures, where no desired alcohol products were detected. Finally, a methyl ether substrate 1.12c 
was converted to ketone 1.12, likely proceeding by a hydroxylation to a hemiacetal intermediate.  
Previous attempts to convert Tzo sulfonate esters and sulfonamides to methyl ether using 
methanol as a nucleophile were successful.21 With this precedent in mind, we explored more 
nucleophiles including MeOH, CH3CN/H2O, and even 1,3- and 1,4-dimethoxybenzene. All of the 
results are shown in Table 1.4. Etherification proceeded as expected with aliphatic and benzylic 
substrates (entries 1&2). A Ritter-type reaction was successful for benzylic substrate (entry 3) 
while aliphatic substrate gave only elimination product (entry 4). Further, remote C-C bond 
formation was achieved with dimethoxybenzene nucleophiles. 
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Table 1.3 Substrate Scope for Remote Hydroxylationa 
entry                         substrate                               product(s)                    yield(%)b 
 
 
S
O O
N2 BF4
S
O O
1.2c 1.2
OH
S
O O
N2 BF4
S
O O OH
S
O O
OMe
N2 BF4
S
O O
O
S
O O
N2 BF4
S
O O
OH
OMe OMe
S
O O
N2 BF4
S
O O
OH
Cl Cl
1
2
3
4
52
28
71
55
40
S
O O
N2 BF4
S
O O
5 16
OH
S
O O
N2 BF4
S
O O
6 trace
OH
S
O O
N2 BF4
S
O O
Ph7 ~49
(1:3.45,
1.8/1.8d)
OH
SO
O
S
O O
N2 BF4
8 0
S
O O
N2 BF4
9 0
10
n = 1, 2
1.3c 1.3
1.4c 1.4
1.6c 1.6
1.5c 1.5
1.7c 1.7
1.8c 1.8 1.8d
no alcohol products isolated
no alcohol products isolated
1.9c
1.10c (n = 1), 1.11c (n = 2)
1.12c 1.12
aReaction conditions: 0.2 mmol of diazonium salt, 10 mL CH3NO2, 2 mL H2O, 0.5 mol% 
Ru(bpy)3Cl2, Temp = 26 - 28 oC, 24 h irradiation with blue LEDs. bIsolated yields. 
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Table 1.4 Etherification, Amidation, and Arylationa 
entry                            substrate                                   product                     yield (%)b 
Based on the results we obtained, a proposed mechanism may proceed as follows (Figure 
1.7): ground state Ru(bpy)32+ is excited by irridiation using blue LEDs (lmax = 452 nm) to excited 
state,15a which reduces the diazonium ion 1.1c to aryl radical 1.13 with the loss of nitrogen gas,23 
followed by a 1,6-HAT generating a more stable benzylic radical 1.14,24,21 which has an oxidation 
aReaction conditions: 0.2 mmol of diazonium salt, 10 mL CH3NO2, 2 mL H2O, 0.5 mol% 
Ru(bpy)3Cl2, temp = 26 - 28 oC, 24 h irradiation with blue LEDs. bIsolated yields. c100 µL of 
MeOH added. d100 µL of CH3CN, 0.2 mmol H2O added. e1.0 mmol of 1,4-dimethoxybenzene 
added. f1.0 mmol of 1,3-dimethoxybenzene added. 
 
 
S
O O
N2 BF4
S
O O
OMe
1c 59
1.1c 1.1d
S
O O
N2 BF4
S
O O
1.2c 1.2d
OMe
2c 38
S
O O
N2 BF4
S
O O
NHAc
3d 51
1.1c 1.1e
S
O O
N2 BF4
S
O O
1.2c 1.2e
4d 60
S
O O
N2 BF4
S
O O
5e 34
1.1c 1.1f
S
O O
N2 BF4
S
O O
6f 19
1.1c 1.1g
MeO
OMe
OMe
OMe
 13 
half potential between +0.1 V and +0.4 V (SCE).25 Oxidation with Ru(bpy)33+ (E1/2  = +1.29 V vs  
SCE) leads to the carbenium ion 1.15,26 which is further attacked by nucleophiles to generate the 
final products. At the same time, Ru(bpy)33+ is reduced to ground state Ru(bpy)32+ to complete the 
catalytic cycle. Regarding the process 1.14  ® 1.15, instead of closing the photoredox cycle via 
SET, the oxidaton of radical 1.14 (~ +0.1 V to +0.4 V vs SCE) by diazonium ion 1.1c (-0.08 V vs 
SCE) may also result in the formation of 1.13 and 1.15 through a chain process (Figure 1.7). 
Irreversible loss of N2 might be a driving force for such a chain process since, at face value, 
electron transfer is not favorable based on redox potential. 
1.4       Summary 
A mild, visible-light-promoted remote aliphatic C-H functionalization has been achieved 
using low loadings of the photocatalyst Ru(bpy)3Cl2. Intramolecular HAT and SET oxidation of 
radical to carbocation intermediate are likely.  In addition, the well-known 1,5-HAT is not very 
facile in this system. Transformations including remote hydroxylation, etherification, amidation, 
and arylation have been demonstrated. This method provides an efficient approach to the 
elaboration of alkyl iodides to value-added products of C-H functionalization. 
 
Figure 1.7 Proposed Mechanism for Remote C-H Functionalization 
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1.5       Experimental 
1.5.1.   General Methods 
Reagents were purchased from Sigma-Aldrich, Alfa Aesar, or Fisher Scientific and used 
as received. Flash column chromatography was performed using 60 Å silica gel purchased from 
Fisher Scientific.  1H NMR and 13C NMR spectroscopy were performed on a Bruker AV-400 and 
AV-500 spectrometer.  Mass spectra were obtained using an Agilent 6210 electrospray time-of-
flight mass spectrometer.  Qualitative TLC was performed on aluminum sheets (Merck, silica gel 
60, F254).  Compounds were visualized by UV absorption (254 nm) and stained with anisaldehyde.  
Deuterated solvents were acquired from Cambridge Isotope Labs.  All reactions were carried out 
under an atmosphere of dry nitrogen or, in the case of photochemical reactions, subjected to three 
cycles of freeze-pump-thaw before irradiation.  Remote hydroxylation reactions were conducted 
in round bottom flasks and irradiated with 4 W blue LEDs (Creative Lighting Solutions, λmax = 
455 nm) which were wrapped around a crystallizing dish as pictured in figure 1.8. 
1.5.2    Procedures and Characterization 
Synthesis and evaluation of o-triazenylphenyl alkyl sulfone 1.1c in remote hydroxylation: 
Synthetic procedure for preparation of o-triazenylphenyl thioether 1.1a: 
 
 
OH 1). PPh3, I2, imidazole, DCM S Ph
NH22). DBU, DCM, 2-Aminobenzenethiol   69%
1.1a
Figure 1.8: Experimental Setup 
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A 250 mL round bottom flask was charged with PPh3 (30.0 mmol, 7.87 g) and 150 mL 
dichloromethane. Iodine (30.0 mmol, 7.61 g) was added in small portions under N2 at room 
temperature. The reaction was stirred for 10 minutes. Imidazole (49.9 mmol, 3.40 g) was added to 
the solution in small portions and the reaction was allowed to stir for 10 more minutes. 3-
Phenylpropan-1-ol (20.0 mmol, 2.72 mL) was added to the suspension dropwise in 5 minutes and 
the reaction was stirred for 1 hour at room temperature. 150 mL Sat. Na2S2O5 was added to the 
reaction mixture and the aqueous layer was extracted with 150 mL dichloromethane twice. The 
organic layer was dried over MgSO4 and concentrated in ice bath under low pressure to around 
100 mL. The obtained iodide compound was used without further purification. 2-
Aminobenzenethiol (24.0 mmol) was added to the alkyl iodide/DCM solution under N2 and cooled 
to 0 °C. 1, 8-Diazabicycloundec-7-ene (DBU, 22.7 mmol, 3.40 mL) was added to the reaction 
dropwise at 0 °C. The reaction was warmed to room temperature and stirred for 2 hours. Water 
(100 mL) was added to the reaction. The aqueous layer was extracted with 100 mL DCM twice. 
The organic layer was dried over MgSO4 and concentrated under vacuum. The resulting oil was 
purified using gradient silica gel column chromatography (0% - 10% ethyl acetate in hexanes) to 
give 3.40 g product 1.1a as a colorless oil. 
Synthetic procedure for preparation of o-triazenylphenyl alkyl sulfide 1.1a’: 
 
A 25 mL RB flask equipped with a stir bar was charged with 2.43 g (9.98 mmol) 1.1a, 
which were then suspended in 10 mL concentrated hydrochloric acid to obtain a white slurry. The 
resulting mixture was cooled to 0 °C, and 1.035 g (15.00 mmol) sodium nitrite in 5 mL H2O was 
added dropwise to the reaction. The resulting yellow solution was stirred at 0 °C for 10 min after 
which a solution of 1.15 mL (11.1 mmol) diethylamine in 10 mL 1 M KOH was injected to the 
S Ph
NH2
1.1a
1). NaNO2, conc. HCl
2). Et2NH, KOH (1M)
68%
S Ph
N
N
NEt2
1.1a’
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reaction flask using a syringe. The reaction was allowed to proceed at 0 °C for 1 hour before it was 
quenched by dropwise addition of 3 M NaOH until the pH ~ 12. The product was extracted with 
40 mL ethyl acetate three times. The combined organic layer was washed with brine and dried 
over MgSO4. The resulting crude mixture was purified using silica gel column chromatography to 
give 2.21 g (68%) product 1.1a’ as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.32 (dd, J = 7.8, 
1.5Hz, 1H), 7.29 – 7.25 (m, 2H), 7.19 – 7.14 (m, 4H), 7.10 – 7.02 (m, 2H), 3.77 – 3.74 (m, 4H), 
2.91 (t, J = 7.4Hz, 2H), 2.78 (t, J = 7.5Hz, 2H), 2.05 – 1.99 (m, 2H), 1.28 (t, J = 7.1Hz, 6H).  13C 
NMR (125 MHz, CDCl3) δ 148.38, 141.51, 132.27, 128.52, 128.35, 126.33, 125.89, 125.39, 
125.30, 116.62, 35.05, 34.65, 32.86, 31.62, 30.83, 30.60, 30.40.  HRMS (m/z): [M+H]+ calcd. for 
C19H26SN3 328.1842, found 328.1851. 
Synthetic procedure for preparation of o-triazenylphenyl alkyl sulfone 1.1a”:  
 
A 100 mL RBF was charged with 1.63 g (4.98 mmol) 1.1a’ and 30 mL methanol at room 
temperature. 6.15 g (20.0 mmol) Oxone was dissolved in 30 mL water and added to the solution 
at once.  The suspension was stirred for 5 minutes (normally there is a color change from yellow 
to brown).  The reaction was monitored by TLC until starting material had been consumed.  The 
mixture was extracted with 40 mL dichloromethane three times. The combined organic layer was 
dried with MgSO4, filtered, and concentrated under vacuum.  The resulting oil was purified using 
gradient silica gel chromatography (0 - 15 % hexanes in ethyl acetate) to give 1.36 g (76 %) product 
1.1a” as a yellow oil.  1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 7.9, 1.3Hz, 1H), 7.57 (dd, J = 
8.2, 1.0Hz, 1H), 7.52 – 7.49 (m, 1H), 7.25 – 7.20 (m, 3H), 7.16 (t, J = 7.3Hz, 1H), 7.08 (d, J = 
7.1Hz, 2H), 3.82 – 3.77 (m, 2H), 3.58 – 3.52 (m, 4H), 2.70 (t, J = 7.4Hz, 2H), 2.09 – 2.03 (m, 2H), 
1.34 (t, J = 7.2Hz, 3H), 1.17 (t, J = 7.2Hz, 3H) . 13C NMR (125 MHz, CDCl3) δ 149.09, 140.30, 
Oxone (4 equiv.)
MeOH, H2O
76%
S Ph
N
1.1a”
N
NEt2
O O
S Ph
N
1.1a’
N
NEt2
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134.09, 131.52, 129.42, 128.47, 128.42, 126.21, 124.49, 117.70, 54.21, 49.58, 42.42, 34.33, 24.04, 
14.44, 11.24.  HRMS (m/z): [M+H]+ calcd. for C19H26SN3O2 360.1740, found 360.1747. 
Representative synthetic procedure for remote hydroxylation of o-triazenylphenyl alkyl sulfone 
1.1a”: 
 
To a vigorously stirred solution of 100.0 mg (0.2781 mmol) triazene 1.1a” and 18.2 mg 
(0.0278 mmol) fac-Ir(ppy)3 in 10 mL CH3NO2 and 2 mL deionized H2O was added 50 µL (0.5568 
mmol) 48% HBF4 via gas-tight syringe. The reaction was subjected to freeze-pump-thaw cycles 
three times to get rid of oxygen. Irradiation of the solution with blue LEDs (λmax = 455 nm) 
commenced and the reaction mixture was stirred vigorously for 18 h. 10 mL of 5% NaHCO3 was 
then added at once. The aqueous layer was extracted with 10 mL DCM three times. The combined 
organic layers were dried over Na2SO4, filtered and concentrated to 97.6 mg of a yellow oil.  Silica 
gel chromatography (0 - 30 % hexane in ethyl acetate) of the oil residue afforded 23.1 mg (30%) 
of 1.1 as a pale solid.  1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.3Hz, 2H), 7.64 (t, J = 7.5Hz, 
1H), 7.56 – 7.52 (m, 2H), 7.33 – 7.30 (m, 2H), 7.28 – 7.25 (m, 3H), 4.78 (t, J = 5.1Hz, 1H), 3.26 
– 3.15 (m, 2H), 2.43 (s, 1H), 2.16 – 2.07 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 143.02, 138.95, 
133.74, 129.32, 128.68, 127.99, 127.98, 125.59, 72.13, 52.82, 31.73.  HRMS (m/z): [M+Na]+ 
calcd. for C15H16SO3Na 299.0712, found 299.0719. 
Synthesis and evaluation of o-diazoniaphenyl alkyl sulfone tetrafluoroborates for remote 
hydroxylation: 
Previously-reported o-aminothioethers made using the method described above (isolated yields 
and references for spectral data in parentheses): 
 
fac-Ir(ppy)3  (10 mol %), 
48% HBF4 
CH3NO2 : H2O = 10ml : 2ml
Blue LEDs, 18 h
S Ph
N
1.1a”
N
NEt2
O O
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O O
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2-((3-phenylpropyl)thio)aniline 1.1a (3.40 g, yield 70%, starting with 2.72 mL 3-phenyl-1-
propanol) colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.34 (d, J = 7.7 Hz, 1H), 7.23 (t, J = 7.5Hz, 
2H), 7.16 – 7.11 (m, 3H), 7.07 (t, J = 7.9Hz, 1H), 6.67 – 6.63 (m, 2H), 4.21 (s, 2H), 2.73 – 2.67 
(m, 4H), 1.88 – 1.82 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 148.17, 141.40, 135.71, 129.50, 
128.42, 128.31, 125.85, 118.40, 117.80, 114.82, 34.55, 34.01, 31.04.  HRMS (m/z): [M+H]+ calcd. 
for C15H18NS 244.1154, found 244.1159. 
 
2-(isopentylthio)aniline 1.2a (2.25 g, yield 57%, starting with 2.20 mL isoamyl alcohol) light 
yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 7.7, 1.4Hz, 1H), 7.09 (td, J = 8.0, 1.5Hz, 
1H), 6.71 – 6.66 (m, 2H), 4.32 (s, 2H), 2.74 (t, J = 7.8Hz, 2H), 1.71 – 1.65 (m, 1H), 1.48 – 1.43 
(m, 2H), 0.85 (d, J = 6.8Hz, 6H).  13C NMR (125 MHz, CDCl3) δ 148.06, 135.48, 129.35, 118.43, 
118.36, 114.81, 38.59, 32.92, 27.30, 22.27.  HRMS (m/z): [M+H]+ calcd. for C11H18NS 196.1154, 
found 196.1146. 
 
2-((2-cyclohexylethyl)thio)aniline 1.3a (3.47 g, yield 73%, starting with 2.80 mL 2-
cyclohexylethanol) colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 7.7, 1.4Hz, 1H), 7.10 
– 7.07 (m, 1H), 6.71 – 6.66 (m, 2H), 4.31 (s, 2H), 2.75 (t, J = 7.7Hz, 2H), 1.68 (s, 2H), 1.66 (s, 
3H), 1.48 – 1.44 (m, 2H), 1.39 – 1.32 (m, 1H), 1.24 – 1.08 (m, 3H), 0.90 – 0.82 (m, 2H). 13C NMR 
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(125 MHz, CDCl3) δ 148.02, 135.41, 129.30, 118.45, 118.43, 114.80, 37.17, 36.83, 33.01, 32.50, 
26.55, 26.23.  HRMS (m/z): [M+H]+ calcd. for C14H22NS 236.1467, found 236.1460. 
2-((3-(4-methoxyphenyl)propyl)thio)aniline 1.4a (4.64 g, yield 85%, starting with 3.20 mL 3-(4-
methoxyphenyl)-1-propanol) colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.34 (dd, J = 7.6, 1.5Hz, 
1H), 7.09 – 7.06 (m, 1H), 7.04 (d, J = 8.6Hz, 2H), 6.80 – 6.78 (m, 2H), 6.68 – 6.64 (m, 2H), 4.30 
(s, 2H), 3.74 (s, 3H), 2.71 (t, J = 7.5Hz, 2H), 2.63 (t, J = 7.8Hz, 2H), 1.82 (m, 2H). 13C NMR (125 
MHz, CDCl3) δ 157.77, 148.18, 135.68, 133.44, 129.47, 129.31, 118.38, 117.86, 114.80, 113.74, 
55.17, 33.96, 33.62, 31.27.  HRMS (m/z): [M+H]+ calcd. for C16H20NSO 274.1260, found 
274.1263. 
2-((3-(4-chlorophenyl)propyl)thio)aniline 1.5a (1.327 g, yield 90%, starting with 1.487 g 1-chloro-
4-(3-iodopropyl)benzene) colorless oil 1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 7.6Hz, 1H), 
7.21 (d, J = 8.3Hz, 2H), 7.10 (t, J = 7.7Hz, 1H), 7.05 (d, J = 8.3Hz, 2H), 6.71 (d, J = 8.0Hz, 1H), 
6.67 (t, J = 7.5Hz, 1H), 4.35 – 4.29 (br, 2H), 2.71 (t, J = 7.3Hz, 2H), 2.67 (t, J = 7.7Hz, 2H), 1.83 
(quint, J = 7.4Hz, 2H).  13C NMR (125 MHz, CDCl3) δ 148.43, 140.05, 136.03, 131.79, 129.99, 
129.85, 128.64, 118.68, 117.85, 115.09, 34.05, 34.03, 31.14.  HRMS (m/z): [M+H]+ calc. for 
C15H17NSCl 278.0765, found 278.0775. 
 
2-((4-phenylbutyl)thio)aniline 1.7a (2.432 g, yield 99%, starting with 2.493 g (4-
iodobutyl)benzene) light yellow oil 1H NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 7.9, 1.3Hz, 1H), 
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7.29 – 7.25 (m, 4H), 7.27 – 7.22 (m, 2H), 6.73 – 6.67 (m, 2H), 4.37 – 4.26 (br, 2H), 2.77 (t, J = 
7.2Hz, 2H), 2.60 (t, J = 7.6Hz, 2H), 1.74 (quint, J = 7.7Hz, 2H), 1.62 (quint, J = 7.3Hz, 2H).  13C 
NMR (125 MHz, CDCl3) δ 148.37, 142.41, 135.94, 129.69, 128.59, 128.49, 125.93, 118.65, 
118.33, 115.03, 35.62, 34.85, 30.60, 29.34.  HRMS (m/z): [M+H]+ calc. for C16H20NS 258.1311, 
found 258.1316. 
 
2-(phenethylthio)aniline 1.8a (1.27 g, yield 28%, starting with 2.40 mL 2-phenylethanol) colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 7.38 (m, 1H), 7.27 – 7.24 (m, 2H), 7.19 – 7.16 (m, 1H), 7.13 
(d, J = 8.4Hz, 2H), 7.11 – 7.08 (m, 1H), 6.70 – 6.66 (m, 2H), 4.18 (s, 2H), 2.99 – 2.96 (m, 2H), 
2.84 – 2.81 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 148.36, 140.41, 135.89, 129.76, 128.64, 
128.51, 126.40, 118.56, 117.77, 115.01, 36.13, 36.05. HRMS (m/z): [M+H]+ calcd. for C14H16NS 
230.0998, found 230.0999. 
 
2-(isobutylthio)aniline 1.9a (0.54 g, yield 15%, starting with 1.85 mL isobutanol) yellow oil. 1H 
NMR (500 MHz, CDCl3) δ 7.37 – 7.35 (m, 1H), 7.11 – 7.07 (m, 1H), 6.72 – 6.66 (m, 2H), 4.28 (s, 
2H), 2.63 (d, J = 6.9Hz, 2H), 1.80 – 1.72 (m, 1H), 1.00 (d, J = 6.7Hz, 6H). 13C NMR (125 MHz, 
CDCl3) δ 147.90, 135.38, 129.27, 118.28, 118.50, 114.85, 43.95, 28.51, 21.91. HRMS (m/z): 
[M+H]+ calcd. for C10H16NS 182.0998, found 182.1004. 
 
2-(propylthio)aniline 1.10a (2.02 g, yield 61%, starting with 1.50 mL 1-propanol) colorless oil. 1H 
NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 7.7, 1.3Hz, 1H), 7.11 – 7.08 (m, 1H), 6.72 – 6.66 (m, 
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2H), 4.32 (s, 2H), 2.71 (t, J = 6.8Hz, 2H), 1.61 – 1.54 (m, 2H), 0.98 (t, J = 7.4Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 148.14, 135.69, 129.41, 118.42, 118.25, 114.81, 36.85, 22.98, 13.31. Spectral 
data matched that previously reported in literature.27 
 
2-(butylthio)aniline 1.11a (3.18 g, yield 88%, starting with 2.27 mL 1-iodobutane) light purple oil. 
1H NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 7.7, 1.4Hz, 1H), 7.11 – 7.08 (m, 1H), 6.72 – 6.66 (m, 
2H), 4.32 (s, 2H), 2.73 (t, J = 7.4Hz, 2H), 1.57 – 1.51 (m, 2H), 1.44 – 1.37 (m, 2H), 0.89 (t, J = 
7.4Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 148.10, 135.58, 129.37, 118.43, 118.35, 114.81, 34.55, 
31.74, 21.83, 13.65. Spectral data matched that previously reported in literature.28 
 
2-((3-methoxybutyl)thio)aniline 1.12a (2.53 g, yield 61%, starting with 2.22 mL 3-methoxy-1-
butanol) colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 7.7, 1.5Hz, 1H), 7.11 – 7.08 
(m, 1H), 6.71 – 6.66 (m, 2H), 4.33 (s, 2H), 3.45 – 3.39 (m, 1H), 3.27 (s, 3H), 2.86 – 2.76 (m, 2H), 
1.79 – 1.72 (m, 1H), 1.67 – 1.61 (m, 1H), 1.10 (d, J = 6.2Hz, 3H) . 13C NMR (125 MHz, CDCl3) 
δ 148.16, 135.63, 129.50, 118.42, 117.93, 114.84, 75.28, 56.02, 36.40, 30.78, 18.87.  HRMS (m/z): 
[M+H]+ calcd. for C11H18NSO 212.1104, found 212.1106. 
Representative synthetic procedure for sulfonylaniline preparation: 
 
A 250ml round bottom flask was charged with 1.1a (10.0 mmol, 2.43 g) and 50 mL 
methanol at room temperature. Oxone (40.0 mmol, 12.3 g) was dissolved in 50 mL water and 
S Ph
NH2
1.1a
Oxone (4 equiv.)
MeOH, H2O
92%
S Ph
NH2
O O
1.1b
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added quickly to the solution at once. The suspension was stirred for 5 minutes (normally there is 
a color change (yellow to brown) meaning the reaction was complete). The resulting mixture was 
extracted with 3 X 100 mL DCM. The organic layer was dried with MgSO4, filtered, and 
concentrated under vacuum. The resulting oil was purified using gradient silica gel column 
chromatography (0% - 20% ethyl acetate in hexanes) to give 2.53g sulfonylaniline product 1.1b 
of a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 8.0, 1.5Hz, 1H), 7.33 – 7.30 (m, 
1H), 7.26 – 7.23 (m, 2H), 7.19 – 7.16 (m, 1H), 7.09 (dd, J = 8.2, 1.2Hz, 2H), 6.77 (td, J = 7.1, 
1.0Hz, 1H), 6.70 (dd, J = 8.2, 0.75Hz, 1H), 4.91 (s, 2H), 3.14 – 3.10 (m, 2H), 2.67 (t, J = 7.5Hz, 
2H), 2.06 – 2.00 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 146.59, 140.08, 135.11, 130.23, 128.54, 
128.36, 126.32, 120.23, 117.74, 117.61, 53.34, 34.07, 23.90.  HRMS (m/z): [M+Na]+ calcd. for 
C15H17NSO2Na 298.0872, found 298.0872. 
 
2-(isopentylsulfonyl)aniline 1.2b (2.03 g, yield 89%, starting with 1.96 g 1.2a) yellow oil. 1H 
NMR (500 MHz, CDCl3) δ 7.67 (dd, J = 8.0, 1.4Hz, 1H), 7.37 – 7.33 (m, 1H), 6.83 – 6.79 (m, 
1H), 6.75 (d, J = 8.2Hz, 1H), 5.04 (s, 2H), 3.16 – 3.13 (m, 2H), 1.64 – 1.57 (m, 3H), 0.87 (d, J = 
6.4Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 146.54, 135.06, 130.26, 120.36, 117.76, 117.56, 52.44, 
30.67, 27.20, 22.06.  HRMS (m/z): [M+H]+ calcd. for C11H18NSO2 228.1053, found 228.1061. 
 
2-((2-cyclohexylethyl)sulfonyl)aniline 1.3b (2.07 g, yield 78%, starting with 2.35 g 1.3a) colorless 
oil.  1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 8.0, 1.5Hz, 1H), 7.35 – 7.29 (m, 1H), 6.80 – 6.75 
(m, 2H), 5.11 (s, 2H), 3.17 – 3.13 (m, 2H), 1.68 – 1.56 (m,7H), 1.29 – 1.22 (m,1H), 1.21 – 1.05 
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(m, 3H), 0.88 – 0.81 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 146.63, 135.03, 130.11, 120.15, 
117.59, 117.56, 51.98, 36.52, 32.74, 29.26, 26.25, 25.98.  HRMS (m/z): [M+Na]+ calcd. for 
C14H21NSO2Na 290.1185, found 290.1190. 
 
2-((3-(4-methoxyphenyl)propyl)sulfonyl)aniline 1.4b (2.76 g, yield 90%, starting with 2.73 g 1.4a) 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.0Hz, 1H), 7.34 (td, J = 8.3, 1.2Hz, 1H), 
7.01 (d, J = 8.5Hz, 2H), 6.81 – 6.77 (m, 3H), 6.71 (d, J = 8.2Hz, 1H), 5.01 (s, 2H), 3.77 (s, 3H), 
3.12 (t, J = 7.8Hz, 2H), 2.62 (t, J = 7.5Hz, 2H), 2.00 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 
158.10, 146.55, 135.11, 132.08, 130.26, 129.30, 120.20, 117.76, 117.56, 113.95, 55.24, 53.26, 
33.18, 24.12.  HRMS (m/z): [M+Na]+ calcd. for C16H19NSO3Na 328.0978, found 328.0974. 
 
2-((3-(4-chlorophenyl)propyl)sulfonyl)aniline 1.5b (2.75 g, yield 89%, starting with 2.77 g 1.5a) 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 8.0, 1.4Hz, 1H), 7.34 (m, 1H), 7.25 – 
7.21 (m, 2H), 7.02 (d, J = 8.4Hz, 2H), 6.80 (td, J = 8.0, 0.7Hz, 1H), 6.72 (d, J = 8.1Hz, 1H), 4.99 
(s, 2H), 3.12 – 3.10 (m, 2H), 2.66 (t, J = 7.6Hz, 2H), 2.05 – 1.99 (m, 2H). 13C NMR (125 MHz, 
CDCl3) δ 146.58, 138.54, 135.20, 132.15, 130.25, 129.73, 128.68, 120.27, 117.87, 117.63, 53.11, 
33.41, 23.83.  HRMS (m/z): [M+H]+ calcd. for C15H17NSO2Cl 310.0663, found 310.0665. 
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2-((4-phenylbutyl)sulfonyl)aniline 1.7b (1.56 g, yield 54%, starting with 2.57 g 1.7a) light yellow 
oil 1H NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 8.0, 1.5 Hz, 1H), 7.36 – 7.33 (m, 1H), 7.25 – 7.09 
(m, 5H), 6.82 – 6.78 (m, 1H), 6.73 (dd, J = 8.3, 0.7Hz, 1H), 5.04 – 4.97 (br, 2H), 3.15 (t, J = 7.9Hz, 
2H), 2.58 (t, J = 7.5Hz, 2H), 1.76, (quint, J = 7.2Hz, 2H), 1.69 (quint, J = 7.2Hz, 2H).  13C NMR 
(125 MHz, CDCl3) δ 146.71, 141.55, 135.28, 130.47, 128.58, 128.51, 126.15, 120.50, 118.02, 
117.74, 54.05, 35.46, 30.21, 22.18.  HRMS (m/z): [M+H]+ calc. for C16H20NO2S 290.1209, found 
290.1215. 
 
2-(phenethylsulfonyl)aniline 1.8b (1.85 g, yield 66%, starting with 2.30 g 1.8a) colorless oil. 1H 
NMR (500 MHz, CDCl3) δ 7.71 (dd, J = 8.0, 1.4Hz,  1H), 7.37 – 7.34 (m,  1H), 7.27 – 7.24 (m, 
2H), 7.20 – 7.18 (m, 1H), 7.12 (d, J = 7.4Hz, 2H), 6.82 – 6.80 (m, 1H), 6.74 (d, J = 8.2Hz, 1H), 
5.05 (s, 2H), 3.43 – 3.40 (m, 2H), 3.04 – 3.00 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 146.63, 
137.70, 135.30, 130.33, 128.78, 128.33, 126.84, 120.03, 117.93, 117.66, 55.24, 28.55. HRMS 
(m/z): [M+H]+ calcd. for C14H16NSO2 262.0896, found 262.0899. 
 
2-(isobutylsulfonyl)aniline 1.9b (0.31 g, yield 50%, starting with 0.54 g 1.9a) light yellow oil 1H 
NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 8.4, 1.4Hz, 1H), 7.35 (td, J = 7.5, 1.5Hz, 1H), 6.81 (td, J 
= 7.6, 0.8Hz, 1H), 6.74 (d, J = 8.2Hz, 1H), 5.02 (s, 2H), 3.05 (d, J = 6.4Hz, 2H), 2.28 – 2.20 (m, 
1H), 1.05 (d, J = 6.8Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 146.36, 135.01, 129.97, 121.41, 
 25 
117.86, 117.56, 61.56, 23.91, 22.79. HRMS (m/z): [M+H]+ calcd. for C10H16NSO2 214.0896, 
found 214.0895. 
 
2-(propylsulfonyl)aniline 1.10b (1.56 g, yield 78%, starting with 1.67 g 1.10a) light yellow oil 1H 
NMR (500 MHz, CDCl3) δ 7.6 (d, J = 8.0Hz, 1H), 7.35 (td, J = 7.7, 1.2Hz, 1H), 6.81 (t, J = 7.6Hz, 
1H), 6.74 (d, J = 8.2Hz, 1H), 5.03 (s, 2H), 3.14 – 3.11 (m, 2H), 1.78 – 1.71 (m, 2H), 0.99 (t, J = 
7.5Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 146.56, 135.07, 130.32, 120.35, 117.79, 117.54, 55.89, 
16.24, 12.95. Spectral data matched that previously reported in literature.29 
 
2-(butylsulfonyl)aniline 1.11b (1.50 g, yield 70%, starting with 1.81 g 1.11a) light green oil. 1H 
NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 7.7, 1.4Hz, 1H), 7.09 (td, J = 7.9, 1.2Hz, 1H), 6.81 (td, J 
= , 2H), 4.16 (s, 2H), 2.73 (t, J = 7.4Hz, 2H), 1.57 – 1.51 (m, 2H), 1.44 – 1.36 (m, 2H), 0.88 (t, J 
= 7.4Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 148.10, 135.62, 129.41, 118.49, 118.42, 114.88, 
34.59, 31.78, 21.87, 13.69. Spectral data matched that previously reported in literature.29 
 
2-((3-methoxybutyl)sulfonyl)aniline 1.12b (1.46 g, yield 60%, starting with 2.12 g 1.12a) 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.66 (dd, J = 8.0, 1.5Hz, 1H), 7.36 – 7.32 (m, 1H), 
6.80 (td, J = 8.1, 1.0Hz, 1H), 6.74 (dd, J = 8.3, 0.8Hz, 1H), 5.08 (s, 2H), 3.56 – 3.40 (m, 1H), 3.29 
- 3.27 (m, 1H), 3.23 (s, 3H), 3.22 – 3.17 (m, 1H), 1.95 – 1.88 (m, 1H), 1.83 – 1.76 (m, 1H), 1.10 
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(d, J = 6.2Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 146.62, 135.11, 130.16, 120.15, 117.66, 117.58, 
74.55, 55.97, 50.43, 28.83, 18.81.  HRMS (m/z): [M+H]+ calcd. for C11H18NSO3 244.1002, found 
244.1006. 
Representative synthetic procedure for o-diazoniaphenyl alkyl sulfone tetrafluoroborate synthesis: 
  
A 50 mL round bottom flask was charged with sulfonylaniline 1.1b (5.0 mmol, 1.38 g) and 
cooled to 0 °C. 48% tetrafluoroboric acid (13.5 mmol, 1.80 mL) in 2.5 mL deionized water was 
added to 1.1b over the course of 5 minutes with stirring under N2. A solution of sodium nitrite 
(6.45 mmol, 445 mg) in 1 mL deionized water was added dropwise over 2 minutes period to the 
aqueous solution and the stirring rate was increased. The reaction was stirred for 2 hours at 0 °C. 
The resulting mixture was filtered and washed with 1 mL cold deionized water. The solid was 
added to a 250 mL Erlenmeyer flask and dissolved in 15 mL acetone. The remaining solid was 
filtered out. One hundred milliliters anhydrous diethyl ether was added to the solution. The 
precipitated diazonium salt was filtered, washed with 50 mL anhydrous diethyl ether, and dried 
under high vacuum for 1 hour to afford 1.12 g 1.1c of a light yellow powder. Owing to the 
instability at room temperature, the freshly made diazonium salt should be used immediately or 
stored at -2 °C for less than a week prior to use. 1H NMR (500 MHz, CD3CN) δ 8.82 (d, J = 1.0Hz, 
1H), 8.48 (td, J = 7.8, 1.2Hz, 1H), 8.40 (dd, J = 8.0, 1.2Hz, 1H), 8.31 – 8.27 (m, 1H), 7.34 – 7.31 
(m, 2H), 7.26 – 7.22 (m, 3H), 3.56 (m, 2H), 2.78 (t, J = 7.6Hz, 2H), 2.17 – 2.09 (m, 2H). 13C NMR 
(125 MHz, CD3CN) δ 143.33, 140.75, 139.75, 137.24, 137.01, 134.53, 129.16, 129.07, 126.99, 
113.93, 56.30, 33.92, 24.17.  HRMS (m/z): [M]+ calcd. for C15H15SO2N2+ 287.0849, found 
287.0840. 
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2-(isopentylsulfonyl)benzenediazonium tetrafluoroborate 1.2c (1.35 g, yield 83%, starting with 
1.14 g 1.2b) pale solid. 1H NMR (500 MHz, CD3CN) δ 8.82 (dd, J = 8.3, 0.8Hz, 1H), 8.49 – 8.46 
(m, 1H), 8.41 (dd, J = 7.9, 1.0Hz, 1H), 8.29 – 8.25 (m, 1H), 3.53 (t, J = 8.0Hz, 2H), 1.74 – 1.66 
(m, 3H), 0.91 (d, J = 6.2Hz, 6H). 13C NMR (125 MHz, CD3CN) δ 143.30, 139.92, 137.19, 136.98, 
134.55, 113.94, 55.49, 30.35, 27.62, 21.71.  HRMS (m/z): [M]+ calcd. for C11H15SO2N2+ 239.0849, 
found 239.0849. 
 
2-((2-cyclohexylethyl)sulfonyl)benzenediazonium tetrafluoroborate 1.3c (590.1 mg, yield 32%, 
starting with 1.34 g 1.3b) light brown solid. 1H NMR (500 MHz, CD3CN) δ 8.81 (dd, J = 8.3, 
1.0Hz, 1H), 8.47 (td, J = 8.3, 1.1Hz, 1H), 8.40 (dd, J = 7.9, 1.2Hz, 1H), 8.27 (td, J = 8.3, 1.2Hz, 
1H), 3.56 – 3.52 (m, 2H), 1.70 – 1.61 (m, 7H), 1.40 – 1.34 (m, 1H), 1.26 – 1.11 (m, 3H), 0.96 – 
0.89 (m, 2H). 13C NMR (125 MHz, CD3CN) δ 143.29, 139.93, 137.19, 136.99, 134.54, 113.95, 
55.17, 36.95, 32.86, 29.05, 26.56, 26.34.  HRMS (m/z): [M]+ calcd. for C14H19SO2N2+ 279.1162, 
found 279.1153. 
 
2-((3-(4-methoxyphenyl)propyl)sulfonyl)benzenediazonium tetra-    fluoroborate 1.4c (1.87 g, 
yield 92%, starting with 1.53 g 1.4b) yellow solid. 1H NMR (500 MHz, CD3CN) δ 8.83 (dd, J = 
8.3, 1.2Hz, 1H), 8.48 (td, J = 7.8, 0.9Hz, 1H), 8.39 (dd, J = 7.9, 1.0Hz, 1H), 8.29 (td, J = 8.2, 1.0Hz, 
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1H), 7.13 (d, J = 8.6Hz, 2H), 6.87 (d, J = 8.6Hz, 2H), 3.78 (s, 3H), 3.54 (t, J = 9.2Hz, 2H), 2.71 (t, 
J = 7.5Hz, 2H), 2.11 – 2.04 (m, 2H). 13C NMR (125 MHz, CD3CN) δ 158.90, 143.31, 139.77, 
137.23, 137.02, 134.52, 132.61, 130.11, 114.50, 113.94, 56.27, 55.44, 33.04, 24.35.  HRMS (m/z): 
[M]+ calcd. for C16H17SO3N2+ 317.0954, found 317.0961. 
 
2-((3-(4-chlorophenyl)propyl)sulfonyl)benzenediazonium tetrafluoro-borate 1.5c (1.01 g, yield 
50%, starting with 1.54 g 1.5b) pale yellow solid. 1H NMR (500 MHz, CD3CN) δ 8.83 (dd, J = 
8.3, 0.9Hz, 1H), 8.48 (td, J = 7.8, 1.1Hz, 1H), 8.40 (dd, J = 7.9, 1.2Hz, 1H), 8.29 (td, J = 7.7, 
1.2Hz, 1H), 7.33 (dd, J = 6.6, 1.8Hz, 2H), 7.22 (d, J = 8.4Hz, 2H), 3.56 – 3.53 (m, 2H), 2.76 (t, J 
= 7.6Hz, 2H), 2.13 – 2.07 (m, 2H). 13C NMR (125 MHz, CD3CN) δ 143.32, 139.67, 139.60, 137.26, 
137.03, 134.56, 132.19, 130.84, 129.07, 113.94, 56.15, 33.20, 23.99.  HRMS (m/z): [M]+ calcd. 
for C15H14ClSO2N2+ 321.0459, found 321.0455. 
 
2-((4-methylpentyl)sulfonyl)benzenediazonium tetrafluoroborate 1.6c (1.05 g, yield 62%, starting 
with 1.21 g 1.6b) pale solid. 1H NMR (500 MHz, CD3CN) δ 8.85 (d, J = 8.1Hz, 1H), 8.50 (td, J = 
7.8, 0.9Hz, 1H), 8.42 (dd, J = 7.9, 0.9Hz, 1H), 8.30 (td, J = 7.9, 1.1Hz, 1H), 3.54 (t, J = 8.0Hz, 
2H), 1.84 – 1.78 (m, 2H), 1.62 – 1.57 (m, 1H), 1.35 – 1.31 (m, 2H), 0.90 (d, J = 6.7Hz, 6H). 13C 
NMR (125 MHz, CD3CN) δ 143.27, 139.93, 137.19, 137.05, 134.51, 113.96, 56.98, 37.21, 27.84, 
22.07, 20.32.  HRMS (m/z): [M]+ calcd. for C12H17SO2N2+ 253.1005, found 253.1004. 
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2-((4-phenylbutyl)sulfonyl)benzenediazonium tetrafluoroborate 1.7c (1.08 g, yield 56%, starting 
with 1.44 g 1.7b) yellow solid. 1H NMR (500 MHz, CD3CN) δ 8.84 (d, J = 8.2Hz, 1H), 8.49 (td, 
J = 7.8, 0.7Hz, 1H), 8.39 (dd, J = 8.2, 1.0Hz, 1H), 8.29 (td, J = 8.2, 1.1Hz, 1H), 7.33 - 7.30 (m, 
2H), 7.23 – 7.21 (m, 3H), 3.58 (t, J = 7.7Hz, 2H), 2.66 (t, J = 7.4Hz, 2H), 1.86 – 1.80 (m, 2H), 
1.79 – 1.74 (m, 2H). 13C NMR (125 MHz, CD3CN) δ 143.26, 142.27, 139.80, 137.22, 137.03, 
134.49, 129.01, 128.96, 126.54, 113.94, 56.61, 35.02, 30.02, 21.80.  HRMS (m/z): [M]+ calcd. for 
C16H17SO2N2+ 301.1005, found 301.1005. 
 
2-(phenethylsulfonyl)benzenediazonium tetrafluoroborate 1.8c (1.12 g, yield 54%, starting with 
1.50 g 1.8b) pale solid. 1H NMR (500 MHz, CD3CN) δ 8.81 (d, J = 8.3Hz, 1H), 8.47 – 8.44 (m, 
1H), 8.39 (d, J = 7.7Hz, 1H), 8.27 (t, J = 7.8Hz, 1H), 7.33 – 7.30 (m, 2H), 7.26 (d, J = 7.3Hz, 3H), 
3.91 – 3.88 (m, 2H), 3.18 (m, 2H). 13C NMR (125 MHz, CD3CN) δ 143.27, 139.78, 137.35, 137.22, 
137.08, 134.63, 129.40, 129.17, 127.73, 113.75, 57.70, 28.30.  HRMS (m/z): [M]+ calcd. for 
C14H13SO2N2+ 273.0692, found 273.0687. 
 
2-(isobutylsulfonyl)benzenediazonium tetrafluoroborate 1.9c (0.23 g, yield 49%, starting with 
0.31 g 1.9b) 1H NMR (500 MHz, CDCl3) δ 8.84 (d, J = 8.2Hz, 1H), 8.50 (t, J = 7.7Hz, 1H), 8.44 
(d, J = 7.6Hz, 1H), 8.29 (t, J = 7.9Hz, 1H), 3.47 (d, J = 6.6Hz, 2H), 2.43 – 2.38 (m, 1H), 1.15 (d, 
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J = 6.7Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 143.32, 140.69, 137.13, 136.88, 134.26, 113.74, 
63.92, 24.52, 22.18. HRMS (m/z): [M]+ calcd. for C10H13N2SO2 225.0692, found 225.0697. 
 
2-(propylsulfonyl)benzenediazonium tetrafluoroborate 1.10c (950 mg, yield 64%, starting with 
1.00 g 1.10b) yellow solid. 1H NMR (500 MHz, CD3CN) δ 8.85 (d, J = 8.8Hz, 1H), 8.50 (td, J = 
7.8, 1.2Hz, 1H), 8.42 (dd, J = 7.9, 1.2Hz, 1H), 8.30 (td, J = 7.7, 1.2Hz, 1H), 3.56 – 3.52 (m, 2H), 
1.88 – 1.81 (m, 2H), 1.06 (t, J = 7.4Hz, 3H). 13C NMR (125 MHz, CD3CN) δ 143.44, 140.04, 
137.36, 137.22, 134.68, 114.13, 58.50, 16.54, 12.61.  HRMS (m/z): [M]+ calcd. for C9H11SO2N2+ 
211.0536, found 211.0535. 
 
2-(butylsulfonyl)benzenediazonium tetrafluoroborate 1.11c (1.12 g, yield 73%, starting with 1.05 
g 1.11b) light yellow solid. 1H NMR (500 MHz, CD3CN) δ 8.85 (dd, J = 8.3, 1.1Hz, 1H), 8.50 (td, 
J = 7.8, 1.2Hz, 1H), 8.43 (dd, J = 7.9, 1.2Hz, 1H), 8.30 (td, J = 8.3, 1.3Hz, 1H), 3.57 -  3.54 (m, 
2H), 1.82 – 1.76 (m, 2H), 1.52 – 1.44 (m, 2H), 0.95 (t, J = 7.4Hz, 3H). 13C NMR (125 MHz, 
CD3CN) δ 143.28, 139.90, 137.19, 137.04, 134.52, 113.96, 56.63, 24.19, 21.57, 13.22.  HRMS 
(m/z): [M]+ calcd. for C10H13SO2N2+ 225.0692, found 225.0693.  
 
2-((3-methoxybutyl)sulfonyl)benzenediazonium 1.12c (1.03 g, yield 59%, starting with 1.23 g 
1.12b) pale yellow power. 1H NMR (500 MHz, CD3CN) δ 8.81 (d, J = 8.3Hz, 1H), 8.48 (td, J = 
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8.0, 1.0Hz, 1H), 8.42 (dd, J = 7.9, 1.1Hz, 1H), 8.27 (m, 1H), 3.68 – 3.54 (m, 2H), 3.44 – 3.38 (m, 
1H), 3.20 (s, 3H), 2.02 – 1.96 (m, 1H), 1.90 – 1.82 (m, 1H), 1.10 (d, J = 6.1Hz, 3H) . 13C NMR 
(125 MHz, CD3CN) δ 143.33, 139.94, 137.20, 136.91, 134.53, 113.93, 74.72, 55.94, 53.86, 28.74, 
18.49.  HRMS (m/z): [M]+ calcd. for C11H15SO3N2+ 255.0798, found 255.0794. 
Representative synthetic procedure for remote hydroxylation of o-diazoniaphenyl alkyl sulfone 
tetrafluoroborate:  
A 50 mL roundbottom flask (RBF) was charged with diazonium salt 1.1c (0.2 mmol, 74.8 
mg) and 0.5 mol % photocatalyst Ru(bpy)3Cl2 (0.001 mmol, 0.75 mg from stock solution).  
Vacuum-purge-backfill under N2 atmosphere was applied three times.  10 mL nitromethane and 2 
mL deionized water, both under N2 atmosphere, were added to the flask using a syringe. The 
solution was deoxygenated three times using freeze-pump-thaw with a dry ice and acetone bath.  
The reaction was then irradiated with 4 W blue LEDs (455 nm) for 24 hours.  10 mL 5% NaHCO3 
was added to the solution and stirred for 1 minute.  The aqueous layer was extracted with 10 mL 
DCM two times.  The organic layer was dried over Na2SO4, filtered, and concentrated under 
vacuum to afford 95.6 mg of crude material. The residue was purified by gradient column 
chromatography using silica gel (0% to 30% ethyl acetate in hexanes) to obtain 43.6 mg product 
1.1 (79% of a pale yellow solid). 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.3Hz, 2H), 7.64 (t, 
J = 7.5Hz, 1H), 7.56 – 7.52 (m, 2H), 7.33 – 7.30 (m, 2H), 7.28 – 7.25 (m, 3H), 4.78 (t, J = 5.1Hz, 
1H), 3.26 – 3.15 (m, 2H), 2.43 (s, 1H), 2.16 – 2.07 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 143.02, 
138.95, 133.74, 129.32, 128.68, 127.99, 127.98, 125.59, 72.13, 52.82, 31.73.  HRMS (m/z): 
[M+Na]+ calcd. for C15H16SO3Na 299.0712, found 299.0719. 
 
Ru(bpy)3Cl2 (0.5 mol %)
CH3NO2 : H2O = 10ml : 2ml
freeze-pump-thaw
Blue LEDs, 24h
S Ph
O O
OH
1.1
S Ph
N
O O
N
BF4
1.1c
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2-methyl-4-(phenylsulfonyl)butan-2-ol, 1.2 (23.7 mg, yield 52%, starting with 65.2 mg 1.2c) 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.93 – 7.91 (m, 2H), 7.68 – 7.65 (m, 1H), 7.59 – 7.56 
(m, 2H), 3.26 – 3.23 (m, 2H), 1.90 – 1.86 (m, 2H), 1.22 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 
139.16, 133.72, 129.32, 128.01, 69.57, 52.20, 35.50, 29.36.  HRMS (m/z): [M+H]+ calcd. for 
C11H17SO3 229.0893, found 229.0902. 
 
1-(2-(phenylsulfonyl)ethyl)cyclohexan-1-ol 1.3 (15.1 mg, yield 28%, starting with 74.0 mg 1.3c) 
yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.93 – 7.91 (m, 2H), 7.67 – 7.64 (m, 1H), 7.59 – 7.56 
(m, 2H), 3.26 – 3.23 (m, 2H), 1.88 – 1.85 (m, 2H), 1.57 – 1.46 (m, 7H), 1.40 – 1.35 (m, 3H). 13C 
NMR (125 MHz, CDCl3) δ 139.26, 133.66, 129.29, 127.99, 70.30, 51.33, 37.44, 34.22, 25.49, 
21.98.  HRMS (m/z): [M+H]+ calcd. for C14H21SO3 269.1206, found 269.1205. 
 
1-(4-methoxyphenyl)-3-(phenylsulfonyl)propan-1-ol 1.4 (33.7 mg, yield 55%, starting with 80.9 
mg 1.4c) pale yellow solid. 1H NMR (500 MHz, CDCl3) δ 7.87 (dd, J = 7.1, 1.2Hz, 2H), 7.65 (td, 
J = 7.4, 1.0 Hz, 1H), 7.55 (td, J = 7.4, 1.0Hz, 2H), 7.19 (d, J = 7.5Hz, 2H), 6.85 (dd, J = 7.5, 1.2Hz, 
2H), 4.74 (s, 1H), 3.79 (s, 3H), 3.26 – 3.13 (m, 2H), 2.18 (s, 1H), 2.13 – 2.09 (m, 2H). 13C NMR 
(125 MHz, CDCl3) δ 159.37, 139.03, 135.10, 133.71, 129.31, 128.02, 126.89, 114.06, 71.89, 55.30, 
52.95, 31.70.  HRMS (m/z): [M+Na]+ calcd. for C16H18SO4Na 329.0818, found 329.0829. 
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1-(4-chlorophenyl)-3-(phenylsulfonyl)propan-1-ol 1.5 (24.8 mg, yield 40%, starting with 81.7 mg 
1.5c) pale solid. 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 7.7Hz, 2H), 7.65 (t, J = 7.4Hz, 1H), 
7.55 (t, J = 7.7Hz, 2H), 7.28 (d, J = 8.4Hz, 2H), 7.20 (d, J = 8.3Hz, 2H), 4.80 (s, 1H), 3.19 (t, J = 
7.7Hz, 2H), 2.57 (s, 1H), 2.13 – 2.03 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 141.60, 138.89, 
133.86, 133.65, 129.39, 128.82, 127.97, 127.02, 71.39, 52.69, 31.74.  HRMS (m/z): [M+H]+ calcd. 
for C15H16ClSO3 311.0503, found 311.0504. 
 
2-methyl-5-(phenylsulfonyl)pentan-2-ol 1.6 (8.0 mg, yield 17%, starting with 68.1 mg 1.6c) white 
solid 1H NMR (500 MHz, CDCl3) δ 7.92 (dd, J = 7.5, 0.8Hz, 2H), 7.68 – 7.65 (m, 1H), 7.59 – 
7.56 (m, 2H), 3.14 (t, J = 7.9Hz, 2H), 1.88 – 1.82 (m, 2H), 1.54 (t, J = 8.5Hz, 2H), 1.20 (s, 6H). 
13C NMR (125 MHz, CDCl3) δ 139.22, 133.70, 129.31, 128.04, 70.59, 56.53, 41.74, 29.34, 17.83. 
HRMS (m/z): [M+Na]+ calcd. for C12H18SO3Na 265.0869, found 265.0870. 
 
1-phenyl-2-(phenylsulfonyl)ethan-1-ol 1.8 (~5.8 mg, yield 11%, starting with 72.0 mg 1.8c) white 
solid. 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.0Hz , 2H), 7.70 – 7.65 (m, 1H), 7.60 (d, J = 
8.0Hz, 2H), 7.34 - 7.27 (m, 5H), 5.28 (d, J = 10.0Hz, 1H), 3.60 (br, J = 2.0Hz, 1H), 3.50 (dd, J = 
13.9, 10.1Hz, 1H), 3.35 (dd, J = 14.4, 1.8Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 140.63, 139.16, 
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134.13, 129.47, 128.76, 128.35, 127.97, 125.65, 68.44, 63.93. Spectral data matched that 
previously reported in literature.30 
 
6,7-dihydrodibenzo[b,d]thiepine 5,5-dioxide 1.8d (~18.7 mg, yield 38%, starting with 72.0 mg 
1.8c) white solid. 1H NMR (500 MHz, CDCl3) δ 8.14 (dd, J = 7.8,1.2Hz, 1H), 7.74 (td, J = 
7.6 ,1.3Hz, 1H), 7.55 (td, J = 7.7 ,1.1Hz, 1H), 7.51 (dd, J = 7.6 ,0.9Hz, 1H), 7.45 – 7.42 (m, 2H), 
7.40 – 7.37 (m, 1H), 7.32 – 7.30 (m, 1H), 3.78 (t, J = 6.9Hz, 2H), 2.99 (br, 2H). 13C NMR (125 
MHz, CDCl3) δ 140.56, 139.45, 137.07, 135.26, 134.24, 130.80, 129.48, 129.15, 129.04, 128.56, 
127.98, 125.65, 63.69, 29.60.  HRMS (m/z): [M+H]+ calcd. for C14H13SO2 245.0631, found 
245.0635. 
 
4-(phenylsulfonyl)butan-2-one 1.12 (30.1 mg, yield 71%, starting with 68.3 mg 1.12c) pale solid. 
1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 7.6Hz, 2H), 7.68 (t, J = 7.4Hz, 1H), 7.58 (t, J = 7.8Hz, 
2H), 3.38 (t, J = 7.3Hz, 2H), 2.93 (t, J = 7.5Hz, 2H), 2.18 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
203.68, 138.98, 133.96, 129.42, 127.97, 50.55, 35.86, 29.88.  HRMS (m/z): [M+Na]+ calcd. for 
C10H12SO3Na 235.0399, found       235.0400. 
Procedure for preparation of 1.1 on 1 mmol scale: 
A 100 mL round-bottom flask was charged with diazonium salt 1.1c (374.1 mg, 1.00 mmol) 
and 0.5 mol % photocatalyst Ru(bpy)3Cl2 (3.7 mg, 0.005 mmol).  Vacuum-purge-backfill under 
N2 atmosphere was applied three times.  50 mL nitromethane and 10 mL deionized water were 
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added to the flask under N2 using a syringe.  The solution was deoxygenated three times using 
freeze-pump-thaw with a dry ice and acetone bath.  The reaction was then irradiated with 4 W blue 
LEDs (455 nm) for 24 hours.  50 mL 5% NaHCO3 solution was added to neutralize acid and 
stirring commenced for 1 minute.  The aqueous layer was extracted with 25 mL DCM twice.  The 
organic layer was dried over Na2SO4, filtered, and concentrated under vacuum to afford 280 mg 
of crude material. The residue was purified by gradient column chromatography using silica gel 
(0% to 33% ethyl acetate in hexanes) to obtain 170.0 mg product 1.1 (62% of a pale-yellow solid). 
Representative procedure for remote etherification using methanol: 
 
A 50 mL roundbottom flask (RBF) was charged with diazonium salt 1.1c (0.2 mmol, 74.8 
mg) and 0.5 mol % photocatalyst Ru(bpy)3Cl2 (0.001 mmol, 0.75 mg from stock solution).  
Vacuum-purge-backfill under N2 atmosphere was applied three times.  10 mL nitromethane and 
100 uL methanol both under N2 atmosphere, were added to the flask using a syringe.  The solution 
was deoxygenated three times using freeze-pump-thaw with a dry ice and acetone bath.  The 
reaction was then irradiated with 4 W blue LEDs (455 nm) for 24 hours.  10 mL 5% NaHCO3 was 
added to the solution and stirred for 1 minute.  The aqueous layer was extracted with 10 mL DCM 
three times.  The organic layer was dried over Na2SO4, filtered, and concentrated under vacuum. 
The residue was purified by gradient column chromatography using silica gel (0% to 30% ethyl 
acetate in hexanes) to obtain 34.2 mg (59%) product 1.1d as a white solid.  1H NMR (500 MHz, 
CDCl3) δ 7.87 (d, J = 7.9Hz, 2H), 7.66 – 7.63 (m, 1H), 7.56 – 7.53 (m, 2H), 7.35 – 7.26 (m, 3H), 
7.21 (dd, J = 8.2, 1.2Hz, 2H), 4.20 (t, J = 6.5Hz, 1H), 3.27 – 3.16 (m, 2H), 3.16 (s, 3H), 2.10 – 
2.06 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 140.48, 139.13, 133.69, 129.31, 128.68, 128.09, 
Ru(bpy)3Cl2 (0.5 mol %)
CH3NO2 (10 mL)
MeOH (0.1 mL)
freeze-pump-thaw
Blue LEDs, 24h
S Ph
O O
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1.1d
S Ph
N
O O
N
BF4
1.1c
 36 
128.05, 126.41, 81.40, 56.72, 52.89, 31.11.  HRMS (m/z): [M+K]+ calcd. for C16H18SO3K 
329.0608, found 329.0611. 
 
 ((3-methoxy-3-methylbutyl)sulfonyl)benzene 1.2d (18.5 mg, yield 38%, starting with 65.2 mg 
1.2c) colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.92 (dd, J = 8.3 ,0.9Hz, 2H), 7.68 – 7.65 (m, 
1H), 7.59 – 7.56 (m, 2H), 3.17 – 3.14 (m, 2H), 3.08 (s, 3H), 1.89 – 1.86 (m, 2H), 1.13 (s, 6H). 13C 
NMR (125 MHz, CDCl3) δ 139.25, 133.66, 129.29, 128.00, 73.16, 51.82, 49.20, 32.02, 24.88.  
HRMS (m/z): [M+K]+ calcd. for C12H18SO3K 281.0608, found 281.0605. 
Representative procedure for remote amidation using CH3CN and H2O: 
 
A 50 mL roundbottom flask (RBF) was charged with diazonium salt 1.1c (0.2 mmol, 74.8 
mg) and 0.5 mol % photocatalyst Ru(bpy)3Cl2 (0.001 mmol, 0.75 mg from stock solution).  
Vacuum-purge-backfill under N2 atmosphere was applied three times.  10 mL nitromethane, 100 
µL CH3CN and 3.6 µL H2O under N2 atmosphere, were added to the flask using a syringe.  The 
solution was deoxygenated three times using freeze-pump-thaw with a dry ice and acetone bath.  
The reaction was then irradiated with 4 W blue LEDs (455 nm) for 24 hours.  10 mL 5% NaHCO3 
was added to the solution and stirred for 1 minute.  The aqueous layer was extracted with 10 mL 
DCM three times.  The organic layer was dried over Na2SO4, filtered, and concentrated under 
vacuum. The residue was purified by gradient column chromatography using silica gel (0% to 30% 
ethyl acetate in hexanes) to obtain 34.0 mg (51%) product 1.1e as a white solid.  1H NMR (500 
MHz, CDCl3) δ 7.88 (dd, J = 7.3, 1.2Hz, 2H), 7.67 (t, J = 7.5Hz, 1H), 7.58 – 7.55  (m, 2H), 7.34 
Ru(bpy)3Cl2 (0.5 mol %)
CH3NO2 (10 mL)
CH3CN (0.1 mL), H2O (1 equiv)
freeze-pump-thaw
Blue LEDs, 24h
S Ph
O O
HN
1.1e
S Ph
N
O O
N
BF4
1.1c
O
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– 7.31 (m, 2H), 7.29 – 7.27 (m, 1H), 7.23  (d, J = 7.1Hz, 2H), 6.28 (d, J = 8.4Hz,  1H), 5.01 (dd, J 
= 14.9, 8.5Hz, 1H), 3.18 – 3.14 (m, 1H), 3.12 – 3.06 (m, 1H), 2.35 – 2.27 (m, 1H), 2.24 – 2.17 (m, 
1H), 1.95 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 169.66, 140.41, 138.94, 133.91, 129.43, 129.04, 
128.04, 127.98, 126.50, 53.52, 51.90, 28.75, 23.27.  HRMS (m/z): [M+Na]+ calcd. for 
C17H19NSO3Na 340.0978, found 340.0983. 
 
((3-methylbut-2-en-1-yl)sulfonyl)benzene 1.2e (25.8 mg, yield 60%, starting with 65.5 mg 1.2c) 
white solid. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 7.5Hz, 2H), 7.66 – 7.63 (m, 1H), 7.59 – 
7.53 (m, 2H), 5.20 – 5.18 (m, 1H), 3.78 (d, J = 7.9Hz, 2H), 1.72 (s, 3H), 1.32 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 142.97, 138.73, 133.52, 128.98, 128.49, 110.42, 56.20, 25.83, 17.73. HRMS 
(m/z): [M+K]+ calcd. for C11H14SO2K 249.0346, found 249.0346. 
Representative procedure for remote arylation: 
 
A 50 mL round-bottomed flask (RBF) was charged with diazonium salt 1.1c (0.2 mmol, 
74.8 mg), 1,4-dimethoxybenzene (1.0 mmol, 138.2 mg), and 0.5 mol % photocatalyst Ru(bpy)3Cl2 
(0.001 mmol, 0.75 mg from stock solution).  Vacuum-purge-backfill under N2 atmosphere was 
applied three times.  10 mL nitromethane was added to the flask using a syringe under N2 
atmosphere. The solution was deoxygenated three times using freeze-pump-thaw and then 
irradiated with 4 W blue LEDs (455 nm) for 24 hours.  10 mL 5% NaHCO3 was added to the 
solution and stirred for 1 minute.  The aqueous layer was extracted with 10 mL DCM three times.  
Ru(bpy)3Cl2 (0.5 mol %)
CH3NO2 (10 mL)
freeze-pump-thaw
Blue LEDs, 24h
S Ph
O O
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The organic layer was dried over Na2SO4, filtered, and concentrated under vacuum. The residue 
(193.2 mg yellow solid crude mixture) was purified by gradient column chromatography using 
silica gel (0% to 30% ethyl acetate in hexanes) to obtain 26.6 mg (34%) product 1.1f as a white 
solid.  1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 7.4, 1.3Hz, 2H), 7.64 (t, J = 7.4Hz, 1H), 7.54 
(t, J = 7.7Hz, 2H), 7.25 – 7.22 (m, 2H), 7.17 – 7.14 (m, 3H), 6.73 (br, J = 8.9Hz, 1H), 6.67 (dd, J 
= 8.8, 3.0Hz, 1H), 6.62 (d, J = 3.0Hz, 1H), 4.34 (t, J = 8.0Hz, 1H), 3.69 (s, 3H), 3.68 (s, 3H), 3.06 
(t, J = 7.9Hz, 2H), 2.40 – 2.34 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 153.66, 151.09, 142.42, 
139.04, 133.60, 132.60, 129.25, 128.52, 128.06, 127.87, 126.52, 114.49, 111.70, 111.29, 55.97, 
55.60, 54.87, 42.24, 27.46.  HRMS (m/z): [M+H]+ calcd. for C23H25SO4 397.1468, found 
397.1476. 
 
2,4-dimethoxy-1-(1-phenyl-3-(phenylsulfonyl)propyl)benzene 1.1g (15.4 mg, yield 19%, starting 
with 74.8 mg 1.1c) white solid. 1H NMR (500 MHz, CDCl3) δ 7.87 (dd, J = 7.4, 1.1Hz, 2H), 7.64 
(t, J = 7.4Hz, 1H), 7.54 (t, J = 7.7Hz, 2H), 7.25 – 7.21 (m, 2H), 7.16 – 7.12 (m, 3H), 6.93 (dd, J = 
9.0, 1.8Hz, 1H), 6.40 – 6.38 (m, 2H), 4.26 (t, J = 8.5Hz, 1H), 3.76 (s, 3H), 3.70 (s, 3H), 3.04 (t, J 
= 8.1Hz, 2H), 2.43 – 2.31 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 159.49, 157.77, 143.11, 139.12, 
133.57, 129.23, 128.44, 128.07, 128.01, 127.79, 126.34, 123.74, 104.29, 98.72, 55.35, 55.30, 54.98, 
41.75, 27.55.  HRMS (m/z): [M+Na]+ calcd. for C23H25SO4 397.1468, found 397.1470. 
Cyclic Voltammetry: 
CV of 1 mM 1.1c in acetonitrile was performed on an AUTOLAB PGSTAT302 instrument 
at a scan rate of 0.1 V/s with Ag/Ag+ reference electrode, Pt counter electrode and glassy carbon 
working electrode. Electrodes were mechanically polished then cleaned with acetone. The 
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electrolyte used was tetrabutylammonium hexafluorophosphate at 0.1 M concentration. Observed 
Ered of 1.1c vs Ag/Ag+ was -0.38 V (-0.28 V measurement – 0.10 V ferrocene calibration offset). 
Ag/Ag+ was converted to SCE by adding 0.30 V to the Ag/Ag+ potential.  Therefore, we report 
the Ered of 1.1c as -0.08 V (SCE) in the text of the Communication so that a direct comparison to 
the (spectro)electrochemistry of Ru(bpy)32+ can be made.  
 
 
Figure 1.9 CV of Arenediazonium Salt 1.1c 
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CHAPTER 2: ACID-CATALYZED O-GLYCOSYLATION WITH STABLE 
THIOGLYCOSIDE DONORS 
2.1 Introduction 
 
 Carbohydrates play essential roles in biological systems.1 Over the past few decades, 
research has revealed the function of carbohydrates in numerous health-related contexts. For 
example, the pathogenesis of diabetes, AIDS, and cancer are all carbohydrate-related processes.2 
Understanding the roles of carbohydrates in these processes has facilitated many biological 
discoveries.3  
  Oligosaccharides are found in numerous natural products and play significant roles in 
therapeutics and vaccines.4 The interactions between oligosaccharides and proteins, lipids, and 
other conjugates are critical for to cell recognition and differentiation.5 Oligosaccharides are 
ubiquitous on the outside of cells. Therefore, the identification of oligosaccharide composition,6 
conformation,7 and interaction with other molecules8 is of great importance. Isolation from natural 
resources provides easy access to test the biological properties of these molecules. However, due 
to the microheterogeneity of naturally occurring oligosaccharides,9 isolates from natural sources 
often contain small quantities of contaminants. Therefore, scientists are exploring chemical10 and 
enzymatic11 synthesis of oligosaccharides to get enough pure material to study and unambiguously 
assign the function. 
Many methods have been developed for the formation of oligosaccharides. Specifically, 
O-glycosylation (Scheme 2.1), a chemical reaction that adds an alcohol to a sugar molecule, plays 
a very important role in the multistep synthesis of oligosaccharides. In O-glycosylation, stereo-
Scheme 2.1 O-Glycosylation 
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control of glycosidic bond formation is still a challenge in glycosylation reactions. Glycosylation 
reactions can undergo both SN1- and SN2-type mechanisms,12 which can confound the control of 
anomeric configuration. Factors, like protecting groups, leaving groups, solvents, and additives 
can be of great importance.  
2.2       Mechanistic Pathways 
In general, the mechanism of chemical glycosylation falls into two categories: 
unimolecular SN1 mechanisms, and bimolecular SN2-like mechanisms (Figure 2.1). For the SN1 
pathway, after activation of the glycosyl donors, dissociation results in the oxocarbenium ion 
intermediate. Attack of glycosyl acceptor from either the top or the bottom face will generate the 
glycosidic linkage. This pathway normally leads to anomeric mixtures since there is often little or 
no stereo-control at the anomeric center. The second mechanism is the SN2-like pathway. After 
activation, the leaving group stays close enough to form a contact ion pair with the resulting 
glycosyl carbocation. As a result, the glycosyl acceptor can only attack from the opposite face, 
generating a single anomer.  There are many other factors that can affect the stereochemical 
outcome of the glycosylation reactions. Understanding the multiple factors contributing to the 
mechanism can explain the stereoselectivity of the reaction and provide insights leading to the 
design of O-glycosylation reactions. 
 
Figure 2.1 Possible Mechanism for Chemical Glycosylation (PG = Protecting Group) 
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2.3       Neighboring Group Participation 
The presence of an acyl protecting group at the C2 position can affect the stereoselectivity 
of the glycosylation reactions.  After generating the oxocarbenium ion intermediate, the carbonyl 
lone pair will interact with the anomeric center resulting in the formation of a dioxolenium ion, 
which blocks the bottom face of the intermediate (Figure 2.2). As a result, the glycosyl acceptor 
can only attack from the top face of the intermediate to generate, exclusively, the b anomer. 
Neighboring group participation is a very important tool to control the stereoselectivity of 
glycosylation reactions. 
2.4       Anomeric Effect 
 The anomeric effect (also called “Edward-Lemieux Effect”) was first discovered by J. T. 
Edward and R. U. Lemieux in the 1960s.13 Electronegative atom substituents on the anomeric 
carbon prefer to be axial. Two possible explanations were proposed. According to molecular 
orbital theory (MOT), hyperconjugation occurs between the lone pair on the oxygen and the σ* 
orbital of the C-OR bond (2a, 2b Figure 2.3).14 The increased bond length of an axial C-Cl bond 
(1.819 Å) compared with the equatorial C-Cl bond (1.718 Å) in a glycosyl chloride further 
Figure 2.2 Neighboring Group Participation (PG = Protecting Group) 
Figure 2.3 MOT and DMT Explanations for Anomeric Effect (PG = Protecting Group) 
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supported this hyperconjugation hypothesis. Another explanation is the dipole moment theory 
(DMT), which stated that the opposing dipoles (2c) were more stabilizing than the aligned dipoles 
(2d) (Figure 2.3).13 
2.5       Solvent Effects 
Another factor to be considered for the stereochemical outcome of glycosylation reactions 
is solvent. The utilization of solvent to control the stereochemistry of glycosylation is attractive 
since the solvent can be simply removed under vacuum. Another advantage is avoiding the use of 
special protecting groups and simplifying the preparation steps for the starting materials. Non-
polar solvents like toluene, benzene, and dichloromethane will not participate in the glycosylation 
process. The purpose of using these solvents is due to temperature and solubility preference of 
glycosylation reactions. For example, some glycosylation reactions require high temperature to 
undergo the SN2-type mechanism. Instead, high boiling point solvents like benzene or toluene can 
be used. Polar, coordinating solvents, such as diethyl ether, acetonitrile, and N, N- 
dimethylformamide will attack the oxocarbenium ion and direct the stereochemical outcome of 
the glycosylation. For example, diethyl ether favors the formation of b-oxonium intermediate 2f 
(Figure 2.4-A), which undergoes an SN2-like process to generate a glycoside (2g) as the major 
Figure 2.4 Effect of Solvents on Glycosylation (PG = Protecting Group) 
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product.15 Acetonitrile, by contrast, prefers to form the a-nitrilium ion 2h that is attacked by 
alcohols to generate the b glycoside 2i (Figure 2.4-B).16 
2.6       Glycosyl Acceptors 
A glycosyl acceptor refers to a carbohydrate mono- or oligosaccharide-ligated alcohol 
which serves as a nucleophile in the formation of glycosidic linkages. The reactivity of glycosyl 
acceptor is strongly determined by the nucleophilicity of an alcohol in O-glycosylation. Some 
commonly used glycosyl acceptors are shown in Figure 2.5. In general, primary alcohols are more 
nucleophilic than secondary alcohols. For example, the free hydroxyl group on carbon 6 (2j) is 
more nucleophilic than the hydroxyl groups on carbons 2 (2k) to 4 (2l). Axial hydroxyl groups 
(2m) are generally less nucleophilic than those at equatorial positions. Protecting groups also have 
a huge impact on the reactivity of glycosyl acceptors. For example, O-benzylated glycosyl 
acceptors (2l) are more reactive than O-benzoylated ones (2n) due to electron-withdrawing 
carbonyl groups. Also, the electronic effect is another concern considering the reactivity of 
glycosyl acceptors. For example, the carbonyl containing glycosyl acceptor (2o) is much less 
reactive than O-benzylated glycosyl acceptors (2l).  
2.7       Glycosyl Donors 
A glycosyl donor refers to a carbohydrate mono- or oligosaccharide which serves as an 
electrophile in the formation of glycosidic linkages and has a leaving group at the anomeric 
position. For the purposes of this dissertation, the alpha (a) and beta (b) carbohydrate anomers are 
Figure 2.5 Representative Examples of Glycosyl Acceptors 
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 defined as follows: a anomer refers to stereoisomers with the cis relationship between the C5-C6 
bond and the C1-H bond (C1 is the anomeric carbon); b anomer refers to stereoisomers with the 
trans relationship between the C5-C6 bond and the C1-H bond (Figure 2.1). Selectivity in obtaining 
the a or b anomer is the key to the synthesis of oligosaccharides, particularly those occurring in 
complex natural glycans.  
                                              a anomer                                    b anomer 
2.7.1    Protecting Groups 
Protecting groups are widely used in glycosyl donors as well as glycosyl acceptors. The 
effects are varying. As the famed carbohydrate chemist Bertram O. Fraser-Reid once said:” 
protecting groups do more than protect.”17 The best-known effect of protecting groups is 
neighboring group participation (vide supra),18 which directly controls the stereochemical outcome 
of the glycosylation reaction. The vast majority of b glycosidic linkages are generated using this 
effect. In some cases, protecting groups can affect the conformation and electronics of the starting 
materials, reaction intermediates, and products.19 For example, the electron withdrawing benzoyl 
protected glycosyl donor 2q (Figure 2.7) is less reactive than the electron donating benzyl 
protected glycosyl donor 2p (Figure 2.7) because the electron-releasing benzyl groups can better 
Figure 2.6 General Configuration of a and b Anomers (PG = Protecting Group) 
Figure 2.7 Examples of Glycosyl Donors 
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stabilize the oxocarbenium ion intermediate. The tert-butyldimethylsilyl (TBS) protected glycosyl 
donor 2r has a twist boat conformation because the C2-C4 C-O bonds, protected by bulky TBS 
groups, occupy the pseudo-axial positions to avoid stereo interaction (Figure 2.7). Though the 
effects of protecting groups have been studied for decades, a paradigm, namely the armed-
disarmed strategy, to distinguish protecting groups’ properties was developed by Fraser-Reid and 
others starting in 1988.20 This strategy is focused on the nucleophilicity of the anomeric heteroatom 
resulting from the electron-withdrawing effects of the protecting groups. The carbonyl-containing 
acyl protecting groups (2q) withdraw electrons from the anomeric heteroatom, which decreases 
the reactivity (disarming) of glycosyl donors toward eventual formation of oxocarbenium or ion 
pairs. To contrast, alkyl substituents (2p) increase the reactivity through release of electrons 
(arming). Benzyl and benzoyl protected donors have become benchmarks for describing armed 
and disarmed glycosyl donors, respectively. Super armed glycosyl donors (2r) are defined as more 
reactive than the per-O-benzylated donors. Super disarmed glycosyl donors like 2s is much less 
reactive because the cyclic protecting groups increase the rigidity of the sugar ring to interfere with 
the flat oxocarbenium ion formation (2e, Figure 2.4). 
2.7.2    Glycosyl Halides 
Fisher and Armstrong21 as well as Koenigs and Knorr22 independently reported that 
glycosyl bromides and chlorides could react with alcohols to form glycosidic linkages in the 
presence of silver or mercury salts in 1901 (Scheme 2.2-A). After that, they extended the 
preparation procedure to synthesize the glycosyl halides. For example, they treated per-O-
acetylated monosaccharides with HBr/AcOH to generate glycosyl bromides (Scheme 2.2-B),23 
which is still an efficient method to make glycosyl bromides today. However, the strongly acidic 
conditions used to make the glycosyl bromide make it incompatible with oligosaccharide synthesis 
especially with acid-sensitive glycosides. Milder synthetic routes are in demand. Mizuno and 
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coworkers24 and Xue and coworkers25 performed the synthesis of glycosyl halides using photo-
redox catalysis.  Regarding glycosyl iodide, most glycosylation reactions used in situ generation 
because of the short shelf life of glycosyl iodides. Many dependable methods to obtain glycosyl 
iodide using either trimethylsilyl iodide (TMSI)26 or HI27 have been developed. Instead of using 
the harsh and reactive TMSI reagent, Field’s group developed another activation method 
combining easily handled hexamethyldisilane and iodine, which generated TMSI in situ as the 
reactive intermediate. Field’s group successfully made acetylated glycosyl iodide using this 
activation method in good yields (Scheme 2.3).28 In 1981, Mukaiyama et al. uncovered the role of 
glycosyl fluoride as glycosyl donor. Glycosyl fluoride could be activated by AgClO4 and SnCl2.29 
Because of the stability of the C-F bond compared with other C-X bonds, the utility and synthesis 
of glycosyl fluoride have been widely developed.30  
2.7.3    Alkenyl/Alkynyl Glycosides 
The prototype alkenyl glycoside is the n-pentenyl glycoside (2.1) because of its versatility. 
The activation of n-pentenyl glycoside is shown in Figure 2.8. Employment of N-
bromosuccinimide (NBS) or N-iodosuccinimide (NIS) results in the bromonium (2.2) or iodonium 
Scheme 2.2 Preparation and Glycosylation with Glycosyl Bromide 
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ion by reaction with the alkene. The following cyclization with the exoanomeric oxygen leads to 
the formation of tetrahydrofuranyl oxonium ion intermediate 2.3. Collapse of 2.3 generates the 
oxocarbenium ion 2.4 with a tetrahydrofuran derivative as leaving group. Then, 2.4 is attacked by 
a nucleophile to generate the final glycosylation product. It is worthy to note that the coupling 
efficiency is higher in gem-dimethyl substituted n-pentenyl glycosides due to Thorpe-Ingold effect 
(Figure 2.9).31  
  Propargyl glycosides were the prototype for Au-catalyzed O-glycosylation. Because of 
the alkynophilic property of gold, this class of glycoside can be activated by AuI or AuIII species 
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(Figure 2.10).32 Coordination of AuCl3 to the propargyl glycoside 2.6 leads to the formation of 
cyclopropyl gold intermediate 2.7. The oxocarbenium ion 2.4 is generated by the expulsion of an 
alkenyl gold complex intermediate 2.8. Intermediate 2.4 is then attacked by an alcohol to generate 
the final product 2.5. Besides the propargyl glycoside, Yu and coworkers introduced a new class 
of alkynyl glycoside called ortho-alkynyl benzoate glycoside 2t, (Figure 2.11), which could be 
activated by gold catalysts and even molecular iodine.33a Hotha and coworkers developed another, 
more useful alternative alkynyl glycoside called glucosyl ethynylcyclohexyl carbonate 2u (Figure 
2.11). The rigidity of the structure conformation makes it a faster and more efficient glycosyl donor 
than 2t in the synthesis of oligosaccharides.33b 
2.7.4    Glycosyl Imidates 
Since they were first introduced by Schmidt and coworker in 1980,34 glycosyl 
trichloroacetimidates have been widely used in oligosaccharide synthesis. The preparation of those 
glycosyl donors involves reacting the anomeric hydroxyl group of a reducing sugar with 
trichloroacetonitrile under basic conditions. The activation of glycosyl imidates requires strong 
Lewis acid such as AgOTf,35 BF3•Et2O,36 TMSOTf,37 ZnBr2,38 or protic acid.39 Protonation of 
nitrogen in the glycosyl trichloroacetimidate 2.9 is followed by the departure of imidoyl group 
Figure 2.11 Structures of Yu’s and Hotha’s Alkynyl Glycoside (PG = Protecting Group) 
Figure 2.12 Activation of Glycosyl Trichloroacetimidate with Lewis Acid 
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resulting in the formation of trichloroacetamide and oxocarbenium ion 2.4, which is further 
attacked by alcohols to generate the final products 2.5 (Figure 2.12). Yu and coworkers have 
introduced an alternative called glycosyl N-phenyl trifluoroacetimidates. Their synthesis involves 
combination of anomeric hydroxyl group with (N-phenyl)trifluoroacetimidoyl chloride in the 
presence of K2CO3. Yu’s group has demonstrated that the stability and efficacy of these N-phenyl 
trifluoroacetimidates is comparable to that of trichloroacetimidates. Due to the relative instability 
of glycosyl imidates, long-term storage should be avoided. For the best results, they should be used 
immediately after preparation. 
 Thio-imidates have also been introduced as glycosyl donors for oligosaccharide synthesis. 
Demchenko and coworkers have made important contributions to the development of thioimidate 
glycosyl donors. They introduced a new thioimidate donor called the S-benzoxazolyl (SBox) 
glycoside (2.11), which has been reported to undergo both a and b selective O-glycosylation 
(Scheme 2.4).40 Typical promoters include Cu(OTf)2,41 MeOTf,42 and NIS/HOTf for thioimidate 
activation. 
2.7.5    Thioglycosides 
Thioglycosides, first introduced as glycosyl donors by R. J. Ferrier et al,43 have become 
one of the most commonly used glycosyl donors in the synthesis of oligosaccharides and complex 
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glycoconjugates. This class of glycoside is remarkably stable towards various protecting group 
manipulations, making them ideal candidates for the orthogonal synthesis of oligosaccharides. 
However, because of the high stability, harsh promotors like AgOTf, CuOTf, NIS/HOTf, and 
PhHgOTf are used to activate thioglycosides.44 More recently, much milder promotors such as 
iodonium dicollidine perchlorate (IDCP),45 Ipy2BF4,48 NBS/HOTf,45 PhIO/Tf2O,47 and the 
photosensitizer Ru(bpy)32+ were applied to activate thioglycosides.49 The aim is to use the 
promoter as an electrophile that can react with or coordinate to sulfur lone pair to convert the 
sulfide to a more efficient leaving group so as to generate the oxocarbenium intermediate 2.4 
(Figure 2.13). 
2.7.6    Glycals 
Glycals, which are an important precursor for making 3,4-unsaturated glycosides, are of 
great importance in carbohydrate chemistry. The Ferrier rearrangement (Figure 2.14) is one such 
process involving glycal substrates.50 This transformation takes place in the presence of Lewis 
acid.  The use of glycals as glycosyl donors in glycosylation reactions was expanded by 
Danishefsky.51 Nucleophilic attack of the alkene on electrophiles generates an onium intermediate 
which can then be attacked by an alcohol to form glycosyl products (Figure 2.15). This method 
has been extensively used in the stereoselective synthesis of O-glycosides. However, the harsh 
Figure 2.14 Ferrier Rearrangement (PG = Protecting Group) 
Figure 2.15 Glycosylation of Glycals (PG = Protecting Group) 
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reaction conditions sometimes limit their use in some glycosylation reactions such as substrates 
containing acid-labile functionality.52 
2.8       Research Significance 
Due to the microheterogeneity of natural oligosaccharides, it is often hard to obtain 
sufficient quantities of pure materials from natural sources. The chemical synthesis of 
oligosaccharides is a significant tool for deepening our understanding of glycobiology.9 In 
particular, O-glycosylation is one of the most important chemical reactions in the multistep 
synthesis of oligosaccharides. Two of the most commonly used donors in O-glycosylation are 
thioglycosides and glycosyl trichloroacetimidates (TCAs, Figure 2.16). As mentioned easier, 
thioglycosides are easily synthesized from glycosyl halides. Due to their high stability, 
thioglycosides are ideal candidates for multistep synthesis though their activation requires harsh 
conditions. TCAs are directedly synthesized from lactols and are activated under mildly acidic 
conditions. However, TCAs are not easily carried through multistep synthesis due to their 
instability in certain systems. N-phenyltrifluoroacetimidates (PTFAs, Figure 2.16), which are more 
stable substituents for TCAs, are still considered unstable and have short shelf life.10   
Recently, the Ragains group has developed a new class of thioglycosides: 4-(4-
methoxyphenyl)-3-butenylthioglycosides (MBTGs, Figure 2.16). MBTGs were first used in a 
visible-light-promoted O-glycosylation reaction (Scheme 2.5-A).49 In this transformation, the 
electron-rich thioglycoside and Umemoto’s reagent formed an electron donor-acceptor (EDA) 
complex, which was activated by blue LED irradiation to generate a glycosylsulfonium ion 
Figure 2.16 Structures of Glycosyl Donors (PG = Protecting Group) 
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intermediate (2v). Subsequent alcohol attack resulted in the formation of glycosidic linkages. In 
contrast to most thioglycoside activation methods, this photo-induced activation of MBTGs is a 
mild approach to O-glycosylation that occurs in the absence of photocatalysts. Subsequently, we 
wondered if the protonation of MBTG would result in a glycosylsulfonium ion intermediate (2w) 
that is similar to 2v using catalytic amounts of strong acid (Scheme 2.5-B). Herein, I report on my 
efforts to develop O-glycosylation by acid-catalyzed activation of MBTGs. 
2.9       Results and Discussion 
2.9.1    Synthesis of MBTG Donors 
2-Amino-2-deoxy sugar derivatives are widely found in natural sources. They are the very 
important building blocks for the synthesis of glycopeptides, which are essential for treating gram-
positive bacterial infections. The synthesis of 2-amino-2-deoxyglucose MBTG donor was divided 
into two parts: the synthesis of alkyl iodide 2.21 and the mercapto glucosamine 2.24 (Scheme 2.6). 
Regarding the synthesis of 2.21, 3-bromopropanol was treated with melted triphenylphosphine at 
120 oC, generating the phosphonium bromide salt 2.19.53 Wittig reaction of 2.19 with p-
anisaldehyde in the presence of lithium bis(trimethylsilyl)amide (LHMDS) resulted in the 
formation of alcohol 2.20,54 which was further treated with iodine, triphenylphosphine, and 
imidazole in dichloromethane to generate alkyl iodide 2.21.55 For the synthesis of mercapto  
Scheme 2.5 Visible-Light-Promoted and Acid-Catalyzed O-Glycosylation 
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glucosamine 2.24, D-glucosamine hydrochloride was treated with 2,2,2-trichloroethoxycarbonyl 
chloride under basic conditions, followed by treatment with pyridine and acetic anhydride to afford 
the protected glucosamine 2.22.56 Conversion to glycosyl bromide 2.23 was achieved using 33% 
HBr/AcOH in DCM.23 Glycosyl bromide 2.23 was further reacted with thiourea, followed by 
hydrolysis to give the mecapto glucosamine 2.24.57 Alkylation of 2.24 with alkyl iodide 2.21 
resulted in the formation of the final 2-amino-2-deoxyglucose MBTG donor 2.25.49 Glycosylation 
of MBTG donor 2.25 with methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside with 10 mol% triflic 
acid in DCM provided 60% yield of disaccharide 2.26 (Scheme 2.7), which demonstrated the 
efficacy of the 2-amino-2-deoxyglucose MBTG donor 2.25 in O-glycosylation. 
2.9.2    Compatibility, Latent-Active Strategy 
Previously, we have demonstrated that the side chain of MBTG donor was stable under 
methanolysis (NaOMe, MeOH). In order to further demonstrate the robustness of the MBTG 
thioglycoside side chain, I have conducted a number of experiments which demonstrated the side  
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chain could tolerate various conditions. Firstly, I synthesized the benzylidene protected MBTG 
donor 2.27. Starting with 2.27a, deacetylation followed by benzylidene protection afforded 2.27b, 
which was then protected by benzyl groups to provide 2.27.49 2.27 was then treated with 
trifluoroacetic acid (TFA) in methanol under reflux. Benzylidene removal product 2.28 was 
observed (Scheme 2.8). Another reaction that I performed was the removal of tert-
butyldimethylsilyl (TBS) from MBTG thiglycoside 2.29. The synthesis of 2.29 commenced with 
2.27a, deacetylation, protection of C6 hydroxyl group with TBS group using imidazole in THF 
followed by benzoyl protection of the remaining hydroxyl groups affording 2.29 (Scheme 2.9). 
Instead of using fluoride-containing reagents, para-toluenesulfonic acid in MeOH was used for 
the removal of TBS group, which yielded the product 2.30 in high yield (Scheme 2.9). These two 
examples demonstrated that the side chain was stable towards mild acids.  
Another important contribution to this work was the development of a latent-active strategy 
for multistep synthesis of oligosaccharides. In this study, I synthesized a 3-butenylthioglycoside 
Scheme 2.8 Synthesis and Removal of Benzylidene-Protected MBTG Donor 2.27 
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donor 2.31 and demonstrated that it had no reactivity under acid-catalyzed conditions (Scheme 
2.10-A). However, the 3-butenylthioglysocide 2.31 could be converted, via cross metathesis, to 
the reactive MTBG thioglycoside 2.32 (Scheme 2.10-B). 
2.10     Summary 
In this study, I have synthesized a 2-amino-2-deoxyglucose MBTG donor and 
demonstrated the efficacy of this donor in O-glycosylation. I also demonstrated that the MBTG 
side chain was stable under mild acid conditions, which broadens the potential utility of MBTGs 
for oligosaccharide synthesis. Further, the latent-active strategy involving cross-metathesis 
provided another viable pathway for oligosaccharide synthesis. 
2.11     Experimental 
2.11.1  General Methods 
Reagents were purchased from Sigma Aldrich and used as received. Flash column 
chromatography was performed using 60Å silica gel purchased from Sigma Aldrich. 1H NMR and 
13C NMR spectroscopy were performed on a Bruker AV-400 or a Bruker AV500 spectrometer. 
Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight mass spectrometer. 
Analytical and preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). 
Compounds were visualized by UV absorption (254 nm) and staining with anisaldehyde. 5 mL 
Pyrex micro reaction vessels (Supelco) were used in the glycosylation reactions. Deuterated 
solvents were obtained from Cambridge Isotope Labs. All solvents were purified according to the 
method of Grubbs.58 
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2.11.2  Procedures and Characterization 
Synthesis of 2.21 
A 250 mL RBF was charged with 5.25 g (20.0 mmol) triphenylphosphine, which was then 
heated to 120 oC. 1.81 mL (20.0 mmol) 3-Bromo-1-propanol was added slowly over a period of 5 
min after the triphenylphosphine was fully dissolved. The reaction was kept at 120 oC for 15 min 
before 70 mL EtOH was added to the suspension. The flask was removed from heating until a 
homogeneous solution was obtained, which was the cooled to 0 oC until a lot of solid precipitating 
out of solution. The suspension was filtered, washed with 200 mL hexanes. The resulting crystal 
2.19 (4.815 g, 60%) was further dried on high vacuum. 
To a mixture of 4.82 g (12.0 mmol) 2.19 in 20 mL dry THF at -20 oC was added 25 mL 
(25 mmol) LHMDS (1 M in THF) dropwise. The mixture was stirred for one hour at -20 oC, and 
then 1.25 mL (10.3 mmol) of para-anisaldehyde was added dropwise. This resulting mixture was 
stirred for another hour at -20 oC before slowly warming to room temperature, and then stirred 
overnight. The reaction was quenched using 40 mL sat. NH4Cl (aq), extracted with 2 X 50 mL 
EtOAc, then dried over Na2SO4. Silica gel chromatography (20% EtOAc in hexanes) afforded 933 
mg (52%) 2.20 of a white solid Spectral data matched that reported in literature.49 
1.52 g (5.99 mmol) I2 was added in three potions to the solution of 1.57 g (5.99 mmol) 
triphenylphosphine in 20 mL DCM and stirred for 10 minutes at room temperature. 680 mg (9.99 
mmol) imidazole was added in one portion and the reaction was stirred for another 10 minutes at 
room temperature. 712.4 mg (3.997 mmol) 2.20 was added to the reaction and stirred for 1 h. 30 
mL sat. Na2S2O5 was added and the layers were separated. The aqueous layer was extracted with 
DCM (2 X 30 mL) and the organic layers were dried over Na2SO4. Silica gel chromatography (5% 
HO Br
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EtOAc in hexanes) afforded 1.02 g (88%) of a white solid. Spectral data matched that reported in 
literature.49 
Synthesis of 2.25 
8.20 mL (60.0 mmol) 2,2,2-Trichlorethoxycarbonyl chloride was added to a vigorously 
stirred solution of 10.8 g (50.1 mmol) D-glucosamine hydrochloride and 12.80 g (150.0 mmol) 
sodium bicarbonate in 100 mL H2O during a period of 10 min at room temperature (18oC). The 
reaction was stirred for an additional hour. The resulting mixture was neutralized by slowly adding 
2 M HCl (55 mL) and filtered. The filter cake was washed with 100 mL H2O and the remaining 
solid material was placed on high vacuum (14 h). The dried solid was dissolved in 50 mL pyridine, 
and 25.0 mL (264 mmol) acetic anhydride was added to the solution. The reaction was stirred 
overnight (12 h) and then concentrated. The resulting crude material was purified using silica gel 
chromatography with an isocratic run of 20% ethyl acetate in hexanes to afford 19.86 g (76%) 
1,2,3,6-tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-D-glucopyranose (2.22) as 
a white solid. Spectral data matched that previously reported in the literature.59 
18.75 mL 33% HBr/HOAc was added at once to a solution of 4.18 g (8.0 mmol) 2.22 in 
30 mL dichloromethane at 0oC. The reaction was allowed to warm to room temperature (19oC) 
and stirred for 3 h. 50 mL cold water was added to the reaction. The aqueous layer was extracted 
with 2 X 30 mL DCM. The combined organic layers were washed with 30 mL sat. NaHCO3, 30 
mL brine, and dried over Na2SO4. The resulting solution was concentrated to a white foam (2.23) 
and carried on without further purification. The resulting white foam was dissolved in 15 mL 
acetone, and 0.91 g (12 mmol) thiourea was then added. The reaction was heated to reflux for 2 h 
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during which a white precipitate formed in the solution. The suspension was filtered. The residue 
was kept, and the filtrate was once again heated to reflux. This process was repeated 3 times until 
there was no more solid precipitate.  The combined precipitates were dissolved in 30 mL DCM, 
and a solution of 1.77 g Na2S2O5 in 15 mL H2O was added. The resulting mixture was stirred 
vigorously and heated to 55 oC for 3 h. The resulting aqueous layer was extracted with 2x15 mL 
DCM. The combined organic layers were dried over Na2SO4 and concentrated. The resulting crude 
material was purified by silica gel chromatography using a gradient solvent system starting at 100% 
hexanes and ending at 25% ethyl acetate in hexanes to afford 3.3 g (83 %) 3,4,6-tri-O-acetyl-2-
deoxy-1-mercapto-2-(2,2,2-trichloroethoxycarbonylamino)-a-D-glucopyranose (2.24) as a white 
powder. 1H NMR (500 MHz, CDCl3) δ 5.38 (d, J = 10.0 Hz, 1H), 5.17 (t, J = 10.0 Hz, 1H), 5.11 
(t, J = 10.0 Hz, 1H), 4.79 (d, J = 15.0 Hz, 1H), 4.72 (d, J = 15.0 Hz, 1H), 4.65 (t, J = 7.5 Hz, 1H), 
4.25 (dd, J = 10.0, 5.0 Hz, 1H), 4.13 (d, J = 15.0 Hz, 1H), 3.78 – 3.71 (m, 2H), 2.48 (d, J = 10.0 
Hz, 1H), 2.10 (s, 3H), 2.04 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 170.9, 170.7, 169.3, 154.4, 
95.3, 80.2, 76.3, 74.6, 73.0, 68.2, 62.1, 59.0, 20.8, 20.64, 20.60.  HRMS (m/z): [M+Na]+ calcd. 
for C15H20NSO9Cl3Na 517.9810, found 517.9816. [α]D25 = +2.2 (c=1, DCM). IR (cm-1): 3325, 
2960, 2951, 1739, 1536, 1219, 1084. 
338 μL DBU (2.26 mmol) was added dropwise to a solution of 993.5 mg (2.000 mmol) 
2.24 and 605.0 mg (2.100 mmol) 1-iodo-4-(4-methoxyphenyl)-3-butene (2.21)7 in 10 mL DCM. 
The reaction was stirred for 1 h and then concentrated. The resulting crude material was purified 
using silica gel chromatography (100% hexanes to 30% ethyl acetate in hexanes) to afford 1.20 g 
(92%) 4-(4-methoxyphenyl)-3-butenyl-3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroethoxy-
carbonylamino)-1-thio-a-D-glucopyranoside (2.25) as a white foam. 1H NMR (500 MHz, CDCl3) 
δ 7.27 (d, J = 10.0 Hz, 2H.), 6.84 (d, J = 10.0 Hz, 2H), 6.38 (d, J = 20.0 Hz, 1H), 6.08 – 6.02 (m, 
1H), 5.23 – 5.17 (m, 2H), 5.08 (t, J = 9.7 Hz, 1H), 4.77 (d, J = 12.0 Hz, 1H), 4.66 – 4.63 (m, 2H), 
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4.25 (dd, J = 12.4, 5.1 Hz, 1H), 4.14 (dd, J = 10.0, 5.0 Hz, 1H), 3.82 – 3.76 (m, 1H), 3.80 (s, 3H), 
3.72 – 3.69 (m, 1H), 2.88 – 2.78 (m, 2H), 2.53 – 2.48 (m, 2H), 2.08 (s, 3H), 2.03 (s, 3H), 2.02 (s, 
3H).  13C NMR (125 MHz, CDCl3) δ 170.7, 169.4, 159.0, 154.0, 131.0, 130.0, 127.2, 125.6, 114.0, 
95.3, 84.6, 77.2, 75.9, 74.5, 73.2, 68.5, 62.3, 55.3, 55.3, 33.3, 30.1, 20.7, 20.6, 20.6.  HRMS (m/z): 
[M+H]+ calcd. for C26H33Cl3NSO10 656.0885, found 656.0884. [α]D25 = -27.0o (c=1, DCM).  IR 
(cm-1): 3338, 2955, 2837, 1742, 1715, 1537, 1219, 1025. 
Synthesis of 2.26 
A reaction vial was charged with 98.5 mg (0.150 mmol) 2.25 and 34.9 mg (0.075 mmol) 
methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. Vacuum-purge-backfill under N2 atmosphere 
was applied three times.  1 mL DCM and then 1.3 μL (0.015 mmol) HOTf, were added to the vial 
using a syringe. The reaction was stirred for 1.5 h. 5.0 μL triethylamine was then added to quench 
the reaction which was concentrated. The resulting crude mixture (180.1 mg) was purified by silica 
gel using a gradient run (100% hexanes to 30% ethyl acetate in hexanes) to afford 42.4 mg (61%) 
2.26 as pale-yellow solid. Spectral data matched that previously reported in the literature.60 
Synthesis of 2.28 
 
To a flame-dried 250 mL round bottomed flask equipped with a stir bar was added 2.75 g 
(5.24 mmol) 4-(4-methoxyphenyl)-3-butenyl-2,3,4,6-tetra-O-acetyl-1-thio-b-D-glucopyranoside 
2.27a and 100 mL MeOH. 0.51 mL (2.1 mmol) of a commercial 5 M solution of  NaOMe in MeOH 
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was added at once at room temperature.  The resulting solution was stirred magnetically for 10 
minutes after which the reaction was judged to be complete by TLC analysis.  The resulting 
solution was concentrated under vacuum. The crude mixture was carried on without further 
purification.  
To a flame dried 100 mL round-bottom flask was added 1.069 g (2.999    mmol) of 4-(4-
methoxyphenyl)-3-butenyl-1-thio-b-D-glucopyranoside and 0.60 mL (3.6 mmol) of commercial 
benzaldehyde dimethyl acetal and vacuum-purge-backfilled with N2 three times. 30 mL of 
acetonitrile was added under N2. Then, 58.1 mg (0.166 mmol) of copper (II) 
trifluoromethanesulfonate was added in one portion. This mixture was sonicated for 30 minutes at 
room temperature after which the reaction was judged to be complete by TLC analysis. The 
reaction mixture was concentrated under reduced pressure and a yellow oil was afforded. Silica 
gel chromatography (isocratic run of 5% MeOH in DCM) afforded 910 mg (68%) 2.27b as a white 
foam. 
900 mg 2.27b (2.024 mmol) and 149.7 mg tetrabutylammonium iodide (TBAI) (0.4053 
mmol) were dissolved in 10 mL DMF. The solution was cooled to 0 oC, and 60% sodium hydride 
(404.1 mg, 10.10 mmol) was added portion-wise. The resulting mixture was stirred for 30 min at 
0 oC. BnBr (720 uL, 5.8 mmol) was added dropwise. The reaction was warmed to rt (21 oC) and 
allowed to stir overnight (12 h). 10 mL Sat. NH4Cl was added to quench the reaction, which was 
then extracted with EtOAc (2 X 30 mL). The organic layer was washed with 300 mL brine, dried 
with Na2SO4, and concentrated. The resulting crude material was purified using silica gel (0% to 
15% ethyl acetate in hexanes) to afford 940.0 mg (74 %) 2.27 as a white solid. 1H NMR (400 
MHz, CDCl3) δ 7.51 – 7.48 (m, 2H), 7.42 – 7.26 (m, 15H), 6.84 (d, J = 8.8Hz, 2H), 6.40 (d, J = 
15.8Hz, 1H), 6.10 (dt, J = 6.9, 15.8Hz, 1H), 5.59 (s, 1H), 4.96 (d, J = 11.3Hz, 1H), 4.89 (d, J = 
10.2Hz, 1H), 4.83 (d, J = 6.0Hz, 1H), 4.80 (d, J = 7.1Hz, 1H), 4.59 (d, J = 9.8Hz, 1H), 4.37 (dd, J 
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= 5.0, 10.4Hz, 1H), 3.84 – 3.70 (m, 3H), 3.81 (s, 3H), 3.51 – 3.44 (m, 2H), 2.94 – 2.81 (m, 2H), 
2.58 – 2.52 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 158.90, 138.36, 137.90, 137.24, 130.88, 
130.07, 128.90, 128.31, 128.31, 128.25, 128.19, 128.00, 127.80, 127.65, 127.16, 125.95, 125.78, 
113.91, 101.09, 86.02, 82.74, 81.55, 81.29, 75.93, 75.17, 70.21, 68.67, 55.24, 33.42, 30.94. HRMS 
(m/z): [M+Na]+ calcd. for C38H40SO6Na 647.2438, found 647.2428. [α]D20 = + 11.2o (c = 1.0, 
DCM). IR (cm-1 ): 3063, 3031, 2875, 1606, 1508, 1362, 1245, 1073, 1028, 741, 692.  
A 25 mL RBF was charged with 208.1 mg 2.27 (0.3331 mmol) and 5 mL MeOH. 0.20 mL 
trifluoroacetic acid was added. The reaction was heated to reflux which was maintained for 6 h 
until starting material had been consumed (monitoring with TLC). The reaction mixture was then 
concentrated. The resulting crude material was purified using silica gel (0% to 40% ethyl acetate 
in hexanes) to afford 155.6 mg (87 %) 2.28 as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.41 
– 7.26 (m, 12H), 6.84 (d, J = 8.7Hz, 2H), 6.41 (d, J = 15.8Hz, 1H), 6.10 (dt, J = 6.9, 15.8Hz, 1H), 
4.98 (d, J = 6.4Hz, 1H), 4.96 (d, J = 5.0Hz, 1H), 4.77 – 4.71 (m, 2H), 4.55 (d, J = 9.6Hz, 1H), 3.92 
– 3.87 (m, 1H), 3.82 (s, 3H), 3.80 – 3.74 (m, 1H), 3.62 – 3.57 (m, 1H), 3.50 (t, J = 8.8Hz, 1H ), 
3.41 (t, J = 9.6Hz, 1H ), 3.38 – 3.33 (m, 1H), 2.94 – 2.81 (m, 2H), 2.59 – 2.53 (m, 2H), 2.33 – 2.28 
(m, 1H), 2.09 – 2.04 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 158.93, 138.36, 137.75, 130.96, 
130.07, 128.70, 128.42, 128.30, 128.04, 127.93, 127.87, 127.20, 125.76, 113.94, 85.88, 85.60, 
81.55, 79.05, 75.42, 75.35, 70.55, 62.80, 55.27, 33.46, 31.08. HRMS (m/z): [M+Na]+ calcd. for 
C31H36SO6Na 559.2125, found 559.2129. [α]D20 = - 18.9o (c = 1.0, DCM). IR (cm-1 ): 3565, 
3344, 3030, 2906, 1605, 1510, 1130, 1050, 1022, 738, 695. 
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Synthesis of 2.30 
To a flame-dried 250 mL roundbottom flask equipped with a stir bar was added 524.6 mg 
(1.000 mmol) 4-(4-methoxyphenyl)-3-butenyl-2,3,4,6-tetra-O-acetyl-1-thio-b-D-glucopyranoside 
2.27a and 20 mL MeOH. 0.1 mL (0.5 mmol) of a commercial 5 M solution of NaOMe in MeOH 
was added at once at room temperature.  The resulting solution was stirred magnetically for 10 
minutes after which the reaction was judged to be complete by TLC analysis.  The resulting 
solution was concentrated under vacuum and co-evaporated with 10 mL toluene. The crude 
mixture was carried on without further purification.  
The resulting solid was dissolved in 8 mL THF in a 50 mL round-bottomed flask followed 
by adding 340.4 mg (5.000 mmol) imidazole and 452.2 mg (3.000 mmol) tert-butyldimethylsilyl 
chloride. The reaction was stirred at room temperature for 1 hour. 50 mL Ethyl acetate was added, 
and the resulting mixture was washed with 20 mL brine twice. The organic layer was dried with 
Na2SO4 and concentrated. The resulting foam oil was dissolved in 5 mL dry pyridine and cooled 
to 0 oC. Benzoyl chloride (0.53 mL, 4.5 mmol) was added dropwise to the solution. The reaction 
was stirred overnight (12 h). The resulting mixture was diluted with 20 mL EtOAc. The organic 
layer was washed sequentially with 2 X 30 mL 1 M HCl, 2 X 30 mL sat. NaHCO3, 20 mL brine, 
and then dried with Na2SO4. The resulting solution was concentrated and purified by 
chromatography (0% to 15% EtOAc in hexanes) to afford 423 mg (54%) of 2.29 as a white solid. 
A 10 mL RBF was charged with 140.0 mg 2.29 (0.1787 mmol), 0.05 mL H2O, and 3 mL 
acetone. p-Toluenesulfonic acid (31.3 mg, 0.182 mmol) was added at rt (21 oC) and the reaction 
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was subsequently stirred for 8 h. The reaction mixture was concentrated, and the resulting crude 
material was purified by chromatography (0% to 30% EtOAc in hexanes) to afford 101.3 mg (85%) 
of 2.30 as a white solid. 
Synthesis of 2.31 
0.46 mL 33% HBr/HOAc was added dropwise to a solution of 1.40 g (2.00 mmol) 
1,2,3,4,6-penta-O-benzoyl-D-glucopyranose61 in 8 mL dichloromethane at 0 oC. The reaction was 
warmed to room temperature (19 oC) and stirred for 12 h. 20 mL cold water was then added to the 
reaction. The aqueous layer was extracted with 2 X 15 mL DCM. The combined organic layers 
were washed with 20 mL sat. NaHCO3, 20 mL brine, and dried over Na2SO4. Evaporation of 
solvent resulted in a material that was carried on without further purification. 180 μL (3.0 mmol) 
CS2 was added dropwise to a suspension of 0.96 g (4.0 mmol) Na2S∙9H2O in 10 mL DMF at room 
temperature (19 oC).  The unpurified material was dissolved in 2.0 mL DMF and injected into the 
solution, whose color turned to orange from dark red. The reaction was stirred for 15 min at 19 oC.  
30 mL H2O was added to quench the reaction.  The aqueous layer was extracted with 2 X 15 mL 
ethyl acetate. The combined organic layers were washed with 50 mL brine, dried with Na2SO4, 
and concentrated. Silica gel chromatography (isocratic run of 30% ethyl acetate in hexanes) 
afforded 0.78 g (65 %) 2,3,4,6-tetra-O-benzoyl-1-mercapto-b-D-glucopyranoside as a white foam. 
Spectral data matched that previously reported in the literature.62 
164 μL (1.10 mmol) DBU was added dropwise to a mixture of 612.6 mg (0.9999 mmol) 
2,3,4,6-tetra-O-benzoyl-1-mercapto-b-D-glucopyranoside and 203 μL (2.00 mmol) 4-bromo-1-
butene in 5 mL DCM at rt. The reaction was allowed to stir overnight (15 h) and was then 
concentrated. The resulting crude material was purified using silica gel (100% hexanes to 20% 
O
BzO
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O
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O
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ethyl acetate in hexanes) to afford 350.6 mg (53 %) 2.31 as a white foam. 1H NMR (500 MHz, 
CDCl3) δ 8.02 (dd, J = 10.0, 5.0 Hz, 2H), 7.95 (dd, J = 10.0, 5.0 Hz, 2H), 7.90 (dd, J = 10.0, 5.0 
Hz, 2H), 7.82 (dd, J = 10.0, 5.0 Hz, 2H), 7.56 – 7.47 (m, 3H), 7.44 – 7.32 (m, 7H), 7.28 – 7.25 (m, 
2H), 5.93 (t, J = 10.0 Hz, 1H), 5.78 – 5.70 (m, 1H), 5.67 (t, J = 10.0 Hz, 1H), 5.57 (t, J = 10.0 Hz, 
1H), 5.03 – 4.95 (m, 2H), 4.88 (d, J = 10.0 Hz, 1H), 4.64 (dd, J = 10.0, 5.0 Hz, 1H), 4.50 (dd, J = 
10.0, 5.0 Hz, 1H), 4.20 – 4.16 (m, 1H), 2.87 – 2.75 (m, 2H), 2.39 – 2.34 (m, 2H). 13C NMR (125 
MHz, CDCl3) δ 166.1, 165.8, 165.2, 165.1, 136.1, 133.4, 133.3, 133.2, 133.1, 129.8, 129.8, 129.7, 
129.5, 128.7, 128.7, 128.4, 128.3, 128.3, 128.3, 116.2, 84.0, 76.7, 76.3, 74.1, 70.6, 69.6, 63.3, 34.0, 
29.7, 29.4.  HRMS (m/z): [M+Na]+ calcd. for C38H34SO9Na 689.1816, found 689.1827. [α]D25 = 
53.9o (c=1, DCM). IR (cm-1): 3068, 3003, 2958, 2924, 1710, 1360, 1251, 1087. 
Synthesis of 2.32 
228 μL (2.02 mmol) 4-vinylanisole was injected into a mixture of 133.3 mg (0.1999 mmol) 2.31, 
and 16.9 mg (0.0199 mmol) 2nd generation Grubbs’ catalyst in 6 mL DCM. The reaction was 
heated to reflux within 5 min and then stirred at reflux for an additional 2 h. The solution was then 
allowed to cool to rt (19 oC) and then concentrated. The resulting crude mixture (223.0 mg) was 
purified by silica gel (100% hexanes to 15% ethyl acetate in hexanes) to afford 124.3 mg (80 %) 
2.32 as a white foam. 
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CHAPTER 3: DEVELOPMENT OF 4-(4-METHOXYPHENYL)-4-PENTENYL 
THIOGLYCOSIDES AS STABLE AND VERSATILE DONORS FOR THE SYNTHESIS 
OF CHALLENGING GLYCOSIDIC LINKAGES 
3.1       Introduction 
Thioglycosides, as previously described, have been widely used for the synthesis of 
oligosaccharides due to their easy synthesis, high stability, and tunable reactivity.1 These merits 
have facilitated the exploration of glycosidic linkage formation using these glycosyl donors.2 
Thioglycosides have proven to be especially useful in the formation of synthetically difficult 
glycosidic linkages.  On the other hand, because of the high stability of thioglycosides, harsh 
activation conditions are often required. Finding easily activated, bench-top stable thioglycosides 
and milder activation conditions are of great importance in the development of chemical 
glycosylation.3  
Progress has been made with the development of new thioglycosides and activation 
methods. For example, the activation of para-tolyl thioglycosides 3a is effected with a range of 
reagent systems of varying reactivity including N-iodosuccinimide with triflic acid (NIS/HOTf),4 
ultraviolet irradiation with the oxidant Cu(OTf)2,5 and even milder gold catalysis6 (Figure 3.1). 
However, these conditions require either stoichiometric or excess amounts of the promoters. Wan 
and coworkers have developed a new 2-(2-propylsulfinyl)benzyl thioglycoside 3b (Figure 3.1) 
which showed great reactivity towards O-glycosylation with various glycosyl acceptors using 
stoichiometric triflic anhydride as activator.7 Recently, our group developed another class of 
thioglycoside called: 4-(4-methoxyphenyl)-3-butenyl thioglycosides (MBTGs) 3c (Figure 3.1). 
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Figure 3.1 Selective Thioglycosides and Activation Methods 
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We have demonstrated that these newly developed MBTG donors could be activated using visible-
light irradiation.8 Excess amounts of Umemoto’s reagent and the mild base 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) or 4Å molecular sieves were required for this transformation. Further, 
we found that this MBTG donor could also undergo O-glycosylation under mild acid-catalyzed 
conditions.9 Nevertheless, poor reactivity was shown with unreactive glycosyl acceptors. 
With our continuing research on acid-catalyzed O-glycosylation with thioglycosides, 
another new class of thioglycoside, called 4-(4-methoxyphenyl)-4-pentenyl thioglycosides 
(MPTGs), has been developed. The new MPTG thioglycosides showed higher reactivity toward 
very hindered glycosyl acceptors.  
3.2       Results and Discussion 
To begin with, I chose the tetra-O-benzoyl protected MPTG donor 3.3 as the model 
substrate. In order to synthesize the model substrate, I developed the following synthetic sequence: 
alcohol 3.1 was obtained by the reaction of 4-methoxyphenyl boronic acid and pent-4-yn-1-ol 
under palladium catalysis in dioxane at 80 oC.10 The alcohol 3.1 was then converted to alkyl iodide 
3.2 following treatment with iodine, triphenylphosphine, and imidazole in DCM.11 Alkylation of 
3.2 with tetra-O-benzoyl mercapto glucoside12 resulted in the formation of target MPTG donor 3.3 
(Scheme 3.1).8   
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68% 3.1 3.2
3.3
Scheme 3.1 Synthesis of MPTG Donor 3.3 
 74 
With 3.3 in hand, reaction conditions were screened. The initial experiment was performed 
using the same conditions previously reported with C6-OH glycosyl acceptor 3.4,13 and 96% yield 
of the disaccharide 3.5 was obtained (Scheme 3.2).  With such a high yield obtained with C6-OH 
3.4, we wondered if this MPTG donor would react with more unreactive glycosyl acceptors like 
C4-OH (3.6) because the previous MBTG donor (3c, Figure 3.1) showed low reactivity towards 
C4-OH. To our delight, we obtained a 70% yield of the desired disaccharide 3.7 (Scheme 3.3). 
Inspired by these results, reaction conditions were screened for the optimization of this 
process using glycosyl donor 3.3 and glycosyl acceptor 3.6 (Table 3.1). We found that the 
concentration and substrate ratio at 0.15 mmol 3.3 and 0.075 mmol 3.6 along with 10 mol% HOTf 
in 1 mL or 2 mL DCM gave us the best yield (entries 1,2). Decreasing (entry 3) or increasing the 
reaction concentration (entry 4) or changing the substrate ratio (entries 5-8) resulted in decreasing 
yields.  Replacement of HOTf with TMSOTf produced diminished yields (entry 9). While studying 
the effects of temperature on this transformation, we found that a complex mixture resulted (as 
shown by crude NMR spectra) and none of the desired product 3.7 was detected at either 0 oC or 
-20 oC (entries 10&11). The possible explanation for this phenomenon is that the MPTG donor 3.3 
decomposes before glycosyl acceptor attacks because the low temperature results in decreased 
Scheme 3.2 O-Glycosylation of MPTG 3.3 with C6-OH 
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overall reactivity of the glycosyl acceptor, especially for unreactive glycosyl acceptors. Regarding 
the amount of acid, one equivalent of HOTf (entry 12) resulted in traces of product while, when 
HOTf was eliminated, no reaction occurred (entry 13).  Finally, more polar solvents such as 
CH3CN and acetone proved inferior to CH2Cl2, and no product was obtained in these cases (entries 
14, 15). After the screening of various conditions, we chose entry 1 as our standard condition for 
O-glycosylation. 
We next studied the substrate scope for this glycosylation reaction (Table 3.2) with a range 
of alcohol acceptors and an expanded set of MPTG donors. With tetra-O-benzoyl donor 3.3, both 
primary and secondary alcohol acceptors were effective for the formation of disaccharide in good 
to excellent yield (entries 1-5). C2-OH acceptor (3f, Figure 3.2) performed well in the glycosylation 
and provided 81% yield of the desired disaccharide (entry 3). Besides the reaction with relatively 
unreactive C4-OH acceptor, it is noteworthy that the MPTG donor 3.3 could even react with the 
C4-OH galactosyl acceptor13 (3g, Figure 3.2, entry 4) and C4-OH glucuronate acceptor14 (3h, 
Figure 3.2, entry 5), respectively. These two acceptors are thought to be among the least reactive 
acceptors in glycosylation reactions because of their steric hindrance 
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Figure 3.2 Glycosyl Acceptors Used in O-Glycosylation 
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Entry Donor 3.3 
(mmol) 
Acceptor 3.6 
(mmol) 
Solventa 
 
Acid/equiv. Yield (%)b Temp. 
(oC) 
1 0.15 0.075 DCM HOTf/0.1 70 20 
2 0.15 0.075 DCM/ 2 mL HOTf/0.1 70 20 
3 0.15 0.075 DCM/10 mL HOTf/0.1 45 20 
4 0.38 0.19 DCM HOTf/0.1 63 20 
5 0.075 0.075 DCM HOTf/0.1 43 20 
6 0.075 0.075 DCM/2 mL HOTf/0.1 37 20 
7 0.1 0.1 DCM HOTf/0.1 44 20 
8 0.12 0.1 DCM HOTf/0.1 46 20 
9 0.15 0.075 DCM TMSOTf/0.1 58 20 
10 0.15 0.075 DCM HOTf/0.1 n.d.c 0 
11 0.15 0.075 DCM HOTf/0.1 n.d. - 20 
12 0.15 0.075 DCM HOTf/1.0 trace 20 
13 0.15 0.075 DCM HOTf/0 n.c.d 20 
14 0.15 0.075 CH3CN HOTf/0.1 n.d. 20 
15 0.15 0.075 Acetone HOTf/0.1 n.d. 20 
aUnless otherwise stated, 1 mL solvent was used. bIsolated yields. cn.d. for none detected. dn.c. 
for no conversion.  
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and electronic deactivation. As for tetra-O-benzyl MPTG donor 3.8, high yield was obtained with 
carbohydrate acceptor (entry 6) and non-carbohydrate acceptors like menthol (3i, Figure 3.2, entry 
7), 1-adamantanol (3j, Figure 3.2, entry 8), and cholesterol (3k, Figure 3.2, entry 9). Without the 
neighboring group participation (no acyl group at the C2 position), all the disaccharides were 
obtained as a mixture a and b anomers. I also performed the experiments using tetra-O-benzyl 
donor 3.8 with the above mentioned C4-OH glycosyl acceptors. The glycosylation proceeded as 
expected, but an inseparable mixture with both anomers and unidentified side-products was 
obtained. Next, we examined the glycosyl donor 3.9, which contained an acetyl group at the C2 
position, resulting in exclusive b linkage formation through neighboring group participation. 
Primary alcohols like C6-OH acceptor (entry 10) and secondary alcohols like C4-OH (3.6, entry 
11), C2-OH (3f, entry 12), and even with C4-OH galactosyl acceptor (3g, entry 13) afforded the 
corresponding disaccharides in good yield. Moderate to good yield was obtained with C6-OH (3.4, 
entry 14) and C4-OH (3.6, entry 15) reacting with per-acetylated donor 3.10. The MBTG analog 
of 3.10, by contrast, provided either low yields (with C4-OH) or substantial by-products (with C6-
OH). This is a reflection of historically poor performance of per-acetylated donors. Our results 
with 3.10, by contrast, are exciting. 
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Table 3.2 Substrate Scopea 
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aAll the reactions were performed using 0.15 mmol donor, 0.075 mmol acceptor, and 10 mol% 
HOTf in 1 mL DCM at room temperature. 
 
 Entry 1 (3.5) 
96%, b only 
Entry 2 (3.7) 
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Entry 3 (3.11) 
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74%, a:b 1:1 
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62%, b only 
Entry 13 (3.21) 
51%, b only 
Entry 14 (3.22) 
35%, b only 
Entry 15 (3.23) 
57%, b only 
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To further demonstrate the utility of MPTG donors as synthetic intermediates, we 
performed a series of transformations. A latent-active strategy which enabled a successful 
synthesis of a trisaccharide was developed. First of all, 4-bromo-4-pentenylthioglycoside 3.24 was 
synthesized by combining mercapto glucose and 2-bromo-5-iodopent-1-ene in the presence of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) in dichloromethane. Compound 3.24 then proved to be 
inert towards O-glycosylation with C6-OH acceptor (Scheme 3.4-A). However, Suzuki reaction of 
3.24 with 4-methoxyphenyl boronic acid in the presence of catalytic Pd(PPh3)4 and cesium fluoride 
in THF at elevated temperature resulted in the formation of glycosyl donor 3.3, which is an 
effective donor, in high yield (Scheme 3.4-B). This latent-active strategy was further used in the 
synthesis of trisaccharide 3.28 (Scheme 3.5).  Glycosylation of 4-bromo-4-pentenylthioglycoside 
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alcohol acceptor 3.25 with MPTG donor 3.3 generated disaccharide 3.26, followed by the Suzuki 
coupling of the vinyl bromide side chain to generate new MPTG donor 3.27, which reacted with 
C6-OH generating the trisaccharide 3.28 (Scheme 3.5). 
3.3       Summary 
I have demonstrated that the newly developed MPTGs are stable thioglycosides that are 
nevertheless activated by catalytic triflic acid for moderate to high yielding O-glycosylation at 
room temperature. O-glycosylation occurs with a range of MBTG donors and alcohol acceptors. 
Challenging 1 ® 4 glycosidic linkages are formed with a sterically hindered C4-OH galactosyl 
acceptor and a sterically hindered and electronically deactivated C4-OH glucuronate acceptor. In 
addition, a latent-active strategy involving Suzuki reaction has been developed, and efforts towards 
trisaccharide synthesis have been successful. 
3.4       Future Work 
As previously reported by Codée,15 additives like DMF and triphenylphosphine oxide were 
used to control the stereoselectivity to obtain exclusively the a anomer using N-phenyl 
trifluoroacetimidates. We wonder if this new MPTG donor could undergo similar process (Figure 
3.3). Several reaction conditions have been screened. When DMF was added, the reaction was shut 
down and starting materials were recovered. When triphenylphosphine oxide was added, starting 
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substrate was consumed but resulted in complex mixtures. More reaction conditions and various 
additives will be screened in the future. 
3.5       Experimental 
3.5.1    General Methods  
Reagents were purchased from Sigma Aldrich, Alfa Aesar and used as received. Flash 
column chromatography was performed using 60Å silica gel purchased from Sigma Aldrich. 1H 
NMR and 13C NMR spectroscopy were performed on a Bruker AV-400 or a Bruker AV-500 
spectrometer. Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight mass 
spectrometer. Optical Rotation were obtained from JASCO P-2000 polarimeter. Analytical and 
preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). Compounds 
were visualized by UV absorption (254 nm) and staining with anisaldehyde. 5 mL Pyrex micro 
reaction vessels (Supelco) were used in the glycosylation reactions. Deuterated solvents were 
obtained from Cambridge Isotope Labs. Solvents (purified according to the method of Grubbs16) 
included Et2O, DCM, CH3CN, DMF, and THF and were used directly from a PureSolv 400-5 
solvent system.  Other solvents were used as received from a commercial vendor. 
3.5.2    Procedures and Characterization 
Synthesis of 3.2 
A 100 mL round bottom flask was charged with PPh3 (8.85 mmol, 2.32 g) and 10.0 mL 
dichloromethane. Iodine (8.86 mmol, 2.25 g) was added in small portions under N2 at room 
temperature (20 °C). The reaction was stirred for 10 minutes. Imidazole (14.7 mmol, 1.00 g) was 
added to the solution in small portions and the reaction was allowed to stir for 10 more minutes.  
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3.1 (5.72 mmol, 1.10 g), which was synthesized according to a previously reported method,17 was 
added to the suspension in one portion and the reaction was stirred for 1 hour at room temperature. 
10 mL Sat. Na2S2O5 was added to the reaction mixture and the aqueous layer was extracted with 
10 mL dichloromethane twice. The organic layer was dried over Na2SO4 and concentrated. The 
resulting crude mixture was purified using silica gel column chromatography to afford 1.45 g (84%) 
product 3.2 as a yellow oil. 1H NMR (500 MHz, CDCl3) d 7.35 – 7.32 (m, 2H), 6.88 – 6.85 (m, 
2H), 5.25 (d, J = 1.4Hz, 1H), 5.03 (d, J = 1.3Hz, 1H), 3.81 (s, 3H), 3.18 (m, 2H), 2.60 (m, 2H), 
1.97 – 1.91 (m, 2H).     13C NMR (126 MHz, CDCl3) d 159.18, 145.74, 132.89, 127.21, 113.75, 
111.96, 55.30, 35.85, 31.67, 6.67.  HRMS (m/z): [M+H]+ calcd. for C12H16OI 303.0246, found 
303.0234. 
Synthesis of 3.3  
240 µL (1.60 mmol) DBU was added dropwise to a mixture of 612.6 mg (1.001 mmol) 
2,3,4,6-tetra-O-benzoyl-1-mercapto-b-D-glucopyranoside12 and 362.0 mg (1.198 mmol) 3.2 in 10 
mL DCM at 20 oC. The reaction was allowed to stir 15 min and then concentrated. The resulting 
crude material was purified using silica gel (0% to 30% ethyl acetate in hexanes) to afford 690.0 
mg (88 %) 3.3 as a white foam.  1H NMR (500 MHz, CDCl3) d 8.02 (dd, J = 1.4, 9.4Hz, 2H), 7.95 
(dd, J = 1.4, 9.7Hz, 2H), 7.90 (dd, J = 1.4, 8.3Hz, 2H), 7.82 (dd, J = 1.5, 8.3Hz, 2H), 7.57 – 7.48 
(m, 3H), 7.45 – 7.33 (m, 7H), 7.31 – 7.25 (m, 4H), 6.83 (d, J = 8.8Hz, 2H), 5.89 (t, J = 9.6Hz, 1H), 
5.65 (t, J = 9.8Hz, 1H), 5.54 (t, J = 9.8Hz, 1H), 5.16 (d, J = 1.5Hz, 1H), 4.91 (d, J = 1.4Hz, 1H), 
4.76 (d, J = 10.0Hz, 1H), 4.60 (dd, J = 3.1, 12.2Hz, 1H), 4.46 (dd, J = 5.4, 12.1Hz, 1H), 4.12 – 
4.08 (m, 1H), 3.81 (s, 3H), 2.79 – 2.68 (m, 2H), 2.54 – 2.49 (m, 2H), 1.79 – 1.73 (m, 2H). 13C 
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NMR (126 MHz, CDCl3) d 166.09, 165.81, 165.20, 165.18, 159.11, 146.42, 133.47, 133.32, 
133.26, 133.15, 129.89, 129.87, 129.85, 129.74, 129.71, 129.15, 128.81, 128.78, 128.43, 128.39, 
128.34, 128.31, 127.22, 126.67, 113.70, 111.57, 84.20, 76.27, 74.12, 70.67, 69.63, 63.33, 55.29, 
34.01, 29.72, 27.98. HRMS (m/z): [M+K]+ calcd. for C46H42SO10K 825.2136, found 825.2141. 
[α]D20 = + 13.3o (c = 1.00, DCM). IR (cm-1): 3066, 3037, 2945, 1721, 1368, 1246, 1086.  
Synthesis of 3.10 
 
A solution of 2,3,4,6-tetra-O-acetyl-1-mercapto-b-D-glucopyranoside18 (728.6 mg, 2.000 
mmol) and 635.5 mg 3.2 (2.103 mmol) in 10 mL of DCM, 350 µL DBU (2.3 mmol) was added to 
the solution dropwise at rt (20 oC).  After fifteen minutes, the solution was concentrated. 
Purification of the resulting crude material by gradient silica gel chromatography (0% to 40% ethyl 
acetate in hexanes) gave 870.3 mg (81%) 3.10 of a yellow oil.  1H NMR (400 MHz, CDCl3) d 
7.34 (d, J = 8.8Hz, 2H), 6.87 (d, J = 8.8Hz, 2H), 5.23 (d, J = 1.6 Hz, 1H), 5.20 (t, J = 9.4 Hz, 1H), 
5.07 (d, J = 11.7Hz, 1H), 5.04 – 4.99 (m, 2H), 4.42 (d, J = 10.0 Hz, 1H), 4.21 (dd, J = 12.4, 4.9 
Hz, 1H), 4.08 (dd, J = 12.4, 2.4 Hz, 1H), 3.82 (s, 3H), 3.65 – 3.61 (m, 1H), 2.74 – 2.63 (m, 2H), 
2.61 – 2.56 (m, 2H), 2.06 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.79 – 1.74 (m, 2H). 13C 
NMR (126 MHz, CDCl3) d 170.6, 170.1, 169.3, 169.3, 159.1, 146.5, 133.1, 127.2, 113.7, 111.5, 
83.74, 75.82, 73.90, 69.91, 68.31, 62.13, 55.25, 34.14, 29.61, 28.09, 20.68, 20.58, 20.55.  HRMS 
(m/z): [M+Na]+ Calcd. for C26H34O10SNa 561.1770, found 561.1768.  [α]D20 = - 67.0o (c = 1.02, 
DCM). IR (cm-1): 3062, 3030, 2909, 2864, 1745, 1510, 1226, 1054, 1035, 737, 697. 
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Synthesis of 3.8 
  
A 100 mL round bottom flask was charged with 1.52 g 3.10 (2.82 mmol) and 28 mL of 
methanol under a nitrogen atmosphere.  5 M solution of NaOMe in MeOH (280 µL, 1.40 mmol) 
was added at once to the reaction solution at rt (25 oC).  The resulting mixture was stirred for 15 
min.  The solvent was evaporated and further co-evaporated with 30 mL toluene yielding crude 
“tetra-ol”.  The residue was then diluted with 30 mL DMF followed by the addition of tetra-n-
butylammonium iodide (416.6 mg, 1.128 mmol), and placed under a stream of nitrogen.  The 
solution was cooled to 0 oC.  60% Sodium hydride (1.13 g, 28.3 mmol, in mineral oil) was added 
in three potions to the solution at 0oC and the suspension was stirred for 30 minutes.  Benzyl 
bromide (2.00 mL, 16.8 mmol) was then added dropwise to the suspension at 0 oC.  The suspension 
was then allowed to warm to room temperature and stirred overnight (12 h).  The reaction was 
then quenched with 40 mL of saturated ammonium chloride at 0 oC followed by extraction with 
40 mL Et2O twice.  The combined organic layers were dried over sodium sulfate, filtered, and 
concentrated.  The resulting crude material was purified by gradient silica gel chromatography (0% 
to 15% EtOAc in hexanes) to give 1.36 g (66% over two steps) 3.8 of a white solid.  1H NMR 
(400 MHz, CDCl3) d 7.39 - 7.17 (m, 22H), 6.84 (d, J = 8.8 Hz, 2H), 5.22 (d, J = 1.4 Hz, 1H), 5.00 
(d, J = 1.4 Hz, 1H), 4.93 (d, J = 2.1 Hz, 1H), 4.90 (d, J = 1.7 Hz, 1H), 4.85 (m, 2H), 4.74 (d, J = 
10.2 Hz, 1H), 4.62 - 4.52 (m, 3H), 4.40 (d, J = 9.7 Hz, 1H), 3.80 (s, 3H), 3.73 - 3.59 (m, 4H), 3.46 
– 3.40 (m, 2H), 2.82 – 2.70 (m, 2H), 2.64 – 2.59 (m, 2H), 1.84 (quint, J = 7.4 Hz, 2H).  13C NMR 
(126 MHz, CDCl3) d 159.0, 146.7, 138.5, 138.2, 138.1, 138.0, 133.2, 128.36, 128.34, 128.32, 
128.29, 128.26, 128.23, 127.9, 127.8, 127.70, 127.66, 127.6, 127.5, 127.2, 113.6, 111.3, 86.61, 
O
S
OMe
BnO
BnO
BnO
OBn
3.8
 85 
85.19, 81.73, 79.06, 77.91, 75.67, 75.42, 74.95, 73.40, 69.03, 55.19, 34.25, 30.26, 28.27.  HRMS 
(m/z): [M+Na]+ Calcd. for C46H50O6SNa 753.3226, found 753.3232.  [α]D20 = - 36.1o (c = 1.02, 
DCM). IR (cm-1): 3061, 3030, 2903, 2861, 1510, 1246, 1063, 1029, 734, 695. 
Synthesis of 3.9 
 
A solution of 2-O-acetyl-3,4,6-tri-O-benzyl-1-mercapto-b-D-glucopyranoside8 (350.0 mg, 
0.6881 mmol) and 225.7 mg 3.2 (0.7470 mmol) in 5 mL of CH2Cl2, 120 µL DBU (0.80 mmol) 
was added to the solution dropwise at rt (20 oC).  After fifteen minutes, the solution was 
concentrated. Purification of the resulting crude material by gradient silica gel chromatography (0% 
to 30% ethyl acetate in hexanes) gave 382.0 mg (81%) 3.9 of a yellow syrup. 1H NMR (400 MHz, 
CDCl3) d 7.34 – 7.17 (m, 17H), 6.82 (d, J = 8.7 Hz, 2H), 5.19 (d, J = 1.5 Hz, 1H), 5.06 – 4.93 (m, 
1H), 4.96 (d, J = 1.5 Hz, 1H), 4.82 – 4.76 (m, 2H), 4.70 – 4.63 (m, 1H), 4.62 – 4.49 (m, 3H), 4.29 
(d, J = 10.0 Hz, 1H), 3.76 (s, 3H), 3.70 – 3.61 (m, 4H), 3.45 – 3.41 (m, 1H), 2.80 - 2.61 (m, 2H), 
2.60 – 2.49 (m, 2H), 1.96 (s, 3H), 1.81 - 1.67 (m, 2H).  13C NMR (101 MHz, CDCl3) d 169.5, 
158.9, 146.6, 138.11, 138.10, 137.9, 133.2, 128.34, 128.32, 128.26, 127.9, 127.74, 127.67, 127.63, 
127.58, 127.5, 127.1, 113.6, 111.3, 84.31, 83.48, 79.38, 77.77, 75.10, 74.97, 73.37, 71.69, 68.75, 
55.14, 34.18, 29.16, 28.14, 20.88.  HRMS (m/z): [M+Na]+ Calcd. for C41H46O7SNa 705.2862, 
found 705.2870.  [α]D20 = - 61.0o (c = 0.995, DCM). IR (cm-1): 3062, 3030, 2909, 2864, 1745, 
1226, 1054, 1035, 737, 697. 
Representative procedure/optimized glycosylation conditions (0.0752 mmol scale): 
A 5 mL Pyrex reactor vial was charged with 0.150 mmol glycosyl donor, 0.0750 glycosyl 
acceptor and 1 mL of dry dichloromethane. TfOH (1.4 µL, 0.015 mmol) was added via gas-tight 
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syringe. The reaction was stirred at room temperature for 70 min or until consumption of alcohol 
acceptor was observed via TLC. Triethylamine (4.20 µL, 0.0300 mmol) was then added to the 
reaction mixture and the crude products were concentrated and then purified by gradient silica gel 
chromatography to afford the desired glycosides.  Determination of anomeric ratios:  The anomeric 
ratio (α : β) was determined based on the integration of key resonances identified with the 
assistance of published 1H NMR data. In the cases where spectral data was unavailable, the 
anomeric products were separated with silica gel chromatography or preparative TLC. 
1 mmol scale glycosylation (synthesis of 3.7 at 1 mmol scale): 
 
A flame-dried 25 mL round bottom flask was charged with 3.3 (1.18 g, 1.50 mmol) and 
methyl-2,3,6-tri-O-benzyl-α-D-glucopyranoside (0.465g, 1.00 mmol) at 20 oC. Anhydrous CH2Cl2 
(7.0 mL) was then added to the solution, followed by TfOH (13 µL, 0.14 mmol). After stirring for 
3 hours, triethylamine (42 µL, 0.30 mmol) was added to the reaction solution which was allowed 
to stir for an additional 5 minutes. Solvents were then removed in vacuo to afford 1.7 g crude 
material. Purification by silica gel chromatrography (0% to 20% EtOAc in hexanes) yielded 750.8 
mg, (72%, b only) of 3.7 as a white foam. Spectral data matched that previously reported in 
literature.19 
Synthesis of 3.7 
   
OO
BnO
BnO
OBn
OMe
OBzO
BzO
BzO
OBz
3.7
OO
BnO
BnO
OBn
OMe
OBzO
BzO
BzO
OBz
3.7
 87 
A reaction vial was charged with 118.5 mg (0.1506 mmol) 3.3 and 35.0 mg (0.0753 mmol) 
methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 20 oC. The reaction was stirred for 50 min. 5.0 µL 
triethylamine was then added to quench the reaction which was concentrated. The resulting crude 
mixture (190.2 mg) was purified with silica gel chromatography using a gradient run (0% to 30% 
ethyl acetate in hexanes) to afford 55.0 mg (70%) 3.7 as white foam. Spectral data matched that 
previously reported in the literature.19 
Synthesis of 3.5 
 
A reaction vial was charged with 118.5 mg (0.1506 mmol) 3.3 and 38.2 mg (0.082 mmol) 
methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 20 oC. The reaction was stirred for 30 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (167.2 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 82.1 mg (96%) 3.5 as a white foam. Spectral data matched 
that previously reported in the literature.20 
Synthesis of 3.11 
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A reaction vial was charged with 118.2 mg (0.1502 mmol) 3.3 and 34.9 mg (0.0751 mmol) 
methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 20 oC. The reaction was stirred for 30 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (167.8 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 63.6 mg (81%) 3.11 as a white foam. Spectral data matched 
that previously reported in the literature.20 
Synthesis of 3.12 
 
A reaction vial was charged with 117.8 mg (0.1497 mmol) 3.3 and 34.9 mg (0.0751 mmol) 
methyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) 
HOTf were added to the vial using a syringe at 23 oC. The reaction was stirred for 70 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (172.3 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 42.4 mg (54%) 3.12 as a white foam. Spectral data matched 
that previously reported in the literature.7 
Synthesis of 3.13 
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A reaction vial was charged with 118.5 mg (0.1506 mmol) 3.3 and 30.1 mg (0.0748 mmol) 
1-O-methyl-2,3-di-O-benzyl-α-D-glucopyranuronic acid methyl ester. 1 mL DCM and then 1.3 
µL (0.014 mmol) HOTf were added to the vial using a syringe at 20 oC. The reaction was stirred 
for 70 min. 5.0 µL triethylamine was then added to quench the reaction which was then 
concentrated. The resulting crude mixture (194.4 mg) was purified with silica gel chromatography 
using a gradient run (0% to 20% ethyl acetate in hexanes) to afford 43.5 mg (59%) 3.13 as a white 
foam. 1H NMR (400 MHz, CDCl3) d 7.99 – 7.94 (m, 4H), 7.87 (dd, J = 8.2, 1.2 Hz, 2H), 7.80 (dd, 
J = 8.3, 1.3 Hz, 2H), 7.55 – 7.20 (m, 22H), 5.85 (t, J = 9.6 Hz, 1H), 5.64 (t, J = 9.6 Hz, 1H), 5.48 
(dd, J = 9.7, 3.9 Hz, 1H), 5.13 (d, J = 8.0 Hz, 1H), 5.10 (d, J = 10.9 Hz, 1H), 4.88 (d, J = 11.4 Hz, 
1H), 4.74 (d, J = 12.1 Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.53 (d, J = 4.0 Hz, 1H), 4.41 (dd, J = 
12.1, 3.4 Hz, 1H),  4.29 (dd, J = 12.1, 4.7Hz, 1H), 4.11 (dd, J = 9.6, 1.2Hz, 1H), 4.05 – 3.96 (m, 
3H), 3.51 – 3.46 (m, 1H), 3.47 (s, 3H), 3.36 (s, 3H). 13C NMR (100 MHz, CDCl3) d 169.7, 165.9, 
165.8, 165.2, 165.0, 139.0, 138.0, 133.3, 133.15, 133.08, 132.9, 129.8, 129.74, 129.73, 129.65, 
129.60, 129.5, 129.0, 128.80, 128.78, 128.4, 128.3, 128.23, 128.20, 128.11, 128.07, 127.9, 127.20, 
127.15, 100.7, 99.95, 98.76, 79.41, 78.85, 78.60, 75.41, 73.69, 73.11, 72.38, 72.09, 69.60, 63.00, 
55.66, 52.38.  HRMS (m/z): [M+Na]+ Calcd. for C56H52O16Na 1003.3153, found 1003.3172.  
[α]D20 = +13.3o (c = 0.990, DCM). IR (cm-1): 2952, 2920, 2851, 1724, 1451, 1263, 1249, 1093, 
1040, 707. 
Synthesis of 3.14 
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A reaction vial was charged with 105.3 mg (0.1440 mmol) 3.8 and 34.8 mg (0.0749 mmol) 
methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) 
HOTf were added to the vial using a syringe at 19 oC. The reaction was stirred for 70 min. 5.0 
µL triethylamine was then added to quench the reaction which was then concentrated. The re 
sulting crude mixture (147.3 mg) was purified with silica gel chromatography using a gradient 
run (0% to 20% ethyl acetate in hexanes) to afford 61.0 mg (83%, 1.5:1 a:b) 3.14 as a white 
foam. Spectral data matched that previously reported in the literature.21 
Synthesis of 3.15 
 
A reaction vial was charged with 109.7 mg (0.1501 mmol) 3.8 and 11.8 mg (0.0755 mmol) 
menthol. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf were added to the vial using a syringe 
at 21 oC. The reaction was stirred for 70 min. 5.0 µL triethylamine was then added to quench the 
reaction which was then concentrated. The resulting crude mixture (147.8 mg) was purified with 
silica gel chromatography using a gradient run (0% to 20% ethyl acetate in hexanes) to afford 41.5 
mg (81%, 1.3:1 a:b) 3.15 as a colorless oil. Spectral data matched that previously reported in the 
literature.22 
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Synthesis of 3.16 
 
 
A reaction vial was charged with 109.7 mg (0.1501 mmol) 3.8 and 11.4 mg (0.0749 mmol) 
1-adamantanol. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf were added to the vial using a 
syringe at 21 oC. The reaction was stirred for 70 min. 5.0 µL triethylamine was then added to 
quench the reaction which was then concentrated. The resulting crude mixture (143.2 mg) was 
purified with silica gel chromatography using a gradient run (0% to 20% ethyl acetate in hexanes) 
to afford 42.0 mg (83%, 1.1:1 a:b) 3.16 as a colorless oil. Spectral data matched that previously 
reported in the literature.23 
Synthesis of 3.17  
 
A reaction vial was charged with 109.7 mg (0.1501 mmol) 3.8 and 29.0 mg (0.0750 mmol) 
cholesterol. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf were added to the vial using a syringe 
at 21 oC. The reaction was stirred for 70 min. 5.0 µL triethylamine was then added to quench the 
reaction which was then concentrated. The resulting crude mixture (159.6 mg) was purified with 
silica gel chromatography using a gradient run (0% to 20% ethyl acetate in hexanes) to afford 50.3 
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mg (74%, 1:1 a:b) 3.17 as a colorless oil. Spectral data matched that previously reported in the 
literature.24 
Synthesis of 3.18   
 
A reaction vial was charged with 103.2 mg (0.1511 mmol) 3.9 and 34.9 mg (0.0751 mmol) 
methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 19 oC. The reaction was stirred for 70 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (137.2mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 48.2 mg (68%) 3.18 as a colorless oil. Spectral data 
matched that previously reported in the literature.25 
Synthesis of 3.19 
 
A reaction vial was charged with 103.2 mg (0.1511 mmol) 3.9 and 35.0 mg (0.0753 mmol) 
methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 19 oC. The reaction was stirred for 70 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (153.1mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 47.9 mg (68%) 3.19 as a colorless oil. Spectral data 
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matched that previously reported in the literature.26 
Synthesis of 3.20                     
 
A reaction vial was charged with 102.5 mg (0.1501 mmol) 3.9 and 34.8 mg (0.0749 mmol) 
methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 20 oC. The reaction was stirred for 70 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (169.3 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 43.4 mg (62%) 3.20 as a white solid. Spectral data matched 
that previously reported in the literature.8 
Synthesis of 3.21 
 
A reaction vial was charged with 101.7 mg (0.1489 mmol) 3.9 and 34.0 mg (0.0732 mmol) 
methyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) 
HOTf were added to the vial using a syringe at 20 oC. The reaction was stirred for 120 min. 5.0 
µL triethylamine was then added to quench the reaction which was then concentrated. The 
resulting crude mixture (170.7 mg) was purified with silica gel chromatography using a gradient 
run (0% to 20% ethyl acetate in hexanes) to afford 35.1 mg (51%) 3.21 as a white solid. Spectral 
data matched that previously reported in the literature.27 
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Synthesis of 3.22 
 
A reaction vial was charged with 85.8 mg (0.1593 mmol) 3.10 and 34.4 mg (0.0741 
mmol) methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 
mmol) HOTf were added to the vial using a syringe at 20 oC. The reaction was stirred for 70 
min. 5.0 µL triethylamine was then added to quench the reaction which was then concentrated. 
The resulting crude mixture (150.3 mg) was purified with silica gel chromatography using a 
gradient run (0% to 20% ethyl acetate in hexanes) to afford 20.6 mg (35%) 3.22 as a colorless 
oil. Spectral data matched that previously reported in the literature.28 
Synthesis of 3.23   
 
A reaction vial was charged with 85.8 mg (0.1593 mmol) 3.10 and 35.0 mg (0.0753 mmol) 
methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf 
were added to the vial using a syringe at 20 oC. The reaction was stirred for 70 min. 5.0 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (130.1 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 34.0 mg (57%) 3.23 as a colorless oil. Spectral data 
matched that previously reported in the literature.29 
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Additional Transformations with MPTGs 
Synthesis of 3.24 
 
180 µL (1.20 mmol) DBU was added dropwise to a mixture of 612.6 mg (1.000 mmol) 
2,3,4,6-tetra-O-benzoyl-1-mercapto-b-D-glucopyranoside and 329.9 mg (1.200 mmol) 2-bromo-
5-iodopent-1-ene30 in 10 mL DCM at 20 oC. The reaction was allowed to stir 15 min and then 
concentrated. The resulting crude material was purified using silica gel (0% to 30% ethyl acetate 
in hexanes) to afford 630.0 mg (83 %) 3.24 as a white foam.  1H NMR (400 MHz, CDCl3) d 8.04 
(dd, J = 8.2, 1.4 Hz, 2H), 7.96 (dd, J = 8.6, 1.4 Hz, 2H), 7.91 (dd, J = 8.5, 1.4 Hz, 2H), 7.82 (dd, J 
= 8.5, 1.4 Hz, 2H), 7.58 - 7.48 (m, 3H), 7.46 - 7.33 (m, 7H), 7.31 - 7.26 (m, 2H), 5.94 (t, J = 9.5 
Hz, 1H), 5.68 (t, J = 9.8 Hz, 1H), 5.57 (t, J = 9.7 Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 5.34 (d, J = 
1.3 Hz, 1H), 4.86 (d, J = 9.9 Hz, 1H), 4.64 (dd, J = 11.0, 3.0 Hz, 1H), 4.50 (dd, J = 12.2, 5.5 Hz, 
1H), 4.21 - 4.17 (m, 1H), 2.83 - 2.77 (m, 1H), 2.73 - 2.66 (m, 1H), 2.48 - 2.43 (m, 2H), 1.92 - 1.84 
(m, 2H). 13C NMR (126 MHz, CDCl3) d 166.0, 165.7, 165.12, 165.10, 133.4, 133.3, 133.2, 133.12, 
133.09, 133.0, 129.78, 129.75, 129.6, 129.5, 129.0, 128.70, 128.66, 128.3, 128.23, 128.21, 117.5, 
84.00, 81.29, 76.28, 74.02, 70.55, 69.53, 63.20, 39.73, 28.68, 27.72. HRMS (m/z): [M+K]+ calcd. 
for C39H35SO9BrK 797.0822, found 797.0808. [α]D20 = + 96.2o (c = 0.490, DCM). IR (cm-1): 2951, 
1721, 1257, 1066, 705. 
Suzuki-Coupling of 3.24/p-Methoxyphenylboronic acid: 
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A vial was charged with 102.1 mg (0.1344 mmol) 3.24, 61.2 mg (0.403 mmol) p-
methoxyphenyl boronic acid, 7.8 mg (0.0067 mmol) Pd(PPh3)4 and 102 mg (0.672 mmol) cesium 
fluoride. Vacuum-purge-backfill was performed three times. 2 mL THF was added under N2. The 
vial was then sealed with a cap. The resulting mixture was heated to 90 oC for 3 h. The reaction 
was cooled to rt and 3 mL water was added. The reaction mixture was extracted with 3 X 10 mL 
ethyl acetate. The combined organic layer was dried with sodium sulfate and then concentrated. 
The resulting crude mixture (230.0 mg) was purified by silica gel (100% hexanes to 10% ethyl 
acetate in hexanes) to afford 85.0 mg (80 %) 3.3 as a white foam. 
 
Synthesis of 3.25a 
 
A solution of 2,3,4,6-tetra-O-acetyl-1-mercapto-b-D-glucopyranoside (700.0 mg, 1.921 
mmol) and 550.1 mg (2.001 mmol) 2-bromo-5-iodopent-1-ene in 10 mL DCM at rt. 350 µL DBU 
(2.19 mmol) was added to the solution dropwise at rt (20 oC). The reaction was allowed to stir 15 
min and then concentrated. The resulting crude material was purified using silica gel (0% to 30% 
ethyl acetate in hexanes) to afford 790.2 mg (80 %) 3.25a as a colorless oil. 1H NMR (400 MHz, 
CDCl3) d 5.60 (d, J = 1.5 Hz, 1H), 5.42 (d, J = 1.7 Hz, 1H), 5.21 (t, J = 9.4 Hz, 1H), 5.07 (t, J = 
9.8 Hz, 1H), 5.02 (t, J = 9.7 Hz, 1H), 4.48 (d, J = 10.0 Hz, 1H), 4.22 (dd, J = 12.4, 5.0 Hz, 1H), 
4.12 (dd, J = 12.4, 2.4 Hz, 1H), 3.72 – 3.68 (m, 1H), 2.74 - 2.69 (m, 1H), 2.66 – 2.59 (m, 1H), 2.55 
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– 2.50 (m, 2H), 2.07 (s, 3H), 2.05 (s, 3H), 2.02 (s, 3H), 2.00 (s, 3H), 1.92 – 1.84 (m, 2H).  13C 
NMR (126 MHz, CDCl3) d 170.5, 170.1, 169.32, 169.30, 133.1, 117.5, 83.62, 75.87, 73.81, 69.80, 
68.27, 62.11, 39.89, 28.60, 27.74, 20.68, 20.65, 20.54, 20.52.  HRMS (m/z): [M+Na]+ Calcd. for 
C19H27O9SBrNa 533.0457, found 533.0467.  [α]D20 = + 10.7o (c = 1.10, DCM). IR (cm-1): 2962, 
2945, 1739, 1368, 1219, 1032, 898. 
Synthesis of 3.25b 
   
A 100 mL RBF was charged with 670.0 mg (1.310 mmol) 3.25a and 30 mL MeOH. 0.13 
mL 5 M sodium methoxide in methanol was added to the solution and stirred for 15 min at 21 oC. 
The solution was evaporated to yield the deacetylated thioglycoside which was then co-evaporated 
with 30 mL toluene to remove any remaining volatile compounds. The resulting tetra-ol was 
dissolved in 20 mL THF followed by sequential addition of TBS-Cl (590.7 mg, 3.919 mmol) and 
imidazole (446.0 mg, 6.551 mmol). After 1 hour, EtOAc (70 mL) was added and the resulting 
solution was washed with H2O (2 x 40 mL). The organic layer was dried over Na2SO4, 
concentrated, and placed on high vacuum for 2 h. The resulting white solid was dissolved in 5 mL 
pyridine. 760 µL (6.54 mmol) benzoyl chloride was added dropwise to the solution over a period 
of 2 min at rt (21 oC). The reaction was stirred for 3 h at 21 oC. 20 mL water and 40 mL DCM 
were added. The organic layer was washed with 30 mL 1 M HCl three times, followed by 50 mL 
sat. NaHCO3, dried with Na2SO4, and concentrated. The resulting crude mixture (768.3 mg) was 
purified by silica gel (0% to 30% ethyl acetate in hexanes) to afford 620.0 mg (61 % two-step 
yield) 3.25b as a white foam. 1H NMR (400 MHz, CDCl3) d 7.95 (dd, J = 8.5, 1.4 Hz, 2H), 7.92 
(dd, J = 8.5, 1.4 Hz, 2H), 7.81 (dd, J = 8.4, 1.4 Hz, 2H), 7.54 - 7.50 (m, 2H), 7.45 - 7.36 (m, 5H), 
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7.30 - 7.26 (m, 2H), 5.86 (t, J = 9.5 Hz, 1H), 5.56 (d, J = 1.6 Hz, 1H), 5.56 - 5.51 (m, 2H), 5.41 (d, 
J = 1.6 Hz, 1H), 4.77 (d, J = 9.9 Hz, 1H), 3.89 - 3.81 (m, 3H), 2.87 - 2.80 (m, 1H), 2.77 – 2.70 (m, 
1H), 2.52 (t, J = 7.1 Hz, 2H), 1.96 – 1.86 (m, 2H), 0.88 (s, 9H), 0.034 (s, 3H), 0.029 (s, 3H). 13C 
NMR (100 MHz, CDCl3) d 165.8, 165.1, 165.0, 133.2, 133.13, 133.05, 129.8, 129.68, 129.65, 
129.2, 129.1, 128.9, 128.34, 128.30, 128.2, 117.4, 83.48, 79.50, 74.42, 70.64, 69.37, 62.72, 39.95, 
28.20, 27.63, 25.78, 18.25, -5.39, -5.44. HRMS (m/z): [M+H]+ calcd. for C38H46SO8BrSi 
769.1866, found 769.1841. [α]D20 = - 22.0o (c = 1.11, DCM). IR (cm-1): 2928, 2855, 1725, 1249, 
1066, 834, 704. 
Synthesis of 3.25 
 
3 mL of tetra-n-butylammonium fluoride (1M in THF) was acidified to pH 6 by dropwise 
addition of acetic acid and careful monitoring with pH paper. 3.0 mL of the premixed AcOH/TBAF 
solution was added to 3.25b (450.0 mg, 0.5846 mmol) in a 10 mL round bottom flask at 21 oC. 
After 6 hours, the reaction solution was diluted with EtOAc (15 mL). The organic layer was 
washed with sat. NH4Cl (aq.) (3 mL) and sat. NaCl (aq.) (10 mL) then dried over Na2SO4 and 
concentrated. Silica gel chromatography (0% to 30% EtOAc in hexanes) yielded 283.2 mg (74%) 
3.25 as a white foam. 1H NMR (400 MHz, CDCl3) d 7.97 - 7.94 (m, 4H), 7.83 (dd, J = 8.5, 1.4 
Hz, 2H), 7.56 - 7.51 (m, 2H), 7.46 - 7.37 (m, 5H), 7.30 - 7.24 (m, 2H), 5.95 (t, J = 9.6 Hz, 1H), 
5.56 (d, J = 1.8 Hz, 1H), 5.54 – 5.48 (m, 2H), 5.41 (d, J = 1.7 Hz, 1H), 4.82 (d, J = 10.0 Hz, 1H), 
3.90 - 3.81 (m, 2H), 3.77 - 3.73 (m, 1H), 2.87 - 2.80 (m, 1H), 2.77 - 2.71 (m, 1H), 2.54 - 2.49 (m, 
3H), 1.95 - 1.87 (m, 2H). 13C NMR (126 MHz, CDCl3) d 165.8, 165.7, 165.0, 133.5, 133.2, 133.1, 
133.0, 129.8, 129.7, 129.5, 129.0, 128.7, 128.4, 128.3, 128.2, 117.4, 83.82, 78.85, 73.89, 70.46, 
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69.27, 61.40, 39.74, 28.54, 27.67. HRMS (m/z): [M+H]+ calcd. for C32H32SO8Br 655.1001, found 
655.0993. [α]D20 = + 21.0o (c = 1.03, DCM). IR (cm-1): 3526, 3064, 2940, 2871, 1722, 1176, 1066, 
1024, 704. 
 
Synthesis of 3.26 
 
A reaction vial was charged with 118.3 mg (0.1503 mmol) 3.3 and 48.0 mg (0.0732 mmol) 
3.25. 1 mL DCM and then 1.3 µL (0.014 mmol) HOTf were added to the vial using a syringe at 
20 oC. The reaction was stirred for 70 min. 5.0 µL triethylamine was then added to quench the 
reaction which was then concentrated. The resulting crude mixture (180.0 mg) was purified with 
silica gel chromatography using a gradient run (0% to 20% ethyl acetate in hexanes) to afford 72.3 
mg (86%) 3.26 as a white foam. 1H NMR (400 MHz, CDCl3) d 8.04 - 8.00 (m, 4H), 7.94 - 7.81 
(m, 8H), 7.76 (dd, J = 8.5, 1.4 Hz, 2H), 7.58 - 7.24 (m, 21H), 5.89 (t, J = 9.6 Hz, 1H), 5.81 (t, J = 
9.6 Hz, 1H), 5.63 (t, J = 9.7 Hz, 1H), 5.54 (d, J = 1.5 Hz, 1H), 5.51 (dd, J = 9.7, 7.7 Hz, 1H), 5.40 
(d, J = 1.5 Hz, 1H), 5.40 (t, J = 9.2 Hz, 1H), 5.33 (t, J = 9.4 Hz, 1H), 4.98 (d, J = 7.8 Hz, 1H), 4.61 
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(d, J = 9.8 Hz, 2H), 4.42 (dd, J = 12.1, 5.0 Hz, 1H), 4.14 – 4.09 (m, 1H), 4.05 (dd, J = 11.9, 2.1 
Hz, 1H), 4.00 (dt, J = 10.4, 2.8 Hz, 1H), 3.86 (dd, J = 11.5, 7.0 Hz, 1H), 2.67 - 2.62 (m, 1H), 2.54 
– 2.43 (m, 3H), 1.84 – 1.70 (m, 2H). 13C NMR (126 MHz, CDCl3) d 166.0, 165.7, 165.6, 165.3, 
165.10, 165.06, 165.0, 133.42, 133.37, 133.23, 133.16, 133.11, 129.83, 129.77, 129.76, 129.71, 
129.68, 129.6, 129.5, 129.2, 129.1, 128.78, 128.75, 128.72, 128.65, 128.4, 128.33, 128.31, 128.23, 
128.18, 117.5, 101.3, 83.36, 78.07, 73.96, 72.84, 72.26, 71.83, 70.40, 69.62, 69.53, 68.55, 62.86, 
39.70, 28.20, 27.56. HRMS (m/z): [M+K]+ calcd. for C66H57SO17BrK 1271.2137, found 
1271.2108. [α]D20 = + 84.6o (c = 0.505, DCM). IR (cm-1): 1721, 1450, 1249, 1066, 1024, 704. 
Synthesis of 3.27 
 
A vial was charged with 130.7 mg (0.1059 mmol) 3.26, 49.3 mg (0.325 mmol) p-
methoxyphenylboronic acid, 11.7 mg (0.0101 mmol) Pd(PPh3)4 and 79.7 mg (0.526 mmol) cesium 
fluoride. Vacuum-purge-backfill was performed three times. 2 mL THF was added under N2. The 
vial was then sealed with a cap. The resulting mixture was heated to 90 oC and kept for 3 h. The 
reaction was cooled to rt and 3 mL water was added. The reaction was extracted with 10 mL ethyl 
acetate three times. The combined organic layer was dried with sodium sulfate and then 
concentrated. The resulting crude mixture (221.4 mg) was purified by silica gel (0% 20% ethyl 
acetate in hexanes) to afford 101.2 mg (76 %) 3.27 as a white foam. 1H NMR (400 MHz, CDCl3) 
d 8.01 (dd, J = 8.2, 1.4 Hz, 2H), 7.98 (dd, J = 8.3, 1.4 Hz, 2H), 7.91 (dd, J = 8.4, 1.4 Hz, 2H), 7.87 
(m, 4H), 7.81 (dd, J = 8.5, 1.4 Hz, 2H), 7.77 (dd, J = 8.4, 1.4 Hz, 2H), 7.54 - 7.25 (m, 23H), 6.87 
(d, J = 8.8 Hz, 2H), 5.86 (t, J = 9.6 Hz, 1H), 5.78 (t, J = 9.4 Hz, 1H), 5.61 (t, J = 9.7 Hz, 1H), 5.49 
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(dd, J = 7.8, 9.8 Hz, 1H), 5.39 (t, J = 9.8 Hz, 1H), 5.31 (t, J = 9.4 Hz, 1H), 5.22 (d, J = 1.4 Hz, 
1H), 4.95 (m, 2H), 4.59 (dd, J = 12.2, 3.2 Hz, 1H), 4.55 (d, J = 9.9 Hz, 1H), 4.40 (dd, J = 12.2, 5.4 
Hz, 1H), 4.10 - 4.06 (m, 1H), 4.03 (dd, J = 12.0, 2.0 Hz, 1H), 3.96  - 3.92 (m, 1H), 3.85 – 3.77 (m, 
1H), 3.80 (s, 3H), 2.66 - 2.60 (m, 1H), 2.54 - 2.47 (m, 3H), 1.69 - 1.60 (m, 2H). 13C NMR (126 
MHz, CDCl3) d 166.0, 165.7, 165.6, 165.3, 165.11, 165.08, 165.0, 159.1, 146.6, 133.41, 133.36, 
133.3, 133.17, 133.15, 133.1, 133.08, 129.83, 129.80,129.71, 129.69, 129.6, 129.5, 129.24, 129.18, 
128.9, 128.80, 128.76, 128.71, 128.38, 128.34, 128.3, 128.23, 128.19, 127.2, 113.7, 111.3, 101.3, 
83.52, 78.06, 74.02, 72.87, 72.22, 71.84, 70.48, 69.67, 69.56, 68.57, 62.90, 55.21, 33.79, 29.23, 
27.89. HRMS (m/z): [M+Na]+ calcd. for C73H64SO18Na 1283.3711, found 1283.3728. [α]D20 = + 
43.6o (c = 1.04, DCM). IR (cm-1): 1721, 1451, 1245, 1065, 1024, 704. 
Synthesis of 3.28 
 
A reaction vial was charged with 100.1 mg (0.07936 mmol) 3.27 and 18.5 mg (0.0398 
mmol) methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. 1 mL DCM and then 0.7 µL (0.008 mmol) 
HOTf were added to the vial using a syringe. The reaction was stirred for 70 min. 2.5 µL 
triethylamine was then added to quench the reaction which was then concentrated. The resulting 
crude mixture (152.3 mg) was purified with silica gel chromatography using a gradient run (0% to 
20% ethyl acetate in hexanes) to afford 45.3 mg (75%) 3.28 as a white foam. Spectral data matched 
that previously reported in the literature.31 
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Tetrahydrothiophene by-product 3.29 
 
The compound was purified from early-eluting column chromatography fractions from O-
glycosylation procedures. 1H NMR: (500 MHz, CDCl3) δ 7.47 – 7.44 (m, 2H), 6.85 – 6.82 (m, 
2H), 3.79 (s, 3H), 3.09 – 3.03 (m, 2H), 2.32 – 2.27 (m, 1H), 2.18 – 2.08 (m, 3H), 1.74 (s, 3H). 13C 
NMR: (125 MHz, CDCl3) δ 157.92, 140.42, 127.43, 113.33, 59.68, 55.29, 45.71, 33.36, 32.88, 
29.63. HRMS (m/z): [M+H]+ calcd. for C12H17SO 209.1000, found 2209.0986. 
3.6       References 
1. (a) Codée, J. D. C.; Litjens, R. E. J. N.; van den Bos, L. J.; Overkleeft, H. S.; van der Marel, 
G. A., Chem. Soc. Rev., 2005, 34, 769-782; (b) Shiao, T. C.; Roy, R., Top. Curr. Chem., 
2011, 301, 69-108; (c) Demchenko, A. V., Synlett., 2003, 1225-1240; (d) Koeller, K. M.; 
Wong, C.-H., Chem. Rev., 2000, 100, 4465-4493; (e) Zhang, Z.; Ollmann, I. R.; Ye, X.-S.; 
Wischnat, R.; Baasov, T.; Wong, C.-H., J. Am. Chem. Soc., 1999, 121, 734-753; (f) S. 
Oscarson in Carbohydrates in Chemistry and Biology (Eds.: E. Beat, G. W. Hart, P. Sinaì), 
Wiley-VCH, Weinheim, 2000, p 93-116. 
2. (a) Crich, D.; Sun, S., Tetrahedron, 1998, 54, 8321-8348. (b) Crich, D.; Li, W., J. Org. 
Chem., 2007, 72, 7794-7797.  
3. Transforming Glycoscience: A Roadmap to the Future (Ed.: National Research Council 
(U.S.) Committee on Assessing the Importance and Impact of Glycomics and 
Glycosciences), The National Academies Press, Washington, 2012. 
4. Boltje, T. J.; Zhong W.; Park, J.; Wolfert, M. A.; Chen, W.-X.; Boons, G.-J., J. Am. Chem. 
Soc., 2012, 134, 14255-14262. 
5. Mao, R.-Z.; Guo, F.; Xiong, D.-C.; Li, Q.; Duan, J.-Y.; Ye, X.-S., Org. Lett., 2015, 17, 
5606-5609. 
6. Vibhute, A. M.; Dhaka, A.; Athiyarath, V.; Sureshan, K. M., Chem. Sci., 2016, 7, 4259-
4263. 
7. Xiao, X.; Zhao, Y.-Q.; Shu, P.-H.; Zhao, X.; Liu, Y.; Sun, J.-C.; Zhang, Q.; Zeng, J.; Wan, 
Q., J. Am. Chem. Soc., 2016, 138, 13402-13407. 
8. Spell, M. L.; Deveaux, K.; Bresnahan, C. G.; Bernard, B. L.; Sheffield, W.; Kumar, R.; 
Ragains, J. R., Angew. Chem. Int. Ed., 2016, 55, 6515-6519. 
MeO
S
3.29
 103 
9. Lacey, K. D.; Quarels, R. D.; Du, S.-F.; Fulton, A.; Reid, N. J.; Firesheets, A.; Ragains, J. 
R., Org. Lett., 2018, 20, 5181-5185. 
10. Rösner, C.; Hennecke, U., Org. Lett., 2015, 17, 3226-3229. 
11. Grzywacz, P.; Plum, L. A.; Clagett-Dame, M.; Deluca, H. F., Bioorg. Chem., 2013, 47, 9-
16.  
12. Jana, M.; Mirsa, A. K., J. Org. Chem., 2013, 78, 2680-2686. 
13. Shie, C.-R.; Tzeng, Z.-H.; Kulkarni, S. S.; Uang, B.-J.; Hsu, C.-Y.; Hung, S.-C., Angew. 
Chem. Int. Ed., 2005, 44, 1665–1668.  
14. Zhang, Y.-J.; Dayoub, W.; Chen, G.-R.; Lemaire, M.; Eur. J. Org. Chem., 2012, 2012, 
1960-1996.  
15. Puchner, C.; Eixelsberger, T.; Nidetzky, B.; Brecker, L., Carbohydr. Res., 2017, 437, 50-
58. 
16. Wang, L.-M.; Overkleeft, H. S.; van der Marel, G. A.; Codée, J. D. C., J. Am. Chem. Soc., 
2018, 140, 4632-4638. 
17. Pangborn, A.B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J., 
Organometallics, 1996, 15, 1518. 
18. Christian, R.; Ulrich, H., Org. Lett., 2015, 17, 3226-3229. 
19. Floyd, N.; Vijayakrishnan, B.; Koeppe, J.R.; Davis, B.G., Angew. Chem. Int. Ed., 2009, 48, 
7798-7802. 
20. Lans, G.; Madsen, R., Eur. J. Org. Chem., 2016, 2016, 3119-3125. 
21. Kaeothip, S.; Pornsuriyasak, P.; Demchenko, A. V., Tetrahedron. Lett., 2008, 49, 1542-
1545. 
22. Nokami, T.; Shibuya, A.; Tsuyama, H.; Suga, S.; Bowers, A. A.; Crich, D.; Yoshida, J., J. 
Am. Chem. Soc., 2007, 129, 10922–10928. 
23. Imagawa, H.; Kinoshita, A.; Fukuyama, T.; Yamamoto, H.; Nishizawa, M., Tetrahedron 
Lett., 2006, 47, 4729–4731. 
24. Chen, G.; Yin, Q.; Yin, J.; Gu, X.; Liu, X.; You, O.; Chen, Y.-L.; Xiong, B.; Shen, J., Org. 
Biomol. Chem., 2014, 12, 9781-9785. 
25. Xia, M.-J.; Yao, W.; Meng, X.-B.; Lou, Q.-H.; Li, Z.-J., Tetrahedron. Lett. 2017, 58, 2389-
2392. 
26. He, H.; Zhu, X. Org. Lett., 2014, 16, 3102-3105.  
 104 
27. Shu, P.-H.; Xiao, X.; Zhao, Y.-Q.; Xu, Y.; Yao, W.; Tao, J.-Y.; Wang, H.; Yao, G.-M.; Lu, 
Z.-M.; Zeng, J.; Wan, Q., Angew. Chem. Int. Ed., 2015, 54, 14432-14436. 
28. Shu, P.-H.; Yao, W.; Xiao, X.; Sun, J.-C.; Zhao, X.; Zhao, Y.-Q.; Xu, Y.; Tao, J.-Y.; Yao, 
G.-M.; Zeng, J.; Wan, Q., Org. Chem. Front., 2016, 3, 177-183. 
29. Xiong, D.-C.; Yang, A.-Q.; Yu, Y.; Ye, X.-S., Tetrahedron Lett., 2015, 56, 211-214. 
30. Dara, S.; Saikam, V.; Yadav, M.; Singh, P. P.; Vishwakarma, R. A., Carbohydr. Res., 2014, 
391, 93-96. 
31. Campbell, C. D.; Greenaway, R. L.; Holton, O. T.; Walker, P. R.; Chapman, H. A.; Russell, 
C. A.; Carr, G.; Thomson, A. L.; Anderson, E. A., Eur. J. Org. Chem., 2015, 21, 12627-
12639. 
32. Geurtsen, R; Holmes, D. S.; Boons, G.-J., J. Org. Chem., 1997, 62, 8145-8154. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 105 
CHAPTER 4: STUDIES TOWARD THE TOTAL SYNTHESIS OF AN 
ACINETOBACTER BAUMANNII LIPOOLIGOSACCHARIDE CORE 
PENTASACCHARIDE 
4.1       Introduction 
Acinetobacter baumannii (A. baumannii) is a pathogenic bacteria prone to infecting people 
with poor immune systems, especially ICU patients.1 It can cause wounded skin infections, 
bacteremia, pneumonia, and urinary tract infections.2 It is a non-fermenting, Gram-negative, 
aerobic coccobacillus, which has become increasingly resistant to most antibiotics.3 It has been 
listed as one of the 6 top-priority dangerous microorganisms by the Infectious Disease Society of 
America. Multidrug-resistant strains have made A. baumannii less susceptible to treatment with 
antibiotic therapy. Therefore, developing novel treatments and prevention strategies is of great 
importance.  
Currently, there is no licensed vaccine for the prevention of A. baumannii infections. 
Potential vaccine candidates include outer membrane complexes (OMCs),4 outer membrane 
vesicles (OMVs),3 a whole cell vaccine,5 single outer membrane proteins like OmpA, Ata, and 
Bap,6 and the K1 capsular polysaccharide (K1 CPS).7 Vaccine for mulations with the 
aforementioned antigens have been proven effective to some degree in preventing A. baumannii 
infections in animal models.  
Carbohydrates on the cell surface play a significant role in biological processes. Nearly 
every protein on the cell surface is modified by glycosylation with a complex carbohydrate. 
Studying bacterial cell surface carbohydrates may provide alternative pathways for the prevention 
of bacterial infections. Therefore, development of synthetic carbohydrate vaccines has great 
promise for the prevention of A. baumannii infections. Particularly, vaccines based on bacterial 
lipopolysaccharide (LPS) and lipooligosaccharide (LOS) are attractive. Lipopolysaccharides and 
lipooligosaccharides are highly immunogenic cell-surface antigens found on Gram-negative 
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bacteria. Their use as immunogens in vaccines is precluded, however, due to their toxicity. 
Chemical synthesis of certain portions of these molecules including the so-called core 
oligosaccharides may circumvent this problem by “leaving out” the toxic lipid A portion (Figure 
4.1). As such, conjugation of core oligosaccharides from the A. baumannii lipooligosaccharide is 
a potentially effective and unexplored approach to the development of an A. baumannii vaccine. 
Chemical synthesis of core oligosaccharide also allows control of the structure being recognized 
by immune receptors and enables us to determine whether this could result in a strongly or weakly-
neutralizing antibodies.8 With regard to lipopolysaccharide-based vaccines, Van Boom and 
coworker9 and Boons and coworker10 both demonstrated that synthetic oligosaccharides derived 
from the core LPS oligosaccharide (of Neisseria meningitidis and Francisella tularensis, 
respectively) could be conjugated to protein carrier molecules, As a result, oligosaccharides that 
cannot typically be complexed to major histocompatibility complex II (MHC II) could, in fact, be 
complexed to T cells and triggering of adaptive immunity. This is because oligosaccharide 
generally cannot complex to MHC II whereas peptides and glycopeptides conjugates can. 
 The structure of the LOS of A. baumannii (Figure 4.1) contains a central pentasaccharide, 
a lipid A moiety attached to two 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and a trisaccharide 
which consists of three D-glucoses.11 The central oligosaccharide has a highly complex nature, 
Figure 4.1 LOS Structure of A. baumannii 
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containing five different sugar molecules that include Kdo (A), glucosamine (B), glucose (C), 
galactosamine (D), and N-acetyl glucosaminuronic acid (E, Figure 4.2). The development of our 
proposed LOS-based vaccine conjugate needs well-defined conjugation to carrier molecules for 
immunizations that can prevent infection with A. baumannii. Herein, a chemical synthesis of the 
A. baumannii core pentasaccharide is being developed, and a potentially safe and effective vaccine 
for the prevention of infection by A. baumannii is a long-term goal of this work.   
4.2       Results and Discussion 
Chemical synthesis of the targeted pentasaccharide is challenging due to its highly 
branched structure, and furthermore, the b-glucosamine 4-B (Figure 4.2), a-linked galactosamine 
4-D (Figure 4.2), and a-N-acetyl glucosaminuronic acid 4-E (Figure 4.2) are all difficult to install. 
Moreover, this molecule contains multiple free amino and carboxylic acid groups, which makes 
the synthesis even more difficult. It is also noteworthy that the gluocosaminuronic acid 4-E 
contains three different O-linkages, which need to be differentiated by orthogonal protecting 
groups in the course of the synthesis so that compatible reaction intermediates can be provided. 
Currently, I’m working on the synthesis of a Kdo acceptor, a glucosamine donor, and a 
disaccharide portion of the core pentasaccharide.  
Figure 4.2 Building Blocks for the Synthesis of Core Pentasaccharide 
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 The preparation of Kdo 4-A commenced with D-mannose, which was protected with 2,2-
dimethoxypropane to generate the protected mannose 4.1, which further underwent the Horner-
Wadsworth-Emmons reaction with a phosphonate ester, followed by desilylation resulting in the 
formation of Kdo ethyl ester 4.2.12 The ethyl ester intermediate 4.2 was then treated with 
diethylaminosulfur trifluoride (DAST) to afford the glycosyl fluoride 4.3. O-glycosylation of 4.3 
with benzyl (3-hydroxypropyl) carbamate promoted by BF3•Et2O afforded 4.4 as a single (a) 
diastereomer.11 Selective removal of the C7, C8 acetonide using zinc nitrate in acetonitrile 
generated diol 4.5. The C8 alcohol was then selectively protected with benzyl group in the presence 
of dibutyltin oxide via a stannyl acetal intermediate, followed by treatment with benzyl bromide 
and cesium fluoride to afford the desired C8-benzylated acceptor 4.6.13  
The previously synthesized glucosamine donor 4-B was prepared and utilized for synthesis 
of a disaccharide intermediate (vide infra).14 
With the donor and acceptor in hand, disaccharide synthesis was performed using either 
photo-induced or acid-catalyzed O-glycosylation (Scheme 4.2).14 Somewhat surprisingly, the 
photo reaction gave us the best yield (Scheme 4.2-A). Previous results indicated that the related 
tetra-O-acetyl MBTG donor 4.10 was not reactive in the photo-induced reaction (Scheme 4.2-D). 
Acid-catalyzed glycosylation with MBTG (4.8)/MPTG (4.9) donors afforded lower yield possibly 
because the isopropylidene acetal was reactive under the acidic conditions. Deprotection of 
Scheme 4.1 Synthesis of Kdo 
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disaccharide 4.7 to generate a simplified analog of the target pentasaccharide is currently underway 
in the laboratory (Scheme 4.3). 
4.3       Future Work 
Synthesis of D-galactosamine donor 4-D and N-acetyl-D-glucosaminuronic acid donor 4-
E are currently underway in the laboratory. Conditions for the synthesis of trisaccharide using 
donor 4-E with disaccharide acceptor 4.8 will be explored. Various hydroxyl protecting groups on 
4-E which can be specifically deprotected for later site selective O-glycosylation for the synthesis 
of tetrasaccharide and pentasaccharide are being installed. Conditions for deprotecting the 
Scheme 4.2 Glycosylation of Kdo 4.6 with MBTG/MPTG Donors 
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protected pentasaccharide will be studied. Eventually, this chemically synthesized pentasaccharide 
will be conjugated to carrier molecules and tested in an animal model for immunogenicity. 
4.4       Experimental 
4.4.1    General Methods 
Reagents were purchased from Sigma Aldrich, Alfa Aesar, TCI and used as received. Flash 
column chromatography was performed using 60Å silica gel purchased from Sigma Aldrich. 1H 
NMR and 13C NMR spectroscopy were performed on a Bruker AV-400 or a Bruker AV-500 
spectrometer. Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight mass 
spectrometer. Optical Rotation was obtained from a JASCO P-2000 polarimeter. Analytical and 
preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). Compounds 
were visualized by UV absorption (254 nm) and staining with anisaldehyde. 5 mL Pyrex micro 
reaction vessels (Supelco) were used for the glycosylation reactions. Deuterated solvents were 
obtained from Cambridge Isotope Labs. Solvents included Et2O, DCM, CH3CN, DMF, and THF 
and were used directly from a PureSolv 400-5 solvent system.  Other solvents were used as 
received from a commercial vendor. 
4.4.2    Procedures and Characterizations 
Synthesis of Ethyl ester α-(dimethoxyphosphinyl) glycolate t-Butyldimethylsilyl Ether 4.11 
Ethyl glyoxylate (48 mL of a ~50% solution in toluene, 240 mmol) was heated to reflux, 
maintained at reflux for 1 h, and cooled to rt (18 oC). To a solution of dimethyl phosphite (22 mL, 
240 mmol) in dry toluene (120 mL) was added Et3N (96 mL, 690 mmol) at 0 °C. After 15 min, the 
cooled solution of ethyl glyoxylate was added at 0 °C at once. The mixture was allowed to stir at 
room temperature for 3 h. After TLC showed the reaction was complete, volatiles were removed 
under reduced pressure and the resulting crude mixture was used directly for the next step without 
MeO P
O
MeO
OTBS
CO2Et
H
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further purification. Dry DMF (220 mL) was added to the solution, and imidazole (31.20 g, 458.3 
mmol) mixture, followed by adding TBS-Cl (51.8 g, 344 mmol). After the reaction mixture was 
allowed to stir overnight (12 h). EtOAc (400 mL) was added to dilute the reaction which was then 
washed with 2X500 mL brine. The combined aqueous layer was extracted with 200 mL EtOAc. 
The combined organic layer was then washed with 300 mL sat. aqueous NaHCO3. The organic 
layer was dried over Na2SO4, filtered and concentrated. The residue was purified by silica gel 
column chromatography (0% to 60% EtOAc in Hexanes) to give 39.2 g (50%) product of a 
colorless oil. Spectral data matched that previously reported in the literature.13 
Synthesis of 4.1  
To a solution of D-mannose (14.40 g, 79.93 mol) and TsOH•H2O (921 mg, 4.84 mmol) in 
dry DMF (100 mL) was added 2,2-dimethoxypropane (16 mL, 130 mmol). After 6 h, additional 
2,2-dimethoxypropane (14 mL, 110 mmol) was added and the mixture was allowed to stir at room 
temperature overnight. The solution was diluted with 200 mL EtOAc, and then poured into 200 
mL sat. NaHCO3, and extracted with 100 mL EtOAc twice. The organic layer was dried over 
Na2SO4, filtered, and concentrated in vacuo to give 17.7 g (85%) 4.1 of a white solid which was 
used directly for the next step without further purification.  
Synthesis of 4.2  
To a suspension of tBuOLi (2.502 g, 31.26 mmol) in dry THF (20 mL) was added a solution 
of ethyl ester α-(dimethoxyphosphinyl) glycolate t-butyldimethylsilyl ether 4.11 (9.29 g, 28.5 
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mmol) in dry THF (10 mL). After stirring for 15 min, 4.48 g (17.2 mmol) 4.1 was added at once. 
The mixture was gradually heated to 50 °C and kept stirring for 1 h. After the solution was cooled 
to room temperature, 10 mL of sat. NH4Cl was added to the reaction mixture, followed by adding 
100 mL EtOAc. The organic layers were washed with 50 mL brine twice, and then dried over 
Na2SO4, filtered, and concentrated in vacuo to give a pale-yellow oil. The crude product was used 
immediately for the next step without further purification. 20% AcOH/H2O (36 mL) was added to 
a solution of the crude Horner-Emmons product in THF (30 mL) at 0 °C, followed by the addition 
of 1 M tetrabutylammonium fluoride (TBAF) in THF (27 mL). After 3 h, the mixture was 
neutralized with 200 mL sat. NaHCO3, followed by adding 200 mL EtOAc. The organic layer was 
washed with 100 mL sat. NaHCO3, dried over Na2SO4, filtered, and concentrated in vacuo. The 
residue was purified by silica gel column chromatography (0% to 25% EtOAc in Hexanes) to give 
2.68 g (7.74 mmol) 4.2 (45%, three step yield) as a colourless oil. Spectral data matched that 
previously reported in the literature.13 
Synthesis of 4.3 
A flame-dried round-bottomed flask was charged with 1.73 g (4.99 mmol) Ethyl [3-deoxy-
4,5-7,8-di-O-isopropylidene-a-D-manno-octulopyranosid] onate1 4.2 and 5.0 g activated 4Å MS. 
80 mL DCM was added under N2. The resulting suspension was then cooled to -50 oC, followed 
by adding 800 µL (6 mmol) diethylaminosulfur trifluoride dropwise over a period of 4 min. The 
reaction was then stirred for 15 min at -50 oC. MeOH (1 mL) and sat. NaHCO3 (20 mL) were 
added. The organic layer was dried with Na2SO4, filtered, and concentrated. The resulting crude 
mixture (1.99 g) was purified by chromatography (0% to 20% EtOAc in hexanes) to afford 800.0 
O
OOO
O CO2Et
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mg (2.30 mmol, 46%) 4.3 of a white solid. 1H NMR (400 MHz, CDCl3) d 4.59 – 4.56 (m, 1H), 
4.43 - 4.38 (m, 2H), 4.28 (q, J = 7.1Hz, 2H), 4.17 (dd, J = 9.0, 6.1Hz, 1H), 4.09 (dd, J = 9.0, 3.9Hz, 
1H), 3.69 (dd, J = 8.4, 2.2Hz, 1H), 3.07 (dd, J = 15.5, 3.6Hz, 1H), 2.03 – 1.94 (m, 1H), 1.45 (s, 
3H), 1.41 (s, 3H), 1.39 (s, 3H), 1.34 (s, 3H), 1.35 – 1.31 (m, 3H).  13C NMR (126 MHz, CDCl3) d 
170.5, 170.1, 169.32, 169.30, 133.1, 117.5, 83.62, 75.87, 73.81, 69.80, 68.27, 62.11, 39.89, 28.60, 
27.74, 20.68, 20.65, 20.54, 20.52.  HRMS (m/z): [M+Na]+ Calcd. for C16H25O7FNa 371.1477, 
found 371.1486 
Synthesis of 4.4 
A flame-dried round-bottomed flask was charged with 130.8 mg (0.3755 mmol) 4.3, 156.8 
mg (0.749 mmol) N-benzyloxycarbonyl-3-amino-propanol and 200 mg activated 4Å MS. 4 mL 
DCM was added under N2. The resulting suspension was then cooled to 0 oC, followed by adding 
50 µL (0.41 mmol) BF3•Et2O at once. The reaction was then stirred for 1 h at 0 oC before 0.1 mL 
Et3N was added to quench the reaction. The resulting mixture was concentrated. The resulting 
crude mixture (0.99 g) was purified by chromatography (0% to 25% EtOAc in hexanes) to afford 
157.0 mg (0.2920 mmol, 78%) 4.4 of a colorless oil. 1H NMR (500 MHz, CDCl3) d 7.35 – 7.29 
(m, 5H), 5.25 (t, J = 5.7Hz, 1H), 5.09 (s, 2H), 4.49 – 4.46 (m, 1H), 4.35 (q, J = 6.1Hz, 1H), 4.27 
– 4.17 (m, 3H), 4.14 – 4.10 (m, 1H), 4.03 (dd, J = 8.8, 5.4Hz, 1H), 3.77 – 3.73 (m, 1H), 3.63 (dd, 
J = 6.7, 1.9Hz, 1H), 3.31 – 3.21 (m, 3H), 2.76 (dd, J = 15.6, 3.9Hz, 1H), 1.82 (dd, J = 15.5, 3.0Hz, 
1H), 1.77 – 1.67 (m, 2H), 1.42 (s, 3H), 1.40 (s, 3H), 1.35 (s, 3H), 1.30 (s, 3H), 1.28 – 1.24 (m, 3H).  
13C NMR (126 MHz, CDCl3) d 168.7, 156.4, 136.7, 128.5, 128.1, 128.0, 109.6, 109.0, 97.40, 
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74.29, 72.04, 71.06, 70.13, 66.57, 66.51, 61.65, 60.57, 38.36, 32.94, 29.33, 26.70, 25.56, 25.45, 
24.95, 14.14.  HRMS (m/z): [M+H]+ Calcd. for C27H40O10N 538.2647, found 538.2646.   
Synthesis of 4.5 
270.0 mg (0.5022 mmol) 4.4 was dissolved in 5 mL CH3CN, followed by adding 500.0 mg 
(1.681 mmol) Zn(NO3)2•6H2O. The resulting suspension was then heated to 50 oC. The reaction 
was then stirred for 30 min at 50 oC. The reaction was concentrated. The resulting crude mixture 
(1.02 g) was purified by chromatography (0% to 5% MeOH in DCM) to afford 124.9mg (0.2510 
mmol, 50%) colorless oil. 1H NMR (400 MHz, CDCl3) d 7.37 – 7.31 (m, 5H), 5.47 (s, 1H), 5.10 
(s, 2H), 4.51 – 4.47 (m, 1H), 4.32 (d, J = 7.6Hz, 1H), 4.29 – 4.19 (m, 2H), 4.02 – 4.00 (m, 1H), 
3.94 (d, J =  10.7Hz, 1H), 3.85 – 3.78 (m, 2H), 3.74 – 3.69 (m, 1H), 3.65 (s, 1H), 3.34 – 3.21 (m, 
3H), 2.70 (dd, J = 15.4, 4.4Hz, 1H), 1.86 (dd, J = 15.6, 3.2Hz, 1H), 1.76 (s, 1H), 1.43 (s, 3H), 1.32 
(s, 3H), 1.29 – 1.26 (m, 3H). HRMS (m/z): [M+H]+ Calcd. for C24H36O10N 498.2334, found 
498.2337.   
Synthesis of 4.6 
110 mg (0.22 mmol) 4.5 was dissolved in 3 mL dry toluene in a flame-dried RBF, followed 
by adding 88.0 mg (0.353 mmol) dibutyltin oxide. The resulting suspension was then heated to 
reflux. The reaction was then refluxed for 3 h, cooled to rt, and about half of the toluene was 
evaporated. Benzyl bromide (40 µL, 0.3 mmol), cesium fluoride (50.1 mg, 0.330 mmol), and 1.5 
mL CH3CN were added to the reaction. The resulting mixture was heated to 70 oC overnight (12 
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h). The resulting suspension was filtered through a celite cake, washed with 10 mL CH3CN, and 
concentrated. The crude mixture (400 mg) was purified by chromatography (0% to 50% EtOAc in 
hexanes) to afford 75mg (59%) white foam. 1H NMR (500 MHz, CDCl3) d 7.35 – 7.28 (m, 10H), 
5.16 (t, J = 6.3Hz, 1H), 5.08 (s, 2H), 4.56 (s, 2H), 4.48 – 4.45 (m, 1H), 4.34 (dd, J = 7.4, 2.1Hz, 
1H), 4.26 – 4.11 (m, 3H), 3.78 – 3.69 (m, 3H), 3.61 – 3.58 (m, 1H), 3.23 – 3.17 (m, 3H), 2.63 – 
2.59 (m, 2H), 1.86 (dd, J = 15.1, 3.4Hz, 1H), 1.68 – 1.64 (m, 2H), 1.42 (s, 3H), 1.31 (s, 3H), 1.29 
– 1.24 (m, 3H).  13C NMR (126 MHz, CDCl3) d 168.7, 156.4, 137.8, 136.7, 128.5, 128.4, 128.1, 
128.0, 127.8, 109.5, 97.70, 73.59, 71.87, 71.04, 70.08, 69.14, 66.49, 61.67, 60.75, 38.36, 33.22, 
29.14, 26.00, 25.22, 14.14. HRMS (m/z): [M+H]+ Calcd. for C31H42O10N 588.2803, found 
588.2805.   
Synthesis of 4.7 
A flame-dried 5 mL Pyrex reactor vial was charged with the MBTG donor (81.3 mg, 0.124 
mmol), Umemoto’s reagent (54.0 mg, 0.134 mmol), glycosyl acceptor 4.7 (36.0 mg, 0.0613 mmol), 
150 mg of freshly activated powdered 4 Å molecular sieves and 1 mL of dry dichloromethane 
under nitrogen atmosphere. The reactor vial was placed 1-2 cm away from a blue LEDs strip and 
irradiated from the side for 24 hours. The reaction maintained a temperature of ~ 28 oC due to 
adventitious heating from the light source. The reaction mixture was then filtered to remove 
molecular sieves, washed with 5 mL DCM, and the crude products were concentrated and then 
purified by gradient silica gel chromatography to afford disaccharide 4.7 (34.7 mg, 0.0330 mmol, 
54%). 1H NMR (400 MHz, CDCl3) d 7.38 – 7.27 (m, 10H), 5.53 (s, 1H), 5.21 (s, 1H), 5.15 – 5.02 
(m, 4H),  4.85 (d, J = 8.5Hz, 1H), 4.76 (dd, J = 9.8, 3.1Hz, 1H), 4.70 – 4.60 (m, 3H), 4.50 (d, J = 
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11.6 Hz, 1H), 4.42 – 4.39 (m, 1H), 4.32 (dd, J = 7.4, 1.8Hz, 1H), 4.27 – 4.08 (m, 6H), 3.96 (d, J = 
10.5Hz, 1H), 3.78 – 3.55 (m, 6H), 3.23 – 3.16 (m, 3H), 2.55 (dd, J = 15.2, 4.4Hz, 1H), 2.05 (s, 
3H), 2.00 (s, 3H), 1.98 (s, 3H), 1.35 (s, 3H), 1.25 (s, 3H), 1.30 – 1.21 (m, 3H).  13C NMR (100 
MHz, CDCl3) d 170.5, 170.3, 169.4, 168.5, 156.4, 154.4, 137.8, 136.7, 128.6, 128.5, 128.40, 
128.36, 127.98, 127.93, 127.88, 127.86, 109.0, 97.65, 95.53, 74.33, 73.48, 72.60, 71.81, 71.22, 
69.94, 68.55, 66.39, 61.97, 61.65, 61.53, 60.91, 56.32, 38.46, 33.05, 29.11, 26.52, 25.74, 24.79, 
20.64, 20.56, 20.53, 14.04.  HRMS (m/z): [M+Na]+ Calcd. for C46H59O19Cl3N2Na 1071.2670, 
found 1071.2684.   
Synthesis of 4.8 
 
A 25 mL round-bottomed flask was charged with a solution of 68.2 mg (0.0649 mmol) 4.7 in 5 
mL MeOH, followed by adding 25 µL (0.33 mmol) trifluoroacetic acid at room temperature (20 
oC). The reaction was stirred for 2 h at 20 oC and concentrated under vacuum. The crude mixture 
was purified by column chromatography to afford 33.4 mg (0.0331 mmol, 51%) 4.8 as a white 
foam. 1H NMR (400 MHz, CDCl3) d 7.40 – 7.31 (m, 10H), 5.32 (brs, 1H), 5.13 – 5.05 (m, 2H), 
5.10 (s, 2H), 5.00 (t, J = 9.6Hz, 1H), 4.81 (d, J = 8.5Hz, 1H), 4.72 (d, J = 12.0Hz, 1H), 4.64 – 4.50 
(m, 3H), 4.33 (d, J = 12.7Hz, 1H), 4.25 – 4.20 (m, 3H), 4.07 – 3.98 (m, 3H), 3.86 (d, J = 10.2Hz, 
1H), 3.76 – 3.62 (m, 3H), 3.52 (d, J = 9.5Hz, 1H), 3.38 – 3.36 (m, 1H), 3.30 – 3.24 (m, 3H), 2.11 
(s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.85 (t, J = 12.1Hz, 1H), 1.69 (m, 2H), 1.26 (t, J = 7.1Hz, 3H). 
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APPENDIX B. NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 1 
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APPENDIX C. NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 2
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APPENDIX D. NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 3
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APPENDIX E. NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 4 
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